Varicose veins

I9_VARICVE

No definition available.

Endpoint definition

↥

Endpoint definition steps	FinnGen
Phenotype data	520210
1. Apply sex-specific rule None	520210
2. Check conditions None	520210
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — I83 Hospital discharge: ICD-9 — 454 Hospital discharge: ICD-8 — 454 Cause of death: ICD-10 — I83 Cause of death: ICD-9 — 454 Cause of death: ICD-8 — 454 2 out of 7 registries used, show all original rules.	39406
4. Check minimum number of events None	39406
5. Include endpoints None	39406
6. Filter based on genotype QC (FinnGen only)	39406

Control definitions (FinnGen only)

Control exclude: I9_DISVEINLYMPH

Extra metadata

Level in the ICD hierarchy: 3
First used in FinnGen datafreeze: DF2
Parent code in ICD-10: I80-I89
Name in latin: Varices membrorum inferiorum

NAME	I9_VARICVE
CONTROL_EXCLUDE	I9_DISVEINLYMPH
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	I83
HD_ICD_9	454
HD_ICD_8	454
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	I83
COD_ICD_9	454
COD_ICD_8	454
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Varicose veins based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	363367	277729	83293
Only index persons	301989	235312	66677
Unadjusted period prevalence (%)
Whole population	6.63	7.95	2.33
Only index persons	7.30	8.65	2.55
Median age at first event (years)
Whole population	47.94	46.71	51.83
Only index persons	46.04	44.90	50.03

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	39406	29234	10172
Unadjusted period prevalence (%)	8.55	9.96	4.48
Median age at first event (years)	44.40	42.12	50.93

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
21524: Matched controls
187598

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

PHL99

NOMESCO Finland

Ultrasound guided foam sclerotherapy of other vein

866.6

323.0

391

PH2DE

NOMESCO Finland

Ultrasound examination of bloodflow in veins of lower extremity with Doppler method

63.1

323.0

1618

241

5611

FHL

Vena saphena Magna and / or swarm of nodule and possible local emissions

3364.0

323.0

4210

I83.1

ICD-10 Finland

Varicose veins of lower extremities with inflammation

114.7

323.0

1963

164

TPH10

NOMESCO Finland

Sclerotherapy of varicose veins

425.1

323.0

432

PHD77

NOMESCO Finland

Resection of short saphenous vein

6761.2

323.0

758

45499

ICD-8 Finland

Varicose veins of lower extremities, Other and unspecified, without ulcer

+∞

323.0

3747

I80.0

ICD-10 Finland

Phlebitis and thrombophlebitis of superficial vessels of lower extremities

27.2

323.0

1497

514

4549X

ICD-9 Finland

Varicose veins of lower extremities, Without mention of ulcer or inflammation

+∞

323.0

5045

K95

ICPC

Varicose veins of leg

19.0

323.0

586

276

PHT99

NOMESCO Finland

Injection of therapeutic or sclerosing agent into other vein

295.0

323.0

500

I80.29

ICD-10 Finland

Phlebitis and thrombophlebitis of other deep vessels of lower extremities

16.0

323.0

567

316

I83.9

ICD-10 Finland

Varicose veins of lower extremities without ulcer or inflammation

436.7

323.0

13585

732

PHD99

NOMESCO Finland

Resection of other vein

4204.2

323.0

7401

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

5.2

323.0

3548

6839

PHD76

NOMESCO Finland

Resection of long saphenous vein

8555.2

323.0

6380

I83.0

ICD-10 Finland

Varicose veins of lower extremities with ulcer

91.8

323.0

1752

181

PHM99

NOMESCO Finland

Endovenous obliteration of other vein

3212.7

323.0

1417

PG1DE

NOMESCO Finland

Other extensive ultrasound examination of artery

7.0

323.0

1363

1795

PHM77

NOMESCO Finland

Endovenous obliteration of v.saphena parva

5600.0

323.0

633

B01AB05

ATC

enoxaparin; parenteral

1.9

323.0

6131

32017

I83

ICD-10 Finland

Varicose veins of lower extremities

16.2

323.0

979

549

PHM76

NOMESCO Finland

Endovenous obliteration of v.saphena magna

4717.6

323.0

2454

I83.2

ICD-10 Finland

Varicose veins of lower extremities with both ulcer and inflammation

86.6

323.0

438

PHD78

NOMESCO Finland

Resection of communicating veins of lower leg and thigh

2640.8

323.0

607

PHD79

NOMESCO Finland

1771.3

323.0

416

5612

FHL

Local excisions and / or perforations of relapsing varicose veins

+∞

323.0

1068

I87.2

ICD-10 Finland

Venous insufficiency (chronic)(peripheral)

34.3

323.0

5492

1855

PHL76

NOMESCO Finland

Ultrasound guided foam sclerotherapy of long saphenous vein

+∞

323.0

370

PHB78

NOMESCO Finland

Ligature of perforating veins of lower extremity

+∞

323.0

363

PHM79

NOMESCO Finland

Endovenous obliteration of v.saphena anterior

+∞

292.1

295

PHB76

NOMESCO Finland

Ligature of long saphenous vein

+∞

273.2

276

I80.3

ICD-10 Finland

Phlebitis and thrombophlebitis of lower extremities, unspecified

5.0

254.1

884

1587

5619

FHL

Other measure in this category

386.4

249.9

264

5613

FHL

Conjunctival occlusion

314.1

235.6

251

PHG76

NOMESCO Finland

Intraluminal laser vein occlusion of long saphenous vein

+∞

227.6

230

65000

ICD-8 Finland

Delivery without mention of complication, Occipital presentation

1.8

211.0

4941

27165

A46

ICD-10 Finland

Erysipelas

2.1

208.8

2826

12744

I80.1

ICD-10 Finland

Phlebitis and thrombophlebitis of femoral vein

38.6

199.9

267

I82.9

ICD-10 Finland

Embolism and thrombosis of unspecified vein

15.7

196.4

340

191

S97

ICPC

Chronic ulcer skin

3.0

187.5

1181

3535

M79.6

ICD-10 Finland

Pain in limb

1.6

180.9

6551

40367

I80.9

ICD-10 Finland

Phlebitis and thrombophlebitis of unspecified site

21.3

177.5

276

114

PHB99

NOMESCO Finland

Ligature of other vein

168.8

174.0

192

M17.1

ICD-10 Finland

Other primary gonarthrosis

1.8

171.9

3911

21107

N02BE01

ATC

paracetamol; systemic, rectal

1.6

168.8

17234

133880

4540A

ICD-9 Finland

Varicose veins of lower extremities, With ulcer

+∞

167.1

169

ZXA10

NOMESCO Finland

Bilateral

1.8

164.3

3406

17817

4511A

ICD-9 Finland

Phlebitis and thrombophlebitis, Of deep vessels of lower extremities

+∞

164.1

166

L97

ICD-10 Finland

Ulcer of lower limb, not elsewhere classified

3.5

158.3

796

2013

I82.88

ICD-10 Finland

Embolism and thrombosis of other specified veins

18.2

156.3

256

124

B01AA03

ATC

warfarin; systemic

1.7

148.8

3594

19642

45400

ICD-8 Finland

Varicose veins of lower extremities, With ulcer

+∞

146.3

148

K94

ICPC

Phlebitis/thrombophlebitis

8.1

145.2

348

379

I80.8

ICD-10 Finland

Phlebitis and thrombophlebitis of other sites

21.5

143.2

222

XPX99

NOMESCO Finland

Other diagnostic examination of periferal vessel

2.4

141.8

1353

5146

QDB10

NOMESCO Finland

Major dressing of wound of skin of lower limb

2.7

138.4

1027

3398

SPAT1148

SPAT

Treatment of chronic ulcer or burn

1.8

133.4

2435

12136

G03CA03

ATC

estradiol; nasal, systemic, rectal, transdermal, vaginal

1.5

132.8

7008

46250

J01DB01

ATC

cefalexin; oral

1.5

132.6

16016

124257

R60.0

ICD-10 Finland

Localized oedema

2.0

124.6

1846

8515

S18

ICPC

Laceration/cut

1.4

122.1

7485

50674

ZXA05

NOMESCO Finland

Left side

1.5

121.1

4633

28370

M17.0

ICD-10 Finland

Primary gonarthrosis, bilateral

1.8

116.5

2305

11762

I87.0

ICD-10 Finland

Postthrombotic syndrome

520.0

113.9

119

E0000UV

ATC

1.4

113.3

6959

46941

ZXA00

NOMESCO Finland

Right side

1.5

109.8

4874

30738

M01AX05

ATC

glucosamine; oral

1.6

108.0

3229

18539

L17

ICPC

Foot/toe symptom/complaint

1.5

107.8

4185

25605

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.4

104.8

8561

60548

I80

ICD-10 Finland

Phlebitis and thrombophlebitis

8.2

103.3

245

263

J01DA01

ATC

[U] cefalexin; systemic

1.4

102.0

12251

92238

D07AC01

ATC

betamethasone; topical

1.4

101.8

6300

42338

SPAT1263

SPAT

Sampling

1.4

98.8

7283

50439

C03CA01

ATC

furosemide; systemic

1.5

97.8

4854

31206

L98.4

ICD-10 Finland

Chronic ulcer of skin, not elsewhere classified

3.9

96.4

428

973

L14

ICPC

Leg/thigh symptom/complaint

2.1

94.7

1182

5069

V252A

ICD-9 Finland

Contraceptive management, Sterilisation

1.8

94.3

1763

8795

379

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the long-term prevention of recurrent deep veinthrombosis and pulmonary embolism

4.8

93.0

329

600

J01FF01

ATC

clindamycin; systemic

1.4

91.6

4918

32037

N02AX02

ATC

tramadol; systemic, rectal

1.3

85.4

7807

55638

B01AF01

ATC

rivaroxaban; oral

1.7

85.2

1826

9497

WX320

NOMESCO Finland

Spinalanesthesy

1.5

84.8

3872

24361

6500B

ICD-9 Finland

Delivery in a completely normal case[PARTUS SINE COMPLICATIONE]

1.4

84.6

4265

27372

NGB20

NOMESCO Finland

Primary total prosthetic replacement of knee joint without patellar part

1.8

84.3

1587

7923

PHL77

NOMESCO Finland

Ultrasound guided foam sclerotherapy of short saphenous vein

+∞

83.0

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

1.4

81.9

4785

31552

SPAT1153

SPAT

Removal of sutures

1.4

81.7

5547

37563

L15

ICPC

Knee symptom/complaint

1.5

80.7

3270

20032

M01AH05

ATC

etoricoxib; oral

1.3

79.7

11136

84228

28920

ICD-8 Finland

Other disease of blood and blood-forming organs, Nonspecific mesenteric lymphadenitis

+∞

78.1

M17.9

ICD-10 Finland

Gonarthrosis, unspecified

1.7

75.9

1789

9557

D09AB01

ATC

zinc bandage without supplements; topical

3.2

74.1

417

1148

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

1.5

73.9

2733

16376

M01AC06

ATC

meloxicam; systemic, rectal

1.3

72.9

6698

47439

K07

ICPC

Swollen ankles/oedema

2.5

72.2

632

2287

NG1AA

NOMESCO Finland

Knee X-ray examination without contrast

1.7

71.8

1790

9712

K06

ICPC

Prominent veins

20.0

71.2

112

SAA02

NOMESCO Finland

Basic examination of mouth

1.3

70.4

11145

85087

PHK76

NOMESCO Finland

Endovenous radiotherapy of long saphenous vein

+∞

69.2

ZXC20

NOMESCO Finland

Use of chemical agents

3.2

69.0

398

1114

L30.9

ICD-10 Finland

Dermatitis, unspecified

1.5

68.7

2853

17506

A08

ICPC

Swelling

2.4

68.4

631

2348

D07AC13

ATC

mometasone; topical

1.4

68.0

5119

35058

M01AE01

ATC

ibuprofen; systemic, rectal

1.4

67.9

17638

144010

PHM78

NOMESCO Finland

Endovenous obliteration of perforating veins of lower extremity

593.2

65.4

SPAT1324

SPAT

Screening procedure

1.4

64.9

3807

24960

M01AE03

ATC

ketoprofen; systemic, rectal

1.3

64.5

6906

49775

PHB77

NOMESCO Finland

Ligature of short saphenous vein

+∞

64.2

WX110

NOMESCO Finland

Local anesthesy

1.3

64.1

12382

96441

SAA01

NOMESCO Finland

Simple examination of mouth

1.3

63.8

12649

98819

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.4

63.4

4855

33269

E000001

ATC

1.4

63.4

3375

21726

J01AA02

ATC

doxycycline; systemic

1.3

63.3

15399

123530

SFA20

NOMESCO Finland

Filling on two surfaces of tooth

1.3

63.3

10214

77687

ZXC35

NOMESCO Finland

Use of radio waves

16.8

61.2

102

SPAT1229

SPAT

Assessment of need for aid

1.8

60.8

1211

6136

J01CA08

ATC

pivmecillinam; oral

1.3

60.5

5973

42464

M25.5

ICD-10 Finland

Pain in joint

1.3

60.3

4760

32731

M54.5

ICD-10 Finland

Low back pain

1.3

60.1

5342

37396

K02.1

ICD-10 Finland

Caries of dentine

1.3

59.9

9759

74102

SPAT1156

SPAT

Guidance concerning treatment of rash and skin

1.5

59.5

2032

11914

SFA10

NOMESCO Finland

Fillning on one surface of tooth

1.3

58.6

9126

68836

M23.2

ICD-10 Finland

Derangement of meniscus due to old tear or injury

1.5

58.5

1946

11336

I85.9

ICD-10 Finland

Oesophageal varices without bleeding

183.5

57.7

EB1AA

NOMESCO Finland

Tooth X-ray examination

1.3

57.0

9833

75009

N81.6

ICD-10 Finland

Rectocele

1.9

56.9

919

4340

M01AB05

ATC

diclofenac; systemic, rectal

1.3

56.5

12649

99508

SPAT1249

SPAT

Treatment-related counselling outside office

1.3

56.4

6442

46624

PHG77

NOMESCO Finland

Intraluminal laser vein occlusion of short saphenous vein

+∞

56.3

TQW80

NOMESCO Finland

Local dermatologic skincare

2.5

56.0

473

1681

SPAT1149

SPAT

Suture or treatment of traumatic wound

1.5

55.9

2009

11904

J01CE08

ATC

benzathine benzylpenicillin; parenteral

4.2

55.7

226

476

A02BC02

ATC

pantoprazole; systemic

1.3

55.1

11943

93443

1412

FHL

Laparoscopy and sterilization

1.7

55.1

1182

6125

S81.8

ICD-10 Finland

Open wound of other parts of lower leg

2.4

54.6

476

1721

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

1.3

53.7

8399

63140

SPAT1211

SPAT

Application of soft bandage

1.6

52.9

1340

7278

J01CA04

ATC

amoxicillin; systemic

1.3

52.6

15015

121031

R06.0

ICD-10 Finland

Dyspnoea

1.3

52.5

3869

26231

J01DA09

ATC

[U] cefadroxil; inhalant, oral

1.3

52.3

4783

33489

GD1AA

NOMESCO Finland

Thorax X-ray examination

1.3

52.1

7228

53486

M01AX17

ATC

nimesulide; oral

1.3

51.3

4178

28747

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.3

51.1

6582

48229

SPAT1301

SPAT

No procedures

1.3

51.0

4971

35096

I89.0

ICD-10 Finland

Lymphoedema, not elsewhere classified

10.1

50.9

106

I26.9

ICD-10 Finland

Pulmonary embolism without mention of acute cor pulmonale

1.9

50.8

759

3483

N81.1

ICD-10 Finland

Cystocele

1.9

50.7

813

3831

M70.6

ICD-10 Finland

Trochanteric bursitis

1.5

50.6

1722

10065

I87.9

ICD-10 Finland

Disorder of vein, unspecified

14.5

50.0

J02AC01

ATC

fluconazole; systemic

1.3

49.9

7007

51848

I80.20

ICD-10 Finland

Phlebitis and thrombophlebitis in the iliac vein

84.5

49.7

D07BC01

ATC

betamethasone and antiseptics; topical

1.5

49.2

2041

12458

M03BX02

ATC

tizanidine; oral

1.2

48.6

11445

89752

SPAT1256

SPAT

Intramuscular and subcutaneous injection

1.3

48.5

6882

50940

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.3

48.4

5714

41335

45100

ICD-8 Finland

Phlebitis and thrombophlebitis, Of lower extremities

5.2

48.0

157

265

ZXC10

NOMESCO Finland

Use of laser

2.5

47.9

396

1392

Z01.2

ICD-10 Finland

Dental examination

1.3

46.8

6679

49411

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

1.5

46.6

1748

10435

D01BA02

ATC

terbinafine; oral; topical

1.3

46.1

4276

29910

QXB99

NOMESCO Finland

Other procedure to treat skin wound, unspecified location

2.9

46.1

293

880

M20.1

ICD-10 Finland

Hallux valgus (acquired)

1.6

45.7

1206

6617

E66.01

ICD-10 Finland

Obesity due to excess calories

1.6

45.5

1224

6750

M17

ICD-10 Finland

Gonarthrosis [arthrosis of knee]

1.5

45.3

1520

8850

B01AB10

ATC

tinzaparin; parenteral

1.7

45.2

1031

5434

NGD05

NOMESCO Finland

Partial excision of meniscus of knee, arthroscopic

1.5

45.0

1894

11584

L13

ICPC

Hip symptom/complaint

1.4

45.0

2226

14055

SPAT1310

SPAT

Counselling related to known health issue

1.3

44.9

4965

35550

B01AB04

ATC

dalteparin; parenteral

1.9

44.4

700

3275

N02AA05

ATC

oxycodone; systemic

1.4

44.2

2182

13767

D07AB08

ATC

desonide; topical

1.5

44.2

1629

9686

S76

ICPC

Skin infection other

1.8

44.1

744

3567

QDG20

NOMESCO Finland

Operation for chronic ulcer or fistula of skin of lower limb

3.6

44.1

207

498

O22.0

ICD-10 Finland

Varicose veins of lower extremity in pregnancy

21.7

44.0

NJ2MA

NOMESCO Finland

Measurement of mechanical axis of lower leg with X-ray

1.7

43.9

960

4995

UJF32

NOMESCO Finland

Coloscopy

1.3

43.7

4202

29511

NGF25

NOMESCO Finland

Operation for osteochondritis of knee, arthroscopic

1.7

43.6

1064

5713

N03AX16

ATC

pregabalin; oral

1.3

43.5

3825

26526

N02AJ06

ATC

codeine and paracetamol; systemic

1.3

43.4

6084

44817

S29

ICPC

Skin symptom/complaint other

1.4

43.2

2429

15690

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

1.3

42.6

3332

22706

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.3

42.5

4903

35249

L90

ICPC

Osteoarthrosis of knee

1.7

42.4

856

4352

M75.1

ICD-10 Finland

Rotator cuff syndrome

1.3

42.0

3965

27751

I48

ICD-10 Finland

Atrial fibrillation and flutter

1.3

41.6

3489

24011

SFA30

NOMESCO Finland

Filling on tree or more surfaces of tooth

1.2

41.1

7152

53900

8221

FHL

Sterilization of the laparotomy pathway

1.9

41.0

606

2771

J01CE02

ATC

phenoxymethylpenicillin; oral

1.2

41.0

12347

98485

M02AA07

ATC

piroxicam; topical

1.2

40.9

6159

45673

Z09.0

ICD-10 Finland

Follow-up examination after surgery for other conditions

1.6

40.7

1211

6850

M01AE02

ATC

naproxen; oral, rectal

1.2

40.0

10002

78210

R60.9

ICD-10 Finland

Oedema, unspecified

1.9

39.8

663

3164

KMAK

NOMESCO Finland

1.2

39.8

8854

68410

L16

ICPC

Ankle symptom/complaint

1.5

39.7

1380

8090

M01AH01

ATC

celecoxib; oral (coxibs)

1.3

39.5

2920

19707

N03AX12

ATC

gabapentin; oral

1.4

39.4

2387

15603

M19.0

ICD-10 Finland

Primary arthrosis of other joints

1.5

39.3

1479

8828

M20.4

ICD-10 Finland

Other hammer toe(s) (acquired)

2.0

39.2

539

2398

D07BB04

ATC

hydrocortisone butyrate and antiseptics; topical

1.4

39.1

1956

12354

SDA02

NOMESCO Finland

Parodonthologic therapy

1.3

38.9

5225

38190

WX002

NOMESCO Finland

Sedation and analgesia

1.3

38.7

2965

20111

D07AB02

ATC

hydrocortisone butyrate; topical

1.3

38.5

4576

32944

I86.2

ICD-10 Finland

Pelvic varices

+∞

38.5

E000006

ATC

1.6

38.4

1058

5863

EB1SA

NOMESCO Finland

Dental X-ray, bite-wing X-ray on one side of the mouth

1.2

37.8

7838

60022

SPAT1255

SPAT

Intravenous administration of medicine

1.6

37.6

995

5458

4538X

ICD-9 Finland

Other venous embolism and thrombosis, Of other specified veins

+∞

37.5

SPAT1260

SPAT

Consultation of another employee

1.3

37.5

2594

17311

Z87.1

ICD-10 Finland

Personal history of diseases of the digestive system

1.2

37.1

7662

58614

G03DC02

ATC

norethisterone; oral

1.4

36.8

1799

11310

M23.9

ICD-10 Finland

Internal derangement of knee, unspecified

1.5

36.7

1284

7536

SPAT1254

SPAT

Administration of medicine

1.4

36.7

1987

12728

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.2

36.6

8749

67874

J01MA02

ATC

ciprofloxacin; systemic

1.2

36.0

6729

50907

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

1.4

35.7

1624

10069

I86.1

ICD-10 Finland

Scrotal varices

8.3

34.8

PH6GT

NOMESCO Finland

Endovascular embolisation of ovarian vein with radiological guidance

+∞

34.6

B01AF02

ATC

apixaban; oral

1.5

34.5

1214

7132

PG9AC

NOMESCO Finland

Arteriography with X-ray not elsewhere classified

4.8

34.1

118

214

K43.9

ICD-10 Finland

Other and unspecified ventral hernia without obstruction or gangrene

1.7

33.9

679

3443

J01MA12

ATC

levofloxacin; systemic

1.3

33.6

3028

20983

L03

ICPC

Low back symptom/complaint

1.3

33.6

3425

24128

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

1.5

33.2

1066

6134

SFC01

NOMESCO Finland

Adjuvant procedure of filling therapy

1.2

33.0

4381

31866

SPAT1312

SPAT

General health counselling

1.2

33.0

4714

34578

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1.5

33.0

1157

6792

J01.0

ICD-10 Finland

Acute maxillary sinusitis

1.3

33.0

3230

22629

L28

ICPC

Limited function/disability (L)

1.4

32.9

2131

14055

E66.8

ICD-10 Finland

Other obesity

1.6

32.8

823

4454

ZXC08

NOMESCO Finland

Other ablative laser

+∞

32.6

QDB05

NOMESCO Finland

Revision of wound of skin of lower limb

2.2

32.5

362

1479

J01EA01

ATC

trimethoprim; systemic

1.3

32.4

3771

26995

M16.0

ICD-10 Finland

Primary coxarthrosis, bilateral

1.6

32.4

939

5274

N81.2

ICD-10 Finland

Incomplete uterovaginal prolapse

1.8

32.1

625

3142

NH3AA

NOMESCO Finland

Foot and toes X-ray examination

1.5

31.9

1220

7298

A98

ICPC

Health maint/preventive medicine

1.3

31.9

18911

159194

M09AX01

ATC

hyaluronic acid; parenteral

1.7

31.9

658

3368

SAA03

NOMESCO Finland

Extended examination of mouth

1.2

31.7

6055

45758

SPAT1144

SPAT

Treatment of reopened or infected surgical wound

1.5

31.7

1057

6137

45309

ICD-8 Finland

Other venous embolism and thrombosis, NUD (cerebri, cordis, mesenterii, pulmonis exceptis)

+∞

31.6

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

1.2

31.2

6381

48532

K57.3

ICD-10 Finland

Diverticular disease of large intestine without perforation or abscess

1.3

31.2

2525

17223

TQX10

NOMESCO Finland

Biopsy of skin and subcutaneous tissue

1.4

30.9

1395

8630

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

1.3

30.8

2649

18222

H02AB06

ATC

prednisolone; systemic

1.2

30.7

8152

63501

A02BC05

ATC

esomeprazole; systemic

1.2

30.7

6902

52952

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

1.2

30.6

4566

33607

SPAT1097

SPAT

Recording of ECG

1.3

30.5

2154

14395

A06AC01

ATC

ispaghula (psylla seeds); oral

1.3

30.3

3674

26404

H03AA01

ATC

levothyroxine sodium; systemic

1.3

30.2

3541

25348

M21.4

ICD-10 Finland

Flat foot [pes planus] (acquired)

2.0

30.1

416

1857

ZZA00

NOMESCO Finland

Split skin graft

1.9

29.9

425

1918

LEF03

NOMESCO Finland

Posterior colporrpahy with sutures for primary rectocele

1.9

29.9

483

2283

LX1AE

NOMESCO Finland

Gynecological ultrasound examination as part of clinical examination

1.5

29.8

1249

7615

I50.9

ICD-10 Finland

Heart failure, unspecified

1.4

29.6

1895

12466

M16.1

ICD-10 Finland

Other primary coxarthrosis

1.4

29.5

1578

10072

D03BA52

ATC

collagenase, combinations; topical

4.0

29.4

123

270

D07AD01

ATC

clobetasol; topical

1.3

29.4

2416

16504

Z00.0

ICD-10 Finland

General medical examination

1.3

29.3

2681

18587

SPAT1216

SPAT

Assessment of functional ability

1.3

29.3

2066

13802

S06

ICPC

Rash localized

1.6

29.1

723

3901

M51.3

ICD-10 Finland

Other specified intervertebral disc degeneration

1.4

28.8

1233

7549

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

1.2

28.7

6504

49854

45610

ICD-8 Finland

Varicose veins of other sites, Of scrotum

+∞

28.6

D68.8

ICD-10 Finland

Other specified coagulation defects

3.5

28.6

138

343

T81.0

ICD-10 Finland

Haemorrhage and haematoma complicating a procedure, not elsewhere classified

1.5

28.2

963

5620

L08

ICPC

Shoulder symptom/complaint

1.3

28.1

2801

19628

I87.8

ICD-10 Finland

Other specified disorders of veins

19.2

28.1

I81

ICD-10 Finland

Portal vein thrombosis

72.0

28.0

I49.9

ICD-10 Finland

Cardiac arrhythmia, unspecified

1.4

27.8

1587

10240

M01AH02

ATC

rofecoxib; oral

1.3

27.7

1963

13115

C03DA01

ATC

spironolactone; oral

1.4

27.7

1455

9254

-1

NOMESCO Finland

1.2

27.5

5048

37887

A02BC03

ATC

lansoprazole; oral

1.2

27.4

4904

36708

J01FA10

ATC

azithromycin; systemic

1.2

27.4

9847

78445

LEF00

NOMESCO Finland

Anterior colporraphy with sutures for primary cystocele

1.9

27.3

390

1765

Z01.8

ICD-10 Finland

Other specified special examinations

1.3

27.2

3324

23877

K78

ICPC

Atrial fibrillation/flutter

1.5

27.1

995

5900

K29

ICPC

Cardiovascular sympt/complt other

1.7

27.1

581

3008

D01AC20

ATC

imidazoles/triazoles in combination with corticosteroids; topical

1.2

27.0

3678

26747

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

1.2

26.9

4366

32346

O22.2

ICD-10 Finland

Superficial thrombophlebitis in pregnancy

29.4

26.7

P01AB01

ATC

metronidazole; oral, rectal

1.2

26.7

6745

52123

4565A

ICD-9 Finland

Varicose veins of other sites, Pelvic varices

+∞

26.7

L30.3

ICD-10 Finland

Infective dermatitis

1.8

26.7

505

2518

0350X

ICD-9 Finland

Erysipelas[ERYSIPELAS ALIA DEFINITA SEU NUD]

3.1

26.6

151

422

M15.9

ICD-10 Finland

Polyarthrosis, unspecified

1.6

26.6

701

3843

L28.0

ICD-10 Finland

Lichen simplex chronicus

2.8

26.5

174

539

J01CF05

ATC

flucloxacillin; systemic

1.7

26.5

520

2624

M02AA10

ATC

ketoprofen; topical

1.3

26.3

2429

16849

R03AC02

ATC

salbutamol; inhalant

1.2

26.2

8955

70949

67100

ICD-8 Finland

Puerperal phlebitis and thrombosis, Thrombophlebitis extremitatis inferioris

67.7

26.1

R07.4

ICD-10 Finland

Chest pain, unspecified

1.2

26.0

4012

29552

Y6099

ICD-8 Finland

Prenatal care and observation

1.6

25.6

687

3782

QDE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin in lower limb

1.8

25.6

431

2070

N39.4

ICD-10 Finland

Other specified urinary incontinence

1.5

25.5

949

5640

Z01.5

ICD-10 Finland

Diagnostic skin and sensitization tests

1.4

25.4

1359

8665

M72.2

ICD-10 Finland

Plantar fascial fibromatosis

1.4

25.3

1073

6555

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

1.3

25.1

1835

12306

Z96.6

ICD-10 Finland

Presence of orthopaedic joint implants

1.7

25.1

496

2505

M15.0

ICD-10 Finland

Primary generalized (osteo)arthrosis

1.9

25.0

367

1681

K28

ICPC

Limited function/disability (K)

2.1

24.9

283

1169

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

1.3

24.8

2089

14299

M71.2

ICD-10 Finland

Synovial cyst of popliteal space [Baker]

1.8

24.5

438

2146

SDE02

NOMESCO Finland

Periodontal treatment by dental hygienist

1.2

24.5

3733

27446

D82

ICPC

Teeth/gum disease

1.2

24.4

5230

39756

U71

ICPC

Cystitis/urinary infection other

1.6

24.3

673

3738

64399

ICD-8 Finland

Spontaneous abortion, Without mention of sepsis or toxaemia

1.7

24.3

508

2613

D07CC01

ATC

betamethasone and antibiotics; topical

1.3

24.2

1946

13238

NGB40

NOMESCO Finland

Primary total prosthetic replacement of knee joint with patellar part - sliding prosthesis

1.9

24.0

340

1536

D19

ICPC

Teeth/gum symptom/complaint

1.2

23.9

3958

29338

G47.3

ICD-10 Finland

Sleep apnoea

1.2

23.9

3444

25163

R74

ICPC

Upper respiratory infection acute

1.2

23.8

3882

28728

E000003

ATC

1.6

23.6

637

3514

S80.1

ICD-10 Finland

Contusion of other and unspecified parts of lower leg

1.9

23.5

377

1781

207

Kela drug reimbursment

Chronic arrhythmias

1.3

23.5

1910

13001

S19

ICPC

Skin injury other

1.7

23.5

507

2632

I86.8

ICD-10 Finland

Varicose veins of other specified sites

19.6

23.3

C03EA01

ATC

hydrochlorothiazide and potassium-sparing agents; oral

1.3

23.2

2118

14648

290

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

1.3

23.2

1826

12380

K04.5

ICD-10 Finland

Chronic apical periodontitis

1.2

23.1

3977

29577

N39.3

ICD-10 Finland

Stress incontinence

1.5

23.1

938

5680

NF1AA

NOMESCO Finland

Hip X-ray examination

1.4

22.9

1090

6808

S21

ICPC

Skin texture symptom/complaint

1.3

22.7

1633

10922

4564A

ICD-9 Finland

Varicose veins of other sites, Scrotal varices

+∞

22.7

G03FB05

ATC

norethisterone and estrogen; systemic (progestogens and estrogens, sequential prep.)

1.4

22.7

1369

8910

Z01.4

ICD-10 Finland

Gynaecological examination (general)(routine)

1.3

22.7

2132

14805

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

1.3

22.6

1783

12089

J01EE02

ATC

sulfadiazine and trimethoprim; systemic

1.2

22.4

4024

30043

WZA90

NOMESCO Finland

Other doctors statement

1.2

22.4

3273

23930

J02AC02

ATC

itraconazole; systemic

1.2

22.3

2925

21134

SPAT1222

SPAT

Counselling/guidance promoting independent living

1.3

22.2

1930

13256

I84.2

ICD-10 Finland

Internal hemorrhoids without complication

1.4

22.2

1116

7040

PH2AE

SPAT

2.5

22.1

174

601

M09AA72

ATC

quinine, combinations with psycholeptics; systemic

1.7

22.1

436

2207

WX290

NOMESCO Finland

Other blockade of nerve

1.2

22.0

6958

54546

D03BA02

ATC

collagenase; topical

4.4

21.9

164

M76.6

ICD-10 Finland

Achilles tendinitis

1.6

21.8

656

3720

N30.0

ICD-10 Finland

Acute cystitis

1.3

21.5

1630

10982

R06AE07

ATC

cetirizine; oral

1.2

21.5

6904

54153

M54.4

ICD-10 Finland

Lumbago with sciatica

1.3

21.3

2371

16804

I70.2

ICD-10 Finland

Atherosclerosis of arteries of extremities

1.4

21.3

1316

8597

TQW75

NOMESCO Finland

Skin pressure therapy

13.3

21.3

ZXC30

NOMESCO Finland

Use of microwaves

7.8

21.2

63230

ICD-8 Finland

Haemorrhage of pregnancy, Threatened abortion

1.8

21.2

351

1676

M51.1

ICD-10 Finland

Lumbar and other intervertebral disc disorders with radiculopathy

1.3

21.2

2179

15293

I87.1

ICD-10 Finland

Compression of vein

34.9

21.1

I49.3

ICD-10 Finland

Ventricular premature depolarization

1.4

21.1

957

5919

G03AC03

ATC

levonorgestrel; systemic

1.3

21.0

2295

16230

T84.0

ICD-10 Finland

Mechanical complication of internal joint prosthesis

1.7

20.9

422

2151

R23.8

ICD-10 Finland

Other and unspecified skin changes

1.3

20.7

2133

14973

D02AE01

ATC

carbamide; topical

1.4

20.7

937

5799

WZB00

NOMESCO Finland

Telephone receipt or other advice

1.2

20.5

4263

32223

R52.9

ICD-10 Finland

Pain, unspecified

1.4

20.5

1086

6912

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

1.2

20.4

2950

21522

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

1.2

20.4

2594

18663

E000002

ATC

1.3

20.4

1551

10454

SPAT1151

SPAT

Treatment of major wounds

2.3

20.4

185

691

PH5GT

NOMESCO Finland

Endovascular embolisation of spermatic vein with radiological guidance

69.8

20.4

65300

ICD-8 Finland

Occipital presentation

2.4

20.3

173

626

K99

ICPC

Cardiovascular disease other

1.8

20.3

345

1665

SPAT1193

SPAT

Pap smear

1.4

20.3

1256

8207

R01BA52

ATC

pseudoephedrine, combinations; oral

1.2

20.2

5200

40028

NGA30

NOMESCO Finland

Exploration of knee joint, arthroscopic

1.5

20.1

682

3975

G03FA01

ATC

norethisterone and estrogen; systemic (progestogens and estrogens, fixed comb.)

1.3

20.1

1546

10439

M01AB08

ATC

etodolac; oral

1.4

20.1

1119

7185

L95.9

ICD-10 Finland

Vasculitis limited to skin, unspecified

4.0

20.1

183

E66.9

ICD-10 Finland

Obesity, unspecified

1.7

20.0

444

2324

J45.9

ICD-10 Finland

Asthma, unspecified

1.2

20.0

2537

18248

WZC30

NOMESCO Finland

Teaching

1.3

20.0

1957

13648

SDA01

NOMESCO Finland

Simple parodonthologic therapy

1.2

20.0

3593

26794

PHS78

NOMESCO Finland

Endoscopic interruption of perforating vein of lower leg

+∞

19.8

I80.2

ICD-10 Finland

Phlebitis and thrombophlebitis of other deep vessels of lower extremities

+∞

19.8

M03BC01

ATC

orphenadrine (citrate); systemic

1.2

19.7

3703

27725

SDA03

NOMESCO Finland

Demanding parodonthologic therapy

1.2

19.6

5807

45186

S80.0

ICD-10 Finland

Contusion of knee

1.5

19.5

802

4869

NH3BA

NOMESCO Finland

Foot and toes extensive X-ray examination

1.6

19.5

490

2660

SCA01

NOMESCO Finland

Simple analysis and advice of nutrition with regard to dentistry

1.2

19.4

3828

28776

I85.0

ICD-10 Finland

Oesophageal varices with bleeding

183.1

19.4

6712B

ICD-9 Finland

Venous complications in pregnancy and the puerperium, Superficial thrombophlebitis[THROMBOPHLEB SUPERFIC EXTR INF,PUERP AIKANA]

32.4

19.4

R01AD12

ATC

fluticasone furoate; nasal

1.2

19.3

4562

34847

R2130

NOMESCO Finland

Counselling and guidance which enhance independent living

1.4

19.2

1102

7111

R51.80

ICD-10 Finland

Headache

1.3

19.2

1887

13167

351

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

1.3

19.1

1561

10626

LCD10

NOMESCO Finland

Vaginal hysterectomy

1.6

19.1

535

2983

A28

ICPC

Limited function/disability NOS

1.3

19.0

1830

12730

NGF35

NOMESCO Finland

Plastic operation of joint cartilage of knee

1.6

18.9

491

2687

JHB30

NOMESCO Finland

Rubber band ligature of haemorrhoids or prolapse of mucosa

1.4

18.9

812

4976

PH2BC

NOMESCO Finland

Extensive flebography of lower extremity with X-ray

41.9

18.9

L89

ICD-10 Finland

Decubitus ulcer and pressure area

2.1

18.8

224

946

D01AE16

ATC

amorolfine; topical

1.3

18.8

1668

11482

R02

ICPC

Shortness of breath/dyspnoea

1.3

18.8

1522

10353

M48.0

ICD-10 Finland

Spinal stenosis

1.3

18.7

1609

11031

SPAT1028

SPAT

Ultrasound examination of paranasal sinuses

1.5

18.7

731

4394

R05

ICPC

Cough

1.2

18.6

3070

22683

NG2AA

NOMESCO Finland

Patella X-ray examination

1.8

18.5

322

1566

TPH04

NOMESCO Finland

Cathetrisation of vein

1.2

18.5

3067

22676

I50.0

ICD-10 Finland

Congestive heart failure

1.4

18.5

948

6002

G04BD12

ATC

mirabegron; oral

1.3

18.4

1270

8439

Y88.3

ICD-10 Finland

Sequelae of surgical and medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1.7

18.3

353

1774

L03.9

ICD-10 Finland

Cellulitis, unspecified

1.9

18.1

266

1222

LEF13

NOMESCO Finland

Colpoperineoplasty and vaginal hysterectomy

1.8

18.1

340

1696

I26.0

ICD-10 Finland

Pulmonary embolism with mention of acute cor pulmonale

2.0

18.0

227

985

TQW11

NOMESCO Finland

Vacuum treatment of wound

1.9

17.9

250

1128

PHL79

NOMESCO Finland

Ultrasound guided foam sclerotherapy of anterior saphenous vein

+∞

17.8

I50

ICD-10 Finland

Heart failure

1.7

17.7

344

1735

R29.8

ICD-10 Finland

Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems

1.3

17.7

1168

7706

X59

ICD-10 Finland

Exposure to unspecified factor

1.2

17.7

2557

18635

4510A

ICD-9 Finland

Phlebitis and thrombophlebitis, Of superficial vessels of lower extremities

13.5

17.6

E03.9

ICD-10 Finland

Hypothyroidism, unspecified

1.3

17.6

1505

10307

O87.0

ICD-10 Finland

Superficial thrombophlebitis in the puerperium

61.2

17.6

C07AB07

ATC

bisoprolol; oral

1.1

17.6

7689

61420

K21.0

ICD-10 Finland

Gastro-oesophageal reflux disease with oesophagitis

1.3

17.5

1404

9531

S99

ICPC

Skin disease other

2.0

17.5

238

1063

L30.0

ICD-10 Finland

Nummular dermatitis

1.6

17.4

462

2540

LCA13

NOMESCO Finland

Curettage of cervix and body of uterus

1.4

17.4

743

4548

K42.9

ICD-10 Finland

Umbilical hernia without obstruction or gangrene

1.5

17.4

641

3810

SPAT1070

SPAT

Doppler ultrasound examination of blood flow in arteries of lower extremity

2.0

17.3

231

1026

S81.9

ICD-10 Finland

Open wound of lower leg, part unspecified

2.9

17.3

110

337

D07BA04

ATC

hydrocortisone and antiseptics; topical

1.3

17.2

1282

8616

9733

FHL

Excision of skin change in operating room or anesthesia

2.1

17.1

204

864

SGA01

NOMESCO Finland

Tooth opening as first aid

1.2

17.1

2287

16530

SPAT1325

SPAT

Vaccination

1.2

16.9

4865

37686

Z30.2

ICD-10 Finland

Sterilization

1.3

16.9

1824

12862

B02AA02

ATC

tranexamic acid; systemic

1.2

16.9

2578

18890

R04.0

ICD-10 Finland

Epistaxis

1.4

16.8

932

5978

M77.4

ICD-10 Finland

Metatarsalgia

1.4

16.8

716

4383

D03AX01

ATC

cadexomer iodine; topical

5.5

16.8

QDB99

NOMESCO Finland

Other procedure for wound of skin of lower limb

3.1

16.7

270

SPAT1099

SPAT

Measurement of blood pressure with Doppler ultrasound device

1.6

16.7

399

2138

E11.5

ICD-10 Finland

Type 2 diabetes mellitus, with peripheral circulatory complications

1.8

16.7

285

1381

NHG77

NOMESCO Finland

Arthroplasty of interphalangeal tarsal joint(s)

1.9

16.6

231

1041

SFA40

NOMESCO Finland

Replacement of krone of tooth

1.2

16.6

3309

24863

QX2XE

NOMESCO Finland

Ultrsound examination of soft tissue not elsewhere classified

1.7

16.5

348

1803

I89.9

ICD-10 Finland

Noninfective disorder of lymphatic vessels and lymph nodes, unspecified

32.0

16.4

U02

ICPC

Urinary frequency/urgency

1.3

16.4

1481

10216

RD211

NOMESCO Finland

1.5

16.4

627

3757

SFA00

NOMESCO Finland

Small filling

1.3

16.3

1824

12916

R09

ICPC

Sinus symptom/complaint

1.4

16.3

960

6220

E66.00

ICD-10 Finland

Metabolic syndrome

1.4

16.3

731

4517

M16.9

ICD-10 Finland

Coxarthrosis, unspecified

1.5

16.2

611

3651

S17

ICPC

Abrasion/scratch/blister

1.9

16.1

253

1191

L03.1

ICD-10 Finland

Cellulitis of other parts of limb

1.7

16.1

309

1557

NK4XE

NOMESCO Finland

Joint ultrasound examination not elsewhere classified

1.4

16.0

890

5715

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

1.3

16.0

1063

7022

VALMI

NOMESCO Finland

1.2

16.0

3493

26452

D01AC03

ATC

econazole; topical

1.4

15.9

862

5512

B35.3

ICD-10 Finland

Tinea pedis

1.5

15.9

484

2760

M04AA01

ATC

allopurinol; systemic

1.2

15.8

1874

13360

XX5WT

NOMESCO Finland

Laser therapy with ultrasound guidance

+∞

15.8

D01AC02

ATC

miconazole; topical

1.3

15.8

1132

7562

NHQ40

NOMESCO Finland

Amputation of toe

1.9

15.8

229

1052

J01FA09

ATC

clarithromycin; systemic

1.2

15.7

5051

39422

R42

ICD-10 Finland

Dizziness and giddiness

1.2

15.6

2946

22021

A01

ICPC

Pain general/multiple sites

1.4

15.6

893

5764

64199

ICD-8 Finland

Abortion induced for other legal indications, Without mention of sepsis or toxaemia

1.4

15.6

898

5800

XQ848

NOMESCO Finland

Dermatological photography

1.7

15.6

336

1753

S08

ICPC

Skin colour change

1.5

15.5

578

3446

8502

FHL

Evacuation and abrasion

1.4

15.5

788

4984

H04.10

ICD-10 Finland

Dry eye syndrome

1.3

15.5

1307

8937

NHG80

NOMESCO Finland

Fusion of first tarsometatarsal joint

1.5

15.4

459

2602

SGC00

NOMESCO Finland

Local medication of root channels of tooth

1.3

15.4

1512

10538

L01

ICPC

Neck symptom/complaint

1.2

15.3

1755

12467

WZC00

NOMESCO Finland

Planning of intervention or health care consultation

1.2

15.3

5017

39197

J01MA01

ATC

ofloxacin; systemic

1.3

15.2

1280

8748

S22

ICPC

Nail symptom/complaint

1.4

15.2

711

4433

G56.0

ICD-10 Finland

Carpal tunnel syndrome

1.2

15.1

1962

14125

NF1DA

NOMESCO Finland

X-ray of hips

1.8

15.1

273

1347

TNX10

NOMESCO Finland

Arthrocentesis, unspecified region, unspecified region

1.4

15.0

917

5979

7504

FHL

Play the depot

26.2

15.0

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

1.3

15.0

1196

8116

SPAT1202

SPAT

Intra-articular injection

1.6

14.9

382

2087

Z35.4

ICD-10 Finland

Supervision of pregnancy with grand multiparity

2.7

14.9

100

318

-54

ICPC

Repair/fix-suture/cast/prosth device

1.7

14.9

322

1681

QDB10

SPAT

2.9

14.8

274

TFP20

NOMESCO Finland

Cardiodefibrillation

1.3

14.8

965

6354

Z46.8

ICD-10 Finland

Fitting and adjustment of other specified devices

1.7

14.8

330

1734

I84.9

ICD-10 Finland

Unspecified hemorrhoids without complication

1.4

14.8

659

4069

NHG26

NOMESCO Finland

Fusion between bones of ankle or ankle and foot

2.2

14.8

159

646

D01AE15

ATC

terbinafine; topical

1.3

14.8

972

6410

K93

ICPC

Pulmonary embolism

2.5

14.7

114

396

P01BA02

ATC

hydroxychloroquine; oral

1.3

14.6

1106

7450

G04BD08

ATC

solifenacin; oral

1.4

14.6

829

5346

R01AD08

ATC

fluticasone; nasal

1.2

14.5

4423

34358

G01AF01

ATC

metronidazole; vaginal

1.3

14.4

1508

10591

E11.7

ICD-10 Finland

Type 2 diabetes mellitus, with multiple complications

1.4

14.4

693

4339

L12

ICPC

Hand/finger symptom/complaint

1.2

14.4

1816

13035

SPAT1295

SPAT

Other function in accordance with physical therapy nomenclature

1.4

14.4

655

4061

AA1AD

NOMESCO Finland

CT of head and brain

1.2

14.3

3361

25576

R32

ICD-10 Finland

Unspecified urinary incontinence

1.7

14.3

284

1447

A49.9

ICD-10 Finland

Bacterial infection, unspecified

1.3

14.3

1437

10045

M01AC01

ATC

piroxicam; systemic, rectal

1.2

14.3

1985

14394

T82

ICPC

Obesity

1.5

14.3

470

2730

SPAT1306

SPAT

Counselling and guidance related to nutrition and weight management

1.2

14.2

1737

12419

K03.64

ICD-10 Finland

Dental calculus supragingival

1.2

14.2

3957

30513

WX408

NOMESCO Finland

General anesthesy, balanced

1.2

14.2

4114

31827

S01

ICPC

Pain/tenderness of skin

1.5

14.2

482

2820

M03BA52

ATC

carisoprodol, combinations excl. psycholeptics; oral

1.5

14.1

447

2573

A02BC01

ATC

omeprazole; systemic

1.2

14.1

4250

32969

XG412

NOMESCO Finland

Flow-volume spirometry with bronchospasmolysis

1.4

14.1

774

4960

R05FA02

ATC

opium derivatives and expectorants; systemic

1.1

14.1

6510

51981

I86.3

ICD-10 Finland

Vulval varices

39.2

14.1

E66.0

ICD-10 Finland

Obesity due to excess calories

2.2

14.0

142

564

SPAT1305

SPAT

Counselling and guidance related to physical exercise

1.3

14.0

1153

7860

HMAK

NOMESCO Finland

1.2

13.9

1681

12005

A03

ICPC

Fever

1.2

13.9

1947

14129

JAD30

NOMESCO Finland

Repair of incisional hernia using prosthetic material

1.8

13.9

227

1087

JAF10

NOMESCO Finland

Repair of umbilical hernia

1.7

13.9

307

1612

R50.9

ICD-10 Finland

Fever, unspecified

1.2

13.9

1879

13587

J01FA06

ATC

roxithromycin; oral

1.1

13.8

6715

53766

NFB30

NOMESCO Finland

Primary total prosthetic replacement of hip joint not using cement

1.3

13.8

883

5801

S01CA01

ATC

dexamethasone and antiinfectives; ophthalmic (ophth., corticosteroids and antiinfectives in comb.)

1.1

13.7

5043

39657

F03

ICPC

Eye discharge

1.4

13.7

720

4583

ZXC84

NOMESCO Finland

Bloodless operation space

2.5

13.7

105

363

WQ045

NOMESCO Finland

69.8

13.7

XQ802

NOMESCO Finland

Epicutan test

1.5

13.7

528

3172

-56

ICPC

Dressing/pressure/compress/tamponade

1.9

13.6

209

979

G03FB06

ATC

medroxyprogesterone and estrogen; systemic (progestogens and estrogens, sequential prep.)

1.4

13.6

602

3714

8113

FHL

Fractional scraping

1.5

13.6

462

2700

B01AX06

ATC

[U] rivaroxaban; oral

1.7

13.6

261

1317

NB1AA

NOMESCO Finland

Shoulder X-ray examination without contrast

1.4

13.6

790

5114

104

Kela drug reimbursment

Thyroid insufficiency

1.3

13.5

880

5799

D06AX01

ATC

fusidic acid; topical (antibiotics for topical use)

1.3

13.4

1251

8663

G03DA02

ATC

medroxyprogesterone; systemic (pregnen (4) derivatives)

1.3

13.4

932

6201

8306

FHL

Hysterectomy (related to abortion 8516, prolapse correction 8436)

1.8

13.4

228

1108

M75.4

ICD-10 Finland

Impingement syndrome of shoulder

1.3

13.3

1015

6843

QDA10

NOMESCO Finland

Incision of skin of lower limb

2.5

13.3

105

368

Z76.9

ICD-10 Finland

Person encountering health services in unspecified circumstances

1.3

13.3

850

5583

L60.0

ICD-10 Finland

Ingrowing nail

1.5

13.3

480

2843

L11

ICPC

Wrist symptom/complaint

1.3

13.3

907

6018

K21.9

ICD-10 Finland

Gastro-oesophageal reflux disease without oesophagitis

1.3

13.2

1264

8781

M79.1

ICD-10 Finland

Myalgia

1.2

13.2

1639

11739

WX111

NOMESCO Finland

Local infiltration anesthesia

1.6

13.2

359

1995

206

Kela drug reimbursment

Chronic coronary artery disease and dyslipidaemia associated with chronic coronary artery disease

0.8

13.2

2135

21771

PD4DE

NOMESCO Finland

Lower extremity artery ultrasound examination with Doppler method

1.9

13.2

203

952

A04

ICPC

Weakness/tiredness general

1.2

13.2

1471

10414

K04.0

ICD-10 Finland

Pulpitis

1.3

13.1

1238

8589

R01AD09

ATC

mometasone; nasal

1.1

13.0

7270

58645

NB1BA

NOMESCO Finland

Shoulder extensive X-ray examination without contrast

1.6

12.9

375

2117

E11.4

ICD-10 Finland

Type 2 diabetes mellitus, with neurological complications

1.6

12.9

302

1613

SHA01

NOMESCO Finland

Correction of physiology of bite - simple therapy visit

1.2

12.8

1418

10024

I839, I872

ICD-10 Finland

+∞

12.8

I82.80

ICD-10 Finland

Emboli and thrombosis in the subclavian vein

+∞

12.8

NG1DA

NOMESCO Finland

X-ray of knees

1.8

12.8

221

1080

J01CR50

ATC

combinations of penicillins; systemic

4.2

12.8

X58

ICD-10 Finland

Exposure to other specified factors

1.2

12.8

1765

12791

R75

ICPC

Sinusitis acute/chronic

1.4

12.7

546

3351

M13.9

ICD-10 Finland

Arthritis, unspecified

1.3

12.6

948

6382

N95.2

ICD-10 Finland

Postmenopausal atrophic vaginitis

1.4

12.6

739

4793

G03CA04

ATC

estriol; systemic, vaginal

1.6

12.6

314

1707

E66.2

ICD-10 Finland

Extreme obesity with alveolar hypoventilation

2.1

12.6

143

597

NHK40

NOMESCO Finland

Osteotomy or rotation osteotomy of II-V metatarsal or tarsal bone

1.8

12.6

208

1003

LC2BE

NOMESCO Finland

Transvaginal ultrasound examination of uterus, parametria and lower abdomen

1.2

12.5

3549

27378

R21

ICPC

Throat symptom/complaint

1.2

12.5

2288

17036

A10BJ02

ATC

liraglutide; parenteral

1.6

12.4

298

1605

I73.0

ICD-10 Finland

Raynaud syndrome

1.9

12.4

189

884

SPAT1083

SPAT

Initiation and monitoring of IV fluid therapy

1.4

12.4

535

3288

N06AX21

ATC

duloxetine; oral

1.2

12.4

1489

10626

SPAT1215

SPAT

Assessment of need for medical rehabilitation

1.4

12.4

500

3036

QD9S1

NOMESCO Finland

Photography of skin or subcutaneous tissue in lower extremities, unspecified

2.7

12.3

283

R53

ICD-10 Finland

Malaise and fatigue

1.2

12.3

2708

20476

E000007

ATC

1.4

12.3

680

4368

A02BA02

ATC

ranitidine; systemic

1.2

12.3

2990

22798

M67.4

ICD-10 Finland

Ganglion

1.3

12.3

819

5419

Z50.9

ICD-10 Finland

Care involving use of rehabilitation procedure, unspecified

1.4

12.2

501

3046

NGF00

NOMESCO Finland

Excision of plica of synovy of knee

1.7

12.2

269

1415

R10.1

ICD-10 Finland

Pain localized to upper abdomen

1.2

12.2

2162

16042

K80.2

ICD-10 Finland

Calculus of gallbladder without cholecystitis

1.2

12.2

1631

11779

R05

ICD-10 Finland

Cough

1.2

12.2

2638

19927

D07AA02

ATC

hydrocortisone; topical

1.2

12.2

1782

12987

M79.0

ICD-10 Finland

Rheumatism, unspecified

1.5

12.1

443

2635

A29

ICPC

General symptom/complaint other

1.2

12.1

1391

9881

D02AX

ATC

Other emollients and protectives

1.5

12.1

368

2102

NHL68

NOMESCO Finland

Tenodesis, shortening or lengthening of tendon of foot

2.0

12.0

155

684

7350A

ICD-9 Finland

Acquired deformities of toe, Hallux valgus (acquired)

2.0

12.0

161

721

M53.1

ICD-10 Finland

Cervicobrachial syndrome

1.2

12.0

1501

10765

S91.0

ICD-10 Finland

Open wound of ankle

2.3

12.0

114

442

JN3AD

NOMESCO Finland

Abdominal CT examination

1.3

11.9

966

6568

N92.0

ICD-10 Finland

Excessive and frequent menstruation with regular cycle

1.2

11.9

1319

9326

M47.82

ICD-10 Finland

Other spondylosis, cervical region

1.4

11.9

494

3014

ZXC50

NOMESCO Finland

Cryotherapy

1.6

11.9

337

1894

LEG12

NOMESCO Finland

Transobturatoric tape

1.8

11.9

196

943

R69

ICD-10 Finland

Unknown and unspecified causes of morbidity

1.7

11.9

262

1381

XF404

NOMESCO Finland

Ambulatory ECG

1.3

11.9

1207

8451

7151F

ICD-9 Finland

Osteo-arthrosis and allied disorders, Osteo-arthrosis, localised, primary[OSTEOARTHROSIS PRIMARIA, POLVI]

1.7

11.9

267

1415

UKC02

NOMESCO Finland

Cystoscopy

1.2

11.9

2501

18847

NH1AA

NOMESCO Finland

Ankle X-ray examination without contrast

1.3

11.9

757

4977

28930

ICD-8 Finland

Other disease of blood and blood-forming organs, Lymphadenitis, unspecified, except mesenteric

+∞

11.8

A01AB09

ATC

miconazole; local oral

1.3

11.8

1116

7742

J01FA01

ATC

erythromycin; systemic

1.2

11.8

1860

13649

SPAT1225

SPAT

Implementation of podiatry rehabilitation plan

1.6

11.8

320

1776

C03EB01

ATC

furosemide and potassium-sparing agents; systemic

1.4

11.8

516

3180

SPAT1262

SPAT

Handing over of treatment supplies

1.2

11.8

2589

19575

M54.6

ICD-10 Finland

Pain in thoracic spine

1.3

11.8

827

5512

WX213

NOMESCO Finland

Lower leg blockade

2.4

11.8

102

378

H29

ICPC

Ear symptom/complaint other

1.3

11.8

1227

8616

NHK30

NOMESCO Finland

Osteotomy or rotation osteotomy of first metatarsal or tarsal bone

1.5

11.8

436

2603

E04.2

ICD-10 Finland

Nontoxic multinodular goitre

1.5

11.8

440

2629

G44.2

ICD-10 Finland

Tension-type headache

1.2

11.7

1686

12265

WX704

NOMESCO Finland

Intubation

1.3

11.7

974

6649

L02.4

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of limb

1.5

11.7

380

2203

-31

ICPC

Medical examin/health eval partial

1.3

11.7

824

5497

XQ800

NOMESCO Finland

Prick test

1.3

11.7

947

6444

160

Kela drug reimbursment

exenatide

1.7

11.6

263

1395

N04BC05

ATC

pramipexole; oral

1.3

11.6

905

6129

L81.7

ICD-10 Finland

Pigmented purpuric dermatosis

3.4

11.6

145

R05FB02

ATC

cough suppressants and expectorants

1.1

11.5

6251

50246

TNX50

NOMESCO Finland

Removal of cutom molded cast and internal stretch

1.4

11.5

572

3611

R06.5

ICD-10 Finland

Mouth breathing

1.3

11.5

1192

8366

N05CF01

ATC

zopiclone; oral

1.1

11.5

5029

39918

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

1.2

11.5

1559

11277

S22.3

ICD-10 Finland

Fracture of rib

1.3

11.5

842

5652

D07CA01

ATC

hydrocortisone and antibiotics; topical

1.2

11.4

1782

13063

NG1BA

NOMESCO Finland

Knee extensive X-ray examination

1.7

11.4

216

1089

R07.3

ICD-10 Finland

Other chest pain

1.3

11.4

1156

8095

L82

ICD-10 Finland

Seborrhoeic keratosis

1.2

11.4

2091

15568

R05DA20

ATC

opium alkaloids and derivatives - combinations

1.1

11.3

3836

29948

W00

ICD-10 Finland

Fall on same level involving ice and snow

1.2

11.3

1391

9957

1220

FHL

Arthroscopy

1.4

11.3

506

3134

R21

ICD-10 Finland

Rash and other nonspecific skin eruption

1.4

11.3

506

3135

6660A

ICD-9 Finland

Postpartum haemorrhage, Third-stage haemorrhage[HAEMORRHAGIA POST PARTUM STADII III]

1.9

11.2

153

691

R5140

NOMESCO Finland

Monitoring the use of the aid

1.2

11.2

1473

10615

L29

ICPC

Musculoskeletal sympt/complt other

1.3

11.2

872

5899

285

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

1.4

11.2

620

3987

S82

ICPC

Naevus/mole

1.2

11.2

1517

10972

D06BX01

ATC

metronidazole; topical

1.2

11.2

1479

10668

M86.9

ICD-10 Finland

Osteomyelitis, unspecified

2.2

11.1

108

423

L84

ICD-10 Finland

Corns and callosities

1.5

11.1

379

2225

J32.0

ICD-10 Finland

Chronic maxillary sinusitis

1.3

11.1

991

6830

J18.9

ICD-10 Finland

Pneumonia, unspecified

1.1

11.1

3601

28032

FM1DE

NOMESCO Finland

Doppler ultrasound examination of heart

1.3

11.0

1179

8308

M23.8

ICD-10 Finland

Other internal derangements of knee

1.5

11.0

432

2610

I48.9

ICD-10 Finland

Atrial fibrillation and atrial flutter, unspecified

1.4

11.0

571

3632

M03BC51

ATC

orphenadrine, combinations; systemic

1.1

11.0

4446

35111

R35

ICD-10 Finland

Polyuria

1.3

11.0

824

5550

XKC03

NOMESCO Finland

Water cystometry

1.5

10.9

352

2040

S04

ICPC

Lump/swelling localized

1.3

10.9

1063

7409

H02AB04

ATC

methylprednisolone; systemic

1.2

10.9

2082

15554

Z11.3

ICD-10 Finland

Special screening examination for infections with a predominantly sexual mode of transmission

0.7

10.9

249

3293

N06AA09

ATC

amitriptyline; systemic

1.2

10.8

1330

9515

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

1.1

10.8

3882

30411

6266A

ICD-9 Finland

Disorders of menstruation and other abnormal bleeding from female genital tract, Metrorrhagia

1.7

10.8

240

1268

R01AD58

ATC

fluticasone, combinations; inhalant, nasal

1.2

10.8

2978

22907

N81.5

ICD-10 Finland

Vaginal enterocele

1.9

10.8

147

662

I48.1

ICD-10 Finland

Persistent atrial fibrillation

1.6

10.8

269

1465

SPAT1104

SPAT

Monitoring of emergency patient

1.3

10.8

820

5534

E11.2

ICD-10 Finland

Type 2 diabetes mellitus, with renal complications

1.5

10.8

403

2411

ND1AA

NOMESCO Finland

Wrist X-ray examination

1.3

10.8

687

4516

I82.0

ICD-10 Finland

Budd-Chiari syndrome

104.6

10.8

JCA22

NOMESCO Finland

Endoscopic ligature of oesophageal varices

7.5

10.8

PG1XE

NOMESCO Finland

Other ultrasound examination of blood vessel not elsewhere classified

2.5

10.8

283

NE1AA

NOMESCO Finland

Pelvis X-ray examination

1.3

10.8

745

4961

6123

FHL

Radical surgery

1.4

10.7

522

3282

SAD01

NOMESCO Finland

Assessment of need for oral health care, standard

1.2

10.7

1505

10928

B01AX05

ATC

fondaparinux; parenteral

2.3

10.7

351

G01AA10

ATC

clindamycin; vaginal

1.2

10.7

2192

16479

S15

ICPC

Foreign body in skin

1.3

10.6

756

5052

A41.0

ICD-10 Finland

Sepsis due to Staphylococcus aureus

1.7

10.6

236

1247

M16

ICD-10 Finland

Coxarthrosis [arthrosis of hip]

1.4

10.6

493

3075

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

1.4

10.6

608

3932

I82

ICD-10 Finland

Other venous embolism and thrombosis

5.1

10.6

Z71.8

ICD-10 Finland

Other specified counselling

1.1

10.5

3180

24620

WX702

NOMESCO Finland

Supraglottic ventilation device

1.3

10.5

701

4641

Z00.8

ICD-10 Finland

Other general examinations

1.3

10.5

824

5585

9271

FHL

Hallux surgery

1.8

10.5

186

921

-50

ICPC

Medication/prescr/renewal

1.4

10.5

509

3200

2180A

ICD-9 Finland

Uterine leiomyoma, Submucous leiomyoma of uterus

1.5

10.5

330

1905

WX725

NOMESCO Finland

Noninvasive ventilation

1.4

10.5

579

3722

L03.0

ICD-10 Finland

Cellulitis of finger and toe

1.3

10.5

837

5689

ZXM10

NOMESCO Finland

Intraoperative use of conventional X-ray imaging

1.3

10.5

713

4735

XFP20

NOMESCO Finland

Check up of cardiac pacemaker

1.3

10.5

781

5257

SPAT1058

SPAT

PEF monitoring instruction

1.3

10.4

986

6845

NH3DA

NOMESCO Finland

Bilateral foot X-ray examination

1.6

10.4

272

1502

M05BA04

ATC

alendronic acid; oral

1.3

10.4

704

4675

-34

ICPC

Blood test

1.5

10.4

333

1929

K30

ICD-10 Finland

Functional dyspepsia

1.2

10.4

1323

9505

S91.3

ICD-10 Finland

Open wound of other parts of foot

1.6

10.4

260

1421

SGB10

NOMESCO Finland

Fiiling of rooth of tooth with one root channel

1.2

10.3

1655

12167

NH3EA

NOMESCO Finland

Feet X-ray examination with load

1.6

10.3

259

1417

63497

ICD-8 Finland

Other complications of pregnancy, Partus prematurus imminens, alibi non classificabilis

1.5

10.3

306

1742

346

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

1.4

10.2

562

3611

TNX32

NOMESCO Finland

Custom moulded splint, unspecified region

1.4

10.2

556

3568

EBA00

NOMESCO Finland

Extraction of tooth

1.1

10.2

4758

37874

U04

ICPC

Incontinence urine

1.4

10.2

449

2776

G03DC05

ATC

[U] tibolone; oral

1.5

10.2

291

1645

H02.3

ICD-10 Finland

Blepharochalasis

1.3

10.2

741

4972

I48.0

ICD-10 Finland

Paroxysmal atrial fibrillation

1.3

10.1

640

4204

C05AA08

ATC

fluocortolone; rectal, topical

1.2

10.1

2081

15640

WX109

NOMESCO Finland

Extensive surface anesthesy of skin with external ointment or geel

6.8

10.1

I48.2

ICD-10 Finland

Chronic atrial fibrillation

1.6

10.1

265

1463

I87

ICD-10 Finland

Other disorders of veins

7.7

10.1

JKA21

NOMESCO Finland

Laparoscopic cholecystectomy

1.2

10.1

1560

11426

J01CF02

ATC

cloxacillin; systemic

1.5

10.1

307

1757

M22.4

ICD-10 Finland

Chondromalacia patellae

1.5

10.1

375

2243

K08.80

ICD-10 Finland

Toothache NOS

1.3

10.1

999

6979

PD4BC

NOMESCO Finland

Extensive arterigography of lower extremity with X-ray

1.8

10.0

176

868

A40.8

ICD-10 Finland

Other streptococcal sepsis

2.1

10.0

108

445

QBE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin of trunk

1.3

10.0

923

6390

NK6QA

NOMESCO Finland

Measurement of bone density from tow or more locations with X-ray

1.3

10.0

714

4777

N17.9

ICD-10 Finland

Acute renal failure, unspecified

1.4

10.0

452

2808

S46.0

ICD-10 Finland

Injury of muscle(s) and tendon(s) of the rotator cuff of shoulder

1.2

10.0

1119

7929

SPAT1266

SPAT

Separate instruction to prepare for procedure

1.5

10.0

328

1912

L98.9

ICD-10 Finland

Disorder of skin and subcutaneous tissue, unspecified

1.8

10.0

175

863

K04

ICPC

Palpitations/awareness of heart

1.4

9.9

524

3344

WVA30

SPAT

1.5

9.9

319

1851

K07.60

ICD-10 Finland

Snapping jaw

1.4

9.9

572

3704

SPAT1147

SPAT

Destruction of skin lesion with external methods

1.7

9.9

198

1017

6453

FHL

Radical surgery of hemorrhoids

1.6

9.8

270

1511

I86.4

ICD-10 Finland

Gastric varices

95.9

9.8

QDE99

NOMESCO Finland

Other excision or repair of lesion of skin of lower limb

2.0

9.8

116

497

M15

ICD-10 Finland

Polyarthrosis

1.4

9.8

480

3025

WQ021

NOMESCO Finland

4.4

9.8

J01DB05

ATC

cefadroxil; oral

1.4

9.8

544

3507

G03DB02

ATC

megestrol; oral (pregnadien derivatives)

1.5

9.7

330

1938

K59.1

ICD-10 Finland

Functional diarrhoea

1.4

9.7

565

3665

SPAT1210

SPAT

Application of cast or individual aid

1.4

9.7

484

3058

Y83.9

ICD-10 Finland

Surgical procedure, unspecified as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1.5

9.7

337

1987

M54.9

ICD-10 Finland

Dorsalgia, unspecified

1.2

9.7

1368

9937

MA2JE

NOMESCO Finland

Ultrasound screening of fetal nuchal translucency

0.6

9.6

167

2340

S83.6

ICD-10 Finland

Sprain and strain of other and unspecified parts of knee

1.3

9.6

572

3724

NA3AD

NOMESCO Finland

Lumbar spine and sacrum CT examination

1.5

9.6

275

1555

NBG15

NOMESCO Finland

Acromioplastia, arthroscopic

1.3

9.6

938

6542

D03AX02

ATC

dextranomer; topical

9.7

9.6

M50.1

ICD-10 Finland

Cervical disc disorder with radiculopathy

1.3

9.6

611

4024

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

1.2

9.5

1248

8992

K74.6

ICD-10 Finland

Other and unspecified cirrhosis of liver

2.0

9.5

114

492

GD1DD

NOMESCO Finland

High resolution CT examination of lungs

1.3

9.5

600

3944

S02.51

ICD-10 Finland

Fracture of tooth, open

1.2

9.5

1430

10449

R31

ICD-10 Finland

Unspecified haematuria

1.2

9.5

1462

10707

E11.8

ICD-10 Finland

Type 2 diabetes mellitus, with unspecified complications

1.2

9.5

1210

8695

M19.9

ICD-10 Finland

Arthrosis, unspecified

1.4

9.5

420

2600

T84.5

ICD-10 Finland

Infection and inflammatory reaction due to internal joint prosthesis

1.8

9.5

158

769

RJ521

NOMESCO Finland

4.1

9.5

202

Kela drug reimbursment

Connective tissue diseases, rheumatoid arthritis and comparable disease

1.2

9.4

1485

10900

JHB00

NOMESCO Finland

Hemorrhoidectomy

1.4

9.4

423

2625

WZA00

NOMESCO Finland

Short statement of of health and health related matters

1.3

9.4

692

4653

SXC05

NOMESCO Finland

Other oral or dental procedure

1.3

9.4

634

4208

H13

ICPC

Plugged feeling ear

1.2

9.4

2367

18076

JN4AD

NOMESCO Finland

Body CT examination

1.3

9.4

961

6741

M67.0

ICD-10 Finland

Short Achilles tendon (acquired)

2.2

9.4

387

I26

ICD-10 Finland

Pulmonary embolism

2.2

9.4

387

K80

ICPC

Cardiac arrhythmia NOS

1.3

9.4

829

5712

R58

ICD-10 Finland

Haemorrhage, not elsewhere classified

1.9

9.4

132

607

M01AB55

ATC

diclofenac, combinations; oral

1.3

9.4

851

5885

C07AA05

ATC

propranolol; systemic

1.1

9.4

2692

20762

R5110

SPAT

1.5

9.4

277

1579

I49.4

ICD-10 Finland

Other and unspecified premature depolarization

1.4

9.3

414

2566

I34.1

ICD-10 Finland

Mitral (valve) prolapse

1.5

9.3

313

1832

U01

ICPC

Dysuria/painful urination

1.3

9.3

696

4685

C03AA03

ATC

hydrochlorothiazide; oral

1.2

9.3

1216

8761

G01AF04

ATC

miconazole; vaginal

1.3

9.3

701

4726

Z95.0

ICD-10 Finland

Presence of electronic cardiac devices

1.3

9.3

577

3782

QXB99

SPAT

2.0

9.3

112

483

C01BC04

ATC

flecainide; systemic

1.4

9.3

398

2450

JAD11

NOMESCO Finland

Laparoscopic repair of incisional hernia

1.9

9.3

135

625

6662

FHL

Cholecystectomy

1.7

9.3

173

871

S83.2

ICD-10 Finland

Tear of meniscus, current

1.3

9.3

873

6058

SPAT1033

SPAT

Irrigation or wax removal of outer auditory canal

1.2

9.3

2602

20028

O22.3

ICD-10 Finland

Deep phlebothrombosis in pregnancy

5.7

9.3

NG4AA

NOMESCO Finland

Lower leg X-ray examination

1.5

9.3

300

1744

R15

ICD-10 Finland

Faecal incontinence

1.6

9.2

240

1327

J31.0

ICD-10 Finland

Chronic rhinitis

1.3

9.2

959

6737

PF1AT

NOMESCO Finland

Intravascular dilatation of arteries of knee, lower leg and ankle (PTA)

2.0

9.2

107

456

TNX92

NOMESCO Finland

Supporting bandage or orthosis of lower limb

1.7

9.2

205

1086

NFC20

NOMESCO Finland

Secondary implantation of hip prosthesis

1.7

9.2

174

881

NGC20

NOMESCO Finland

Secondary implantation of prosthesis in knee joint, normal prosthesis

2.6

9.2

208

A06AD11

ATC

lactulose; oral

1.2

9.2

1928

14512

S83.4

ICD-10 Finland

Sprain and strain involving (fibular)(tibial) collateral ligament of knee

1.5

9.2

352

2119

L57.0

ICD-10 Finland

Actinic keratosis

1.2

9.1

1097

7832

QDE35

NOMESCO Finland

Repair of skin defect in lower limb after surgery or injury

2.8

9.1

176

L95

ICPC

Osteoporosis

1.6

9.1

219

1186

PH1AE

NOMESCO Finland

Ultrasound examination of upper extremity veins

1.8

9.1

149

720

65200

ICD-8 Finland

Occipital presentation

2.1

9.1

400

TNX33

NOMESCO Finland

Custom moulded cast, unspecified region

1.3

9.1

603

3996

B35.1

ICD-10 Finland

Tinea unguium

1.3

9.1

680

4584

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

1.2

9.1

2141

16267

PH2AC

NOMESCO Finland

Flebography of lower extremity with X-ray

8.7

9.1

L04AX03

ATC

methotrexate; systemic (immunosuppressants)

1.2

9.1

1213

8765

M66.0

ICD-10 Finland

Rupture of popliteal cyst

1.8

9.1

145

697

I82.1

ICD-10 Finland

Thrombophlebitis migrans

47.9

9.1

I10

ICD-10 Finland

Essential (primary) hypertension

1.1

9.0

9387

77706

LEG10

NOMESCO Finland

Vaginal urethrocystopexy

1.5

9.0

256

1447

Z25.8

ICD-10 Finland

Need for immunization against other specified single viral diseases

1.2

9.0

1604

11911

WQ026

NOMESCO Finland

10.6

9.0

204

Kela drug reimbursment

Leukemia lymphatica

1.4

9.0

428

2690

LGA21

NOMESCO Finland

Laparoscopic sterilisation by constriction of Fallopian tubes

1.2

9.0

942

6630

K03.82

ICD-10 Finland

Split tooth for reasons other than trauma

1.2

8.9

1011

7174

SPAT1203

SPAT

Injection therapy, other than intramuscular or subcutaneous

1.4

8.9

467

2979

L08.9

ICD-10 Finland

Local infection of skin and subcutaneous tissue, unspecified

1.5

8.9

308

1815

ACC59

NOMESCO Finland

Decompression and freeing of adhesions of peripheral nerve: other or unspecified

1.3

8.9

601

3992

45199

ICD-8 Finland

Phlebitis and thrombophlebitis, Of other and unspecified sites

+∞

8.9

Q87.21

ICD-10 Finland

Klippel-Trénaunay-Weber syndrome

+∞

8.9

K08.1

ICD-10 Finland

Loss of teeth due to accident, extraction or local periodontal disease

1.2

8.9

1298

9463

S11

ICPC

Skin infection post-traumatic

1.8

8.9

158

785

L30.8

ICD-10 Finland

Other specified dermatitis

1.5

8.9

259

1472

SPAT1172

SPAT

Guidance concerning hydration

1.6

8.9

205

1101

UDC00

NOMESCO Finland

Ear microscopy

1.3

8.8

891

6238

310

Kela drug reimbursment

Orlistat, sibutramine and other major and expensive medicines used to treat obesity

1.8

8.8

141

677

D06

ICPC

Abdominal pain localized other

1.3

8.8

871

6083

SGA02

NOMESCO Finland

Opening and dilatation of root canal of tooth

1.2

8.8

1697

12687

S54

ICPC

Skin, Repair/fix-suture/cast/prosth device

1.4

8.8

357

2179

N02CC01

ATC

sumatriptan; nasal, systemic, rectal

1.2

8.8

1731

12963

A99

ICPC

Disease/condition unspecnature/site

1.3

8.8

911

6403

N95.0

ICD-10 Finland

Postmenopausal bleeding

1.3

8.7

902

6333

C01AA05

ATC

digoxin; systemic

1.2

8.7

1029

7337

UDQ12

NOMESCO Finland

Flexible laryngoscopy

1.3

8.7

707

4820

45599

ICD-8 Finland

Haemorrhoids

1.5

8.7

302

1783

Z50.1

ICD-10 Finland

Other physical therapy

1.3

8.7

684

4647

R00.2

ICD-10 Finland

Palpitations

1.3

8.7

800

5545

166

Kela drug reimbursment

Dalteparin and tinzaparin (treatment for more than 6 months)

2.2

8.7

315

K41.9

ICD-10 Finland

Unilateral or unspecified femoral hernia, without obstruction or gangrene

2.3

8.7

280

S02.5

ICD-10 Finland

Fracture of tooth

1.4

8.7

368

2266

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

1.2

8.6

1100

7907

R5110

NOMESCO Finland

Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it

1.2

8.6

1622

12095

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

1.2

8.6

1545

11475

SPAT1292

SPAT

Other function in accordance with SHToL (Finnish classification of nursing interventions)

1.2

8.6

1048

7499

M10.9

ICD-10 Finland

Gout, unspecified

1.3

8.6

816

5673

SPAT1311

SPAT

Counselling and guidance related to occupational health

1.4

8.6

433

2747

TDW99

NOMESCO Finland

Other minor procedure in surgery of ear, nose and larynx

1.4

8.6

386

2401

65310

ICD-8 Finland

Occipital presentation

2.1

8.5

358

J01DC02

ATC

cefuroxime; systemic

1.3

8.5

738

5074

R06AX22

ATC

ebastine; oral

1.1

8.5

2438

18788

NB1AE

NOMESCO Finland

Shoulder ultrasound examination

1.6

8.5

238

1341

WX321

NOMESCO Finland

Acute spinal anesthesia for delivery

1.7

8.4

182

958

SPAT1240

SPAT

Therapeutic discussion

1.2

8.4

1142

8264

D48.5

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Skin

1.3

8.4

725

4984

63701

ICD-8 Finland

Pre-eclampsia, eclampsia and toxaemia, unspecified, Hypertonia

1.7

8.4

178

932

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

1.2

8.4

2029

15447

R55

ICD-10 Finland

Syncope and collapse

1.2

8.4

1316

9657

6262A

ICD-9 Finland

Disorders of menstruation and other abnormal bleeding from female genital tract, Excessive or frequent menstruation[HYPERMENORRHOEA]

1.6

8.4

193

1036

V220A

ICD-9 Finland

Normal pregnancy, Supervision of normal first pregnancy

1.5

8.4

311

1866

A05

ICPC

Feeling ill

1.3

8.4

511

3346

64598

ICD-8 Finland

Other abortion

1.9

8.3

125

588

R07.0

ICD-10 Finland

Pain in throat

1.3

8.3

661

4493

L02

ICPC

Back symptom/complaint

1.2

8.3

985

7027

R52.2

ICD-10 Finland

Other chronic pain

1.4

8.3

363

2247

S70

ICPC

Herpes zoster

1.5

8.3

246

1404

XG466

NOMESCO Finland

Sleep oxymetry

1.4

8.3

411

2604

6256A

ICD-9 Finland

Pain and other symptoms associated with female genital organs, Stress incontinence, female

2.4

8.3

250

S20

ICPC

Corn/callosity

1.6

8.2

219

1218

03599

ICD-8 Finland

Erysipelas

2.5

8.2

228

L52

ICD-10 Finland

Erythema nodosum

2.3

8.2

288

G01AF05

ATC

econazole; vaginal

1.2

8.2

1169

8498

G03DB01

ATC

dydrogesterone; oral

1.2

8.2

1953

14850

67699

ICD-8 Finland

Anaemia of the puerperium

2.2

8.2

296

SPAT1377

SPAT

Polysomnography

1.4

8.2

407

2579

M76.0

ICD-10 Finland

Gluteal tendinitis

1.6

8.2

201

1098

D01AC07

ATC

tioconazole; topical

1.4

8.2

455

2936

FM1BE

NOMESCO Finland

Cardiac ultrasound examination through oesophagus

1.3

8.2

764

5306

PH7YT

NOMESCO Finland

Dilatation of inferior vena cava or lower extremity vein with stent

43.6

8.1

D07AC14

ATC

methylprednisolone aceponate; topical

1.3

8.1

594

3992

NBF25

NOMESCO Finland

Operation for humeroscapular osteochondritis, arthroscopic

1.5

8.1

274

1612

UJF45

NOMESCO Finland

Flexible sigmoidoscopy with biopsy

1.2

8.1

1067

7702

Y1901

ICD-8 Finland

Other studies, Pregnancy study

1.9

8.1

121

571

NH1CG

NOMESCO Finland

Ankle and foot extensive MRI examination with high intensity magnet

1.7

8.0

164

851

Z04.9

ICD-10 Finland

Examination and observation for unspecified reason

1.3

8.0

487

3191

XG470

NOMESCO Finland

Measurement of diffusion capastity of the lungs

1.4

8.0

353

2193

UJD02

NOMESCO Finland

Gastroscopy

1.3

8.0

595

4011

C08CA13

ATC

lercanidipine; oral

1.2

8.0

1572

11776

2402

FHL

External neurolysis of the nerve and possible alteration of the pathway (nerve pressure)

1.6

7.9

179

956

D48.6

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Breast

1.6

7.9

197

1081

A41.9

ICD-10 Finland

Sepsis, unspecified

1.4

7.9

415

2652

Z37.0

ICD-10 Finland

Single live birth

0.8

7.9

427

4897

PHG99

NOMESCO Finland

Intraluminal laser vein occlusion of other vein

+∞

7.9

KH1AE

NOMESCO Finland

Urinary tract ultrasound examination

1.3

7.9

708

4891

6340A

ICD-9 Finland

Spontaneous abortion, Complicated by genital tract and pelvic infection

1.4

7.9

346

2146

UDH02

NOMESCO Finland

Rhinopharyngoscopy

1.2

7.8

819

5765

SPAT1137

SPAT

Taking care of patient’s/customer’s hygiene

1.3

7.8

513

3396

XX3DW

NOMESCO Finland

Time consuming IT work

1.2

7.8

1399

10393

Z01.1

ICD-10 Finland

Examination of ears and hearing

1.2

7.8

1787

13543

50099

ICD-8 Finland

Hypertrophy of tonsils and adenoids

1.2

7.8

1481

11056

2780A

ICD-9 Finland

Obesity and other hyperalimentation, Obesity

2.3

7.8

278

73799

ICD-8 Finland

Hallux valgus and varus

1.8

7.8

119

566

55099

ICD-8 Finland

Inguinal hernia without mention of obstruction

1.3

7.8

533

3554

SPAT1283

SPAT

Restricted health certificate

1.1

7.8

2107

16172

E11.6

ICD-10 Finland

Type 2 diabetes mellitus, with other specified complications

1.6

7.8

216

1218

SPAT1220

SPAT

Assessment of need for rehabilitation and/or rehabilitation plan

1.3

7.8

728

5056

J01MA14

ATC

moxifloxacin; systemic

1.2

7.8

1197

8770

WX720

NOMESCO Finland

Own respiration

1.3

7.8

461

3008

M19.8

ICD-10 Finland

Other specified arthrosis

1.4

7.8

379

2396

U29

ICPC

Urinary symptom/complaint other

1.5

7.8

289

1737

N05CF02

ATC

zolpidem; oral

1.1

7.7

2519

19578

I71.2

ICD-10 Finland

Thoracic aortic aneurysm, without mention of rupture

1.4

7.7

344

2136

O22.1

ICD-10 Finland

Genital varices in pregnancy

7.1

7.7

U07

ICPC

Urine symptom/complaint other

1.3

7.7

610

4151

TMA00

NOMESCO Finland

Episiotomy

0.5

7.7

882

WX199

NOMESCO Finland

Other local analgesia

1.5

7.7

282

1691

I49.1

ICD-10 Finland

Atrial premature depolarization

1.4

7.7

351

2192

NHL16

NOMESCO Finland

Tenolysis or tenosynovectomy of achilles tendon

1.9

7.6

113

530

NG1AA

SPAT

1.3

7.6

526

3511

63499

ICD-8 Finland

Other complications of pregnancy, Other

1.6

7.6

192

1059

JN3BD

NOMESCO Finland

Extensive abdominal CT

1.2

7.6

1402

10447

LCA06

NOMESCO Finland

Biopsy of endometrium

1.2

7.5

1650

12464

B04

ICPC

Blood symptom/complaint

2.6

7.5

173

BAA40

NOMESCO Finland

Unilateral lobectomy of thyroid gland

1.5

7.5

264

1566

7071A

ICD-9 Finland

Chronic ulcer of skin, Ulcer of lower limbs, except decubitus

4.0

7.5

JN3CD

NOMESCO Finland

Abdominal CT examination both without and with contrast

1.4

7.5

425

2751

N92.4

ICD-10 Finland

Excessive bleeding in the premenopausal period

1.3

7.5

560

3778

NHU20

NOMESCO Finland

Removal of internal fixation device from ankle or foot

1.3

7.5

462

3034

JDF11

NOMESCO Finland

Laparoscopic gastric bypass

1.6

7.5

203

1137

D22.7

ICD-10 Finland

Melanocytic naevi of lower limb, including hip

1.6

7.5

176

954

M35.9

ICD-10 Finland

Systemic involvement of connective tissue, unspecified

1.7

7.5

140

711

M17.3

ICD-10 Finland

LabWAS

↥

(ID) Name

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

8043

42136

1.58

241.61

1.7

1.6

1.3

1.2

mg/l

1.87

6260

32495

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

10630

61768

1.44

183.05

3.2

2.9

1459.4

1495.9

ng/l

0.36

9166

52821

(3031040) Bacteria [#/volume] in Urine by Automated count

20794

136638

1.38

167.69

5.3

4.4

1751.0

1495.7

e6/l

0.30

331

1961

(3026008) Bacteria identified in Urine by Culture

10869

64587

1.40

159.35

3.5

3.1

—

(3007853) Bacteria identified in Skin by Aerobe culture

4547

23147

1.56

145.38

2.2

1.7

—

(3013707) Erythrocyte sedimentation rate by Westergren method

23014

155534

1.36

141.17

4.6

4.1

13.6

12.9

mm/h

11.64

21323

143466

(3032080) INR in Blood by Coagulation assay

13564

85103

1.34

134.33

11.4

8.5

1.3

inr

1.38

4029

23924

(3037467) Urinalysis macro (dipstick) panel - Urine

21199

142233

1.33

130.07

5.0

4.3

—

(3022217) INR in Platelet poor plasma by Coagulation assay

5161

27828

1.47

123.80

28.7

23.8

1.4

inr

2.25

847

3929

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

23423

160176

1.34

120.60

4.5

4.1

15.0

14.8

pmol/l

18.03

21311

145328

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

12779

81040

1.31

109.99

4.1

3.6

65.1

68.4

ng/l

0.07

9236

55987

(3013826) Glucose [Moles/volume] in Serum or Plasma

18294

122021

1.29

104.91

4.7

4.5

6.7

6.8

mmol/l

7.59

17274

114399

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

27117

191015

1.36

101.93

5.3

4.8

1.9

2.1

mu/l

3.68

24839

174187

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

28884

205803

1.40

98.35

17.4

14.2

22.9

24.2

mg/l

8.30

23741

163576

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

23604

163404

1.30

96.89

7.8

7.3

78.7

79.3

u/l

0.76

22183

153534

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

14652

95687

1.28

95.77

4.3

3.9

—

(3019550) Sodium [Moles/volume] in Serum or Plasma

29958

215017

1.44

95.65

19.7

16.4

139.7

mmol/l

0.22

29322

209472

(3023103) Potassium [Moles/volume] in Serum or Plasma

30006

215583

1.43

93.27

19.8

16.5

4.0

mmol/l

9.47

29330

209674

(3035350) Ketones [Presence] in Urine by Test strip

15312

100864

1.27

91.67

4.3

3.7

0.0

estimate

1.28

3119

18092

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

16203

107506

1.26

91.05

6.7

6.4

1.2

mmol/l

2.00

13432

90402

(3029937) Albumin [Presence] in Urine by Test strip

8890

54809

1.30

89.46

4.7

4.1

0.0

estimate

0.45

3073

17709

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

13435

87337

1.27

88.79

2.3

2.2

79.9

1131.1

nmol/l

0.50

11972

77923

(3009261) Glucose [Presence] in Urine by Test strip

15498

102500

1.26

88.42

4.3

3.7

0.0

estimate

0.12

3123

18006

(3021601) Nitrite [Presence] in Urine by Test strip

15308

101285

1.26

86.14

5.5

5.0

0.0

estimate

0.05

3127

18408

(3042936) Bacteria identified in Isolate by Culture

4944

28203

1.38

83.19

2.2

1.9

—

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

10440

66332

1.27

81.26

2.6

2.5

56.8

59.2

u/l

2.72

9597

61059

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

12072

78092

1.26

80.66

4.5

3.9

—

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

14673

97169

1.25

79.41

6.0

5.7

1.2

mmol/l

1.34

13214

87598

(3013512) EKG study

9841

62221

1.27

79.24

4.3

3.9

—

(3023368) Bacteria identified in Blood by Culture

9001

56535

1.28

75.70

4.6

4.1

—

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

28241

202251

1.32

74.92

5.0

4.7

5.9

6.0

mmol/l

14.33

25664

183924

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

5156

49255

0.75

70.24

4.6

4.5

22.2

22.1

0.19

2616

25333

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

10107

64875

1.25

69.33

2.2

2.1

187.2

200.8

u/l

0.94

9411

60621

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

6696

61684

0.78

68.94

5.2

4.8

3.7

ug/l

0.48

5919

54808

(3024561) Albumin [Mass/volume] in Serum or Plasma

13887

92407

1.23

67.88

4.8

4.5

34.9

35.4

g/l

15.10

12833

85322

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

16311

110469

1.22

66.61

6.1

5.9

11.4

11.2

umol/l

1.02

15462

104572

(3020564) Creatinine [Moles/volume] in Serum or Plasma

30227

219350

1.37

66.48

19.8

16.7

76.8

77.4

umol/l

2.42

30214

219240

(3019309) Folate [Moles/volume] in Red Blood Cells

6685

41100

1.28

64.90

1.9

1.8

1222.1

1165.1

nmol/l

5.06

5063

30881

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

553

1872

2.25

64.64

1.1

117.4

121.4

1.81

487

1712

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

5581

33552

1.31

64.18

2.0

1.8

—

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

7388

46045

1.27

64.15

1.7

26157619.3

35693778.1

pmol/l

0.82

6006

37853

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

8243

52055

1.26

64.05

2.4

2.2

3.1

3.0

mg/l

5.06

7139

44183

(4306422)

568

1954

2.22

63.89

1.2

—

(3019150) Specific gravity of Urine by Refractometry

7128

44478

1.27

60.72

4.7

4.1

1.0

kg/l

0.37

1106

6820

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

3689

21105

1.36

59.22

3.9

3.3

—

(40761511) CBC panel - Blood by Automated count

29415

213204

1.31

58.89

16.6

13.5

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

558

1974

2.15

58.63

1.1

—

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

26864

192561

1.26

58.55

6.1

5.9

39.9

40.0

mmol/mol

1.74

24705

177205

(3013115) Eosinophils [#/volume] in Blood

15596

106012

1.21

57.87

5.9

5.8

0.2

e9/l

2.23

13871

92592

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

30159

219598

1.33

56.08

11.6

10.4

24.2

25.6

u/l

23.61

29044

211366

(3000494) Fungus identified in Specimen by Culture

4017

23464

1.33

55.95

1.5

1.4

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

3577

34965

0.75

55.45

3.1

0.8

ug/l

0.16

2504

24249

(3021960) Folate [Moles/volume] in Serum or Plasma

7776

49435

1.24

55.44

1.6

1.5

20.7

nmol/l

0.01

6615

42127

(3006315) Basophils [#/volume] in Blood

15107

102691

1.20

54.85

5.8

5.6

0.0

e9/l

2.86

13296

88402

(3001604) Monocytes [#/volume] in Blood

15017

102149

1.20

53.65

5.8

5.6

0.6

e9/l

7.44

13208

87885

(3013650) Neutrophils [#/volume] in Blood by Automated count

17282

119180

1.19

52.57

8.8

4.0

4.1

e9/l

4.72

15346

103791

(3019198) Lymphocytes [#/volume] in Blood

15362

104891

1.19

51.98

5.9

5.7

1.8

1.9

e9/l

4.74

13685

91894

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

5822

36081

1.26

51.26

1.3

32.7

38.3

iu/ml

1.52

1909

11598

(3041096) Erythrocytes [Presence] in Urine by Automated

8340

53784

1.23

51.25

3.9

3.4

—

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

28818

209051

1.27

50.63

5.3

5.1

2.7

2.8

mmol/l

5.43

26372

191846

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

3147

17998

1.35

50.12

3.1

2.8

210.4

218.4

ng/l

0.43

2870

16463

(3001122) Ferritin [Mass/volume] in Serum or Plasma

12774

85970

1.20

50.10

3.0

2.8

130.1

135.0

ug/l

1.07

11742

79038

(3007461) Platelets [#/volume] in Blood

31013

227241

1.35

50.00

25.2

21.0

247.0

252.8

e9/l

47.30

30347

220757

(3010813) Leukocytes [#/volume] in Blood

31029

227404

1.35

49.65

25.2

21.1

6.5

6.7

e9/l

27.95

30268

220156

(3024731) MCV [Entitic volume]

31024

227363

1.35

49.64

25.1

21.0

91.6

91.3

22.06

30578

223712

(3035941) MCH [Entitic mass]

31019

227346

1.35

49.32

25.1

20.9

30.3

1.41

30571

223698

(3026361) Erythrocytes [#/volume] in Blood

31023

227380

1.35

49.32

25.2

21.0

4.4

4.5

e12/l

77.01

30238

220133

(3000963) Hemoglobin [Mass/volume] in Blood

31026

227422

1.34

49.11

25.3

21.2

132.5

134.3

g/l

91.48

30586

223795

(42870588) Differential panel, method unspecified - Blood

10549

69981

1.20

47.77

5.9

5.7

—

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

5495

34168

1.26

46.47

1.3

11.3

13.4

u/ml

1.22

2126

13131

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

13080

88661

1.19

45.99

2.1

2.0

97.2

96.0

pmol/l

1.96

6738

45197

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

546

2119

1.96

44.86

1.3

1.2

3.4

3.7

u/ml

0.18

204

699

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

28203

204779

1.24

43.51

4.8

4.5

4.7

mmol/l

0.46

25955

188874

(3019225) pH of Specimen

3592

21393

1.30

42.69

4.4

4.1

—

(3006504) Eosinophils/100 leukocytes in Blood

14005

95902

1.18

42.38

6.1

5.8

2.9

0.29

13051

88962

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

27982

203132

1.23

42.30

4.7

4.5

1.5

mmol/l

40.37

25642

186316

(3019069) Monocytes/100 leukocytes in Blood

14060

96412

1.17

41.51

6.5

6.1

8.7

8.6

0.91

13168

89855

(3027456) Digoxin [Moles/volume] in Serum or Plasma

893

4120

1.65

41.35

3.3

3.1

0.8

nmol/l

0.13

706

3184

(3044640) Blood type and Crossmatch panel - Blood

9819

65363

1.19

41.25

2.5

2.4

—

(3015377) Calcium [Moles/volume] in Serum or Plasma

10881

73086

1.18

41.17

3.2

3.4

2.4

mmol/l

1.57

9410

63306

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

27099

196275

1.21

40.59

4.2

4.0

1.2

1.3

mmol/l

35.04

24635

178674

(3022948) Iron [Moles/volume] in Serum or Plasma

5238

32885

1.24

39.96

2.6

2.4

12.4

12.9

umol/l

6.11

4809

30303

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

2633

15159

1.34

39.69

1.7

1.6

—

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

1635

8707

1.44

39.42

2.1

1.9

—

(3037522) Nuclear Ab [Titer] in Serum

4459

27564

1.26

38.97

1.4

1.3

605.9

552.6

titre

0.94

1017

5925

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

514

2056

1.90

38.71

1.3

1.2

3.7

u/ml

0.02

233

869

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

7548

49330

1.20

38.34

2.5

2.3

—

(3022096) Basophils/100 leukocytes in Blood

13562

93115

1.17

38.29

6.1

5.9

0.7

1.01

12647

86417

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

386

1401

2.09

38.16

1.1

94.6

96.7

0.84

354

1320

(3000850) Epithelial cells [#/volume] in Urine

6772

43829

1.21

38.12

2.7

2.6

5.6

5.5

e6/l

0.36

5928

38213

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

998

4881

1.56

36.36

2.2

2.0

93.8

91.4

2.74

905

4573

(3002030) Lymphocytes/100 leukocytes in Blood

14287

98737

1.16

36.32

6.2

5.9

27.3

27.6

2.80

13299

91456

(3004789) Transferrin [Mass/volume] in Serum or Plasma

4832

30361

1.24

36.22

2.6

2.4

2.3

g/l

2.58

4422

27967

(40761536) Microorganisms panel - Urine sediment

2859

16934

1.30

35.04

4.6

4.0

—

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

2246

12865

1.34

34.90

3.9

3.4

5.2

kpa

2.47

2050

11837

(3018010) Neutrophils/100 leukocytes in Blood

14058

97255

1.16

34.63

6.0

5.7

57.6

57.5

0.50

13132

90496

(3009343) pH of Capillary blood

2213

12690

1.34

34.11

3.9

3.4

7.4

0.42

303

1638

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

1484

7987

1.42

33.71

2.0

1.8

—

(40768443) Skin Pathology biopsy report

1686

9286

1.39

33.53

1.2

—

(40760892) CBC W Ordered Manual Differential panel - Blood

6761

44199

1.19

33.49

4.6

4.4

—

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

2138

12243

1.34

33.24

3.8

3.4

2.0

1.8

mmol/l

2.08

1646

9084

(3018418) pH of Serum or Plasma

9476

64026

1.16

31.05

4.2

3.9

7.4

0.79

2025

11857

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

4469

28277

1.22

30.88

2.7

2.5

21.4

22.5

4.94

3692

24009

(3036489) Thrombin time

1202

6336

1.45

30.57

1.9

21.7

21.5

0.36

999

5653

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

253

849

2.26

30.48

1.2

1.1

ratio

0.45

307

(3027945) Reticulocytes/100 erythrocytes in Blood

3799

23726

1.24

29.65

2.6

2.3

1.8

2.20

3304

20877

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

6424

42208

1.18

29.49

1.3

1.2

1.4

1.7

u/ml

1.06

1834

11139

(3023520) Reticulocytes [#/volume] in Blood

2908

17675

1.27

28.81

2.7

2.5

69.1

68.9

e9/l

0.07

2239

13480

(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay

189

580

2.47

27.81

1.1

1.0

95.6

99.7

0.95

148

469

(3012095) Magnesium [Moles/volume] in Serum or Plasma

5207

33756

1.20

27.63

3.1

3.2

0.8

mmol/l

0.06

4833

31315

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

3011

18491

1.25

27.24

2.5

2.3

5.5

7.0

ug/l

4.64

2555

15970

(3026493) Urate [Moles/volume] in Serum or Plasma

8269

55745

1.16

27.13

2.7

2.5

4035.8

4874.6

umol/l

1.11

7057

47972

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

1101

5839

1.44

27.12

1.8

1.6

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

3679

23108

1.23

27.04

1.8

1.7

—

(3044889) 12 lead EKG panel

20729

148622

1.14

26.93

4.2

3.8

—

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

3108

19197

1.25

26.69

2.2

2.1

0.2

g/l

12.68

2872

17853

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

2890

17713

1.25

26.57

4.0

3.7

1.2

mmol/l

1.06

2537

15369

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

2695

16399

1.26

26.35

3.6

91.1

90.1

ng/l

0.21

2287

13978

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

6218

41125

1.17

25.91

4.0

3.7

244.3

486.2

ng/l

7.84

4932

32178

(3004588) Protein electrophoresis panel - Serum or Plasma

2418

14557

1.27

25.83

2.3

2.4

—

(3025159) Blasts/100 leukocytes in Blood

2575

15710

1.26

24.57

4.3

4.0

0.5

0.2

0.86

655

3873

(3019060) Gas panel - Arterial blood

2328

14036

1.27

24.53

4.7

—

(3020630) Protein [Mass/volume] in Serum or Plasma

2848

17598

1.24

24.27

2.5

2.6

66.4

66.5

g/l

0.18

2546

15910

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

3653

23167

1.21

24.24

1.8

1.7

—

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

26727

195419

1.15

24.08

15.7

13.4

76.7

78.3

ml/min/173m2

30.53

22535

161481

(3017181) Myelocytes/100 leukocytes in Blood

2843

17591

1.24

23.92

4.2

3.9

1.0

0.9

0.58

807

4965

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

4964

32413

1.18

23.92

1.4

—

(3003458) Phosphate [Moles/volume] in Serum or Plasma

4196

27004

1.20

23.82

5.5

5.4

1.0

mmol/l

1.96

3873

24936

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

552

2602

1.61

23.64

1.6

1.5

58.9

58.1

0.15

333

1626

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

1104

6005

1.40

23.63

1.3

—

(3036481) Cortisol [Moles/volume] in Serum or Plasma

2910

18075

1.24

23.62

2.2

364.1

376.0

nmol/l

2.55

2679

16560

(3021440) Promyelocytes/100 leukocytes in Blood

2709

16713

1.24

23.39

4.2

4.0

0.1

0.27

756

4579

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

878

4590

1.46

23.38

2.2

2.3

197.1

194.3

0.39

827

4345

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

1186

6548

1.38

23.24

3.3

2.8

0.4

0.3

u/ml

0.75

720

3645

(4268621)

338

1397

1.84

23.23

2.3

2.2

—

(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum

196

665

2.23

23.15

1.2

1.1

37.3

15.3

u/ml

0.42

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

4077

26242

1.20

23.05

4.7

4.6

33.1

32.6

2.24

2868

17586

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

853

4451

1.46

22.94

1.4

1.3

—

(3018677) aPTT in Platelet poor plasma by Coagulation assay

4818

31524

1.18

22.53

2.0

1.9

30.0

29.7

2.79

4651

30561

(3000475) Leukocytes [#/volume] in Synovial fluid

943

5032

1.43

22.51

1.7

1.6

14123.6

12760.4

e6/l

0.37

690

3659

(3022313) Gas panel - Capillary blood

1575

9126

1.32

22.47

4.1

3.5

—

(3002179) Metamyelocytes/100 leukocytes in Blood

2583

15925

1.24

22.41

4.0

3.8

0.8

0.7

0.92

581

3566

(21494755) Public health laboratory ask at order entry panel

1660

16048

0.77

22.30

1.4

—

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

1448

8300

1.33

22.28

2.1

1.9

2.2

2.3

ug/l

0.02

1271

7263

(3008152) Bicarbonate [Moles/volume] in Arterial blood

2198

13320

1.26

22.16

6.8

6.9

24.8

24.6

mmol/l

2.40

2049

12398

(40761535) Cells panel - Urine sediment

2828

17628

1.23

22.15

3.9

3.5

—

(3018095) Leukocytes [#/volume] in Urine

10591

73445

1.13

21.80

4.0

3.6

110.2

110.3

e6/l

0.01

7818

52221

(3015171) Extractable nuclear Ab [Units/volume] in Serum

1420

8162

1.33

21.44

1.3

1.2

1.4

0.8

u/ml

0.90

145

756

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

1062

5843

1.39

21.27

1.7

1.6

0.2

g/l

1.58

1011

5517

(40768797) Stomach Pathology biopsy report

4520

29558

1.18

21.17

1.2

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

205

737

2.11

21.04

1.2

1.1

—

(3016502) Oxygen saturation in Arterial blood

3373

21516

1.20

20.90

6.6

7.2

95.6

0.23

3239

20685

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

1089

6035

1.38

20.88

1.7

1.6

1.2

g/l

0.78

1038

5720

(3003396) Base excess in Arterial blood by calculation

3737

24095

1.19

20.58

6.4

6.9

1.4

1.1

mmol/l

6.02

2947

18923

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

1016

5581

1.39

20.56

1.5

1.4

—

(3047181) Lactate [Moles/volume] in Blood

1163

6536

1.36

20.42

5.6

5.8

1.2

1.3

mmol/l

3.26

1027

5763

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

1683

16068

0.78

20.42

1.7

1.8

—

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

3736

24111

1.19

20.35

6.4

6.9

5.1

kpa

1.70

3541

22963

(3027801) Oxygen [Partial pressure] in Arterial blood

3734

24099

1.19

20.33

6.4

6.9

11.9

12.4

kpa

6.24

3538

22931

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

1361

7836

1.33

20.32

4.3

3.7

25.1

24.9

mmol/l

1.96

1248

7167

(3002582) Erythrocytes [#/volume] in Urine

9154

63173

1.13

19.97

3.5

3.2

83.7

99.6

e6/l

0.46

7247

48366

(40768804) Tissue Pathology biopsy report

12426

87346

1.12

19.72

2.2

2.1

—

(3009445) Proteinase 3 Ab [Units/volume] in Serum

1498

8798

1.30

19.37

1.5

19.9

15.1

u/ml

0.41

201

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

4101

26843

1.18

18.83

7.9

7.1

—

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

2005

12277

1.25

18.44

1.8

1.7

—

(3021788) Differential panel - Synovial fluid

713

3759

1.44

18.25

1.6

1.5

—

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

5961

40212

1.15

18.22

3.0

2.5

mmol/l

2.97

5236

34959

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

3643

23688

1.18

18.07

4.1

4.0

249.6

245.3

u/l

0.79

3397

22314

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

1100

6260

1.34

17.82

2.0

1.7

—

(3026782) Osmolality of Urine

6062

41007

1.14

17.73

2.9

2.7

515.8

541.2

mosm/kgh2o

15.54

5182

34800

(3002173) Hemoglobin [Mass/volume] in Arterial blood

3077

19776

1.19

17.43

7.1

7.7

120.3

120.7

g/l

0.38

2953

19046

(3028271) Lactate [Moles/volume] in Capillary blood

621

3221

1.47

17.34

1.9

1.7

mmol/l

0.22

606

3146

(3011397) Hemoglobin [Presence] in Urine by Test strip

7071

48393

1.13

17.18

4.3

3.7

—

(3016628) Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Immunoassay

120

377

2.41

17.02

1.3

1.2

47.8

44.6

mg/l

0.03

276

(3037756) Immunofixation for Serum or Plasma

819

4487

1.39

16.91

1.7

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

1925

11857

1.24

16.78

2.5

2.4

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

303

1350

1.70

16.31

1.5

1.3

—

(3015235) Bicarbonate [Moles/volume] in Capillary blood

937

5279

1.35

16.26

3.2

3.0

25.1

24.8

mmol/l

1.34

805

4634

(40767503) Oxygen content in Capillary blood by calculation

801

4413

1.38

16.01

2.7

2.5

16.1

16.2

0.13

407

2306

(3020779) Urea [Moles/volume] in Serum or Plasma

2794

17943

1.19

15.93

6.9

6.8

10.8

10.2

mmol/l

4.39

2651

16956

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

297

1326

1.70

15.88

1.5

1.4

—

(3037121) Protein [Mass/volume] in Urine

1181

6905

1.30

15.83

3.1

3.0

0.3

g/l

0.07

442

2812

(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence

745

4069

1.39

15.70

1.3

1.2

100.0

144.0

titre

0.60

(3022806) Fractional oxyhemoglobin in Capillary blood

511

2609

1.49

15.50

1.9

1.8

89.1

89.5

0.74

506

2568

(3010421) pH of Blood

953

5423

1.34

15.49

4.1

3.9

7.4

0.29

810

4571

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

143

506

2.14

15.44

1.1

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

524

2697

1.48

15.28

1.5

1.4

—

(3048689) Calprotectin [Mass/mass] in Stool

3508

23043

1.17

15.23

2.1

146.9

137.2

ug/g

0.69

2711

17892

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

403

1964

1.56

15.19

1.6

1.5

30.7

29.4

0.29

243

1194

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

1954

12191

1.22

15.08

1.5

—

(3030981) Hyaline casts [#/volume] in Urine by Automated count

1813

11229

1.23

15.01

2.8

2.7

0.3

e6/l

0.33

1771

10932

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

1294

0.37

14.83

1.5

1.4

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

1293

0.37

14.80

1.5

1.4

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

1292

0.37

14.78

1.5

1.4

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

693

3780

1.39

14.75

1.7

1.6

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

1290

0.37

14.73

1.5

1.4

—

(3028626) Oxygen [Partial pressure] in Capillary blood

808

4524

1.36

14.64

3.2

2.8

8.0

kpa

0.05

747

4194

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

510

2634

1.47

14.64

1.5

1.4

—

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

607

3243

1.42

14.56

1.6

1.4

—

(3010144) Erythrocytes [#/volume] in Synovial fluid

398

1958

1.54

14.42

1.4

139793.1

112409.1

e6/l

0.29

259

1365

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

134

476

2.13

14.37

1.2

1.1

—

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

892

5089

1.33

14.28

2.4

2.3

3.7

g/l

0.10

845

4853

(3024522) Salmonella sp identified in Specimen by Organism specific culture

508

2639

1.46

14.17

1.5

1.4

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

1376

0.40

14.15

1.4

—

(3027315) Oxygen [Partial pressure] in Blood

833

4717

1.34

14.04

4.4

4.0

8.4

8.5

kpa

2.21

816

4592

(4034850)

1170

6944

1.28

14.02

10.3

10.0

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

502

2610

1.46

13.95

1.5

1.4

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

502

2612

1.46

13.90

1.5

1.4

—

(3013290) Carbon dioxide [Partial pressure] in Blood

827

4691

1.34

13.79

4.3

4.0

5.1

5.0

kpa

1.44

810

4567

(3012501) Base excess in Blood by calculation

826

4690

1.34

13.68

4.3

4.0

2.7

2.5

mmol/l

1.16

601

3211

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

918

5299

1.32

13.57

1.3

6.1

6.4

u/ml

0.05

169

849

(3025468) Yersinia sp identified in Specimen by Organism specific culture

499

2607

1.45

13.54

1.5

1.4

—

(3025941) Bacteria identified in Stool by Culture

1811

11352

1.22

13.35

1.3

—

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

766

4320

1.35

13.29

1.3

1.2

5.4

6.1

u/ml

0.12

333

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

903

5217

1.32

13.27

1.3

7.3

5.2

u/ml

0.21

117

528

(3006184) Hemoglobin [Mass/volume] in Capillary blood

842

4820

1.33

13.21

2.4

2.2

128.1

128.5

g/l

0.15

631

3449

(3005322) IgE [Units/volume] in Serum or Plasma

1921

12124

1.21

13.20

1.3

190.8

228.9

u/ml

0.87

1765

11208

(3043238) Trisomy 21 risk [Likelihood] in Fetus

1123

0.37

13.09

1.4

1.5

—

(21491868) Cryoglobulin [Mass/volume] in Serum

160

630

1.92

13.02

1.1

1.2

0.7

0.5

g/l

—

(3021589) Normoblasts [#/volume] in Blood

12733

90902

1.09

13.02

10.9

9.4

0.0

e9/l

0.51

10757

74399

(3030467) Casts [#/volume] in Urine by Automated count

8278

57912

1.11

12.98

3.4

3.1

0.4

e6/l

0.30

6405

43558

(3000570) Elastase.pancreatic [Mass/mass] in Stool

1036

6138

1.28

12.63

1.4

271.0

271.3

ug/g

0.02

649

3596

(3005719) IgG [Mass/volume] in Serum or Plasma

2284

14704

1.19

12.62

2.9

2.7

10.6

10.5

g/l

0.18

2094

13419

(3021901) Oxygen saturation in Capillary blood

693

3881

1.36

12.61

3.0

2.8

—

(4024509)

396

2006

1.50

12.59

1.6

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

825

4745

1.32

12.55

1.7

1.6

—

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

2619

17077

1.17

12.42

2.7

62.4

64.1

ml/min/173m2

1.59

1126

6921

(3007164) IgA [Mass/volume] in Serum or Plasma

5361

36711

1.12

12.41

1.5

1.4

2.6

2.4

g/l

2.51

3205

21728

(3047352) Trisomy 18 risk [Likelihood] in Fetus

1083

0.38

12.39

1.4

—

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

975

5748

1.29

12.36

1.3

1.2

43.7

37.5

u/ml

0.29

318

(3017732) Neutrophils [#/volume] in Blood

2217

14264

1.19

12.34

3.0

2.9

3.9

4.1

e9/l

3.35

1659

10821

(3005033) Fetal Nuchal fold Thickness US

1078

0.38

12.26

1.4

—

(3044927) Protein electrophoresis panel - Urine

411

2110

1.48

12.25

1.2

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

792

4548

1.32

12.19

3.9

3.4

25.6

26.9

mg/l

0.46

506

2895

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

821

4742

1.32

12.13

1.5

1.6

—

(3004616) Nuclear Ab [Presence] in Serum

485

2577

1.43

12.08

1.3

—

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

1129

6807

1.26

11.95

3.1

3.3

38.9

46.4

mg/l

1.26

887

5529

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

378

1920

1.49

11.89

2.9

2.8

—

(3044941) Cell count panel - Synovial fluid

585

3224

1.38

11.81

1.5

1.4

—

(3034860) Kappa light chains.free [Mass/volume] in Serum

1129

6825

1.26

11.69

3.2

3.3

52.1

75.7

mg/l

1.17

886

5543

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

1125

10540

0.80

11.60

1.4

1.5

—

(3014271) Vancomycin [Susceptibility]

242

1117

1.64

11.57

3.4

2.9

—

(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

749

4301

1.32

11.56

1.3

1.2

11.7

u/ml

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

924

8846

0.78

11.49

1.3

36.0

37.2

iu/l

0.48

818

7756

(3022145) Colonoscopy Study observation

3529

23650

1.14

11.49

1.3

—

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

1096

6622

1.26

11.41

3.1

3.3

2.1

3.4

ratio

1.38

504

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

1524

9545

1.22

11.36

1.7

1.6

g/l

0.27

1283

8078

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

160

2110

0.57

11.21

1.6

1.5

—

(3039000) Anion gap in Blood

803

4677

1.30

11.20

6.7

6.6

11.0

11.2

mmol/l

1.18

722

4202

(3018572) Chloride [Moles/volume] in Blood

803

4678

1.30

11.18

6.7

6.6

104.9

105.2

mmol/l

1.14

722

4203

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

319

1586

1.52

11.15

1.6

1.5

30.9

24.7

u/ml

0.88

333

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

2022

13036

1.18

11.00

3.2

3.3

4.4

pmol/l

0.55

1807

11546

(40760888) Immunoglobulin light chains.free panel - Serum

873

5158

1.29

10.93

3.2

3.4

—

(3016879) Cocaine [Presence] in Urine

306

3450

0.67

10.91

1.7

1.8

—

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

1127

6873

1.25

10.84

1.7

1.6

241.8

238.3

titre

0.02

305

(36304419) Bacteria [Presence] in Urine

7968

56051

1.10

10.80

3.3

3.0

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

1185

7283

1.24

10.62

2.7

2.6

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

780

4567

1.30

10.49

1.6

—

(40768800) Prostate Pathology biopsy report

371

4000

0.70

10.43

1.2

—

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

2404

20771

0.86

10.06

1.7

1.5

1.09

2069

18001

(1001926) Buprenorphine [Presence] in Urine by Screen method

248

2867

0.65

10.05

1.7

1.8

—

(3000764) Benzodiazepines [Presence] in Urine

345

3738

0.69

9.99

1.7

1.8

—

(3028300) Cannabinoids [Presence] in Urine

349

3770

0.70

9.94

1.7

1.8

—

(3034891) Synovial lining cells/100 cells in Synovial fluid

216

1009

1.62

9.93

1.5

2.0

4.1

3.00

226

(3027008) Opiates [Presence] in Urine

348

3759

0.70

9.91

1.7

—

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

350

2.08

9.80

1.2

1.1

—

(3027944) Amphetamines [Presence] in Urine

342

3692

0.70

9.72

1.7

1.8

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

213

1002

1.61

9.54

1.5

1.4

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

213

1002

1.61

9.54

1.5

1.4

—

(4010399)

2328

15352

1.16

9.52

1.4

—

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

239

1157

1.56

9.50

2.0

1.9

2.1

2.4

u/field

0.26

169

799

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

739

4357

1.29

9.47

3.4

3.2

502.6

887.6

u/ml

0.67

667

3962

(3028026) IgM [Mass/volume] in Serum or Plasma

1778

11492

1.18

9.41

1.9

1.2

1.4

g/l

1.51

1614

10398

(36660697) Celiac disease serology panel - Serum

2301

15176

1.16

9.40

1.2

—

(3020891) Body temperature

1338

8435

1.21

9.38

4.6

4.7

—

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

1733

11182

1.18

9.36

8.4

9.3

—

(3017704) Immunofixation for Urine

241

1173

1.56

9.36

1.7

1.6

—

(3018405) Lactate [Moles/volume] in Arterial blood

1189

7424

1.22

9.21

4.0

1.3

1.4

mmol/l

1.19

1168

7287

(1616796) Gas panel - Central venous blood

782

4665

1.27

9.15

4.0

3.5

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

16253

118231

1.07

9.12

2.6

2.7

—

(3045414) Leukocytes [Presence] in Urine

1481

9452

1.19

9.09

2.0

1.9

—

(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence

264

1323

1.51

9.00

1.3

67.3

60.1

titre

0.12

109

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

193

901

1.62

8.95

2.5

2.4

—

(3022621) pH of Urine by Test strip

2125

13993

1.16

8.88

3.3

3.0

—

(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum

315

1642

1.45

8.85

1.3

1.2

87.1

70.9

u/ml

0.39

(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum

315

1647

1.45

8.71

1.3

1.2

65.3

41.1

u/ml

1.17

125

(3036670) Protein [Mass/volume] in Synovial fluid

141

611

1.75

8.64

1.3

1.2

40.3

38.9

g/l

0.54

319

(3007930) Methemoglobin/Hemoglobin.total in Blood

1369

8721

1.19

8.60

5.2

4.9

0.9

1.20

1278

8176

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

7872

55827

1.08

8.53

1.7

1.3

1.4

mmol/l

6.45

6445

46616

(3013139) Helicobacter pylori Ag [Presence] in Stool

2151

14223

1.15

8.49

1.2

—

(3011288) Drugs identified in Urine by Screen method

214

2456

0.66

8.46

1.9

2.4

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

1268

11356

0.84

8.35

1.6

1.7

—

(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence

267

1364

1.48

8.34

1.3

673.0

346.8

titre

0.62

103

(3035947) Staphylolysin Ab [Units/volume] in Serum

198

950

1.58

8.25

1.1

3.3

4.2

iu/ml

0.55

(3045424) Erythrocytes [Presence] in Urine

605

3546

1.29

8.19

1.6

1.5

—

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

1384

8866

1.19

8.18

5.1

4.8

1.6

0.17

1292

8321

(3012516) Albumin [Mass/volume] in Urine

8961

63978

1.08

8.13

3.3

3.2

587.2

405.6

mg/l

2.19

5450

39424

(3038026) Centromere Ab [Units/volume] in Serum

318

1692

1.42

8.05

1.3

1.2

52.5

55.2

u/ml

0.04

(3017446) Testosterone [Moles/volume] in Serum or Plasma

1267

11307

0.84

8.03

2.1

11.7

11.8

nmol/l

0.29

1080

9817

(3039443) Prostate specific Ag panel - Serum or Plasma

240

2661

0.68

7.99

1.6

1.7

—

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

18125

132682

1.07

7.98

3.2

3.0

50.6

49.3

u/l

0.90

16745

122787

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

1339

8581

1.19

7.89

2.1

1.9

39.2

39.4

u/l

0.15

1160

7560

(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay

297

1571

1.43

7.78

1.3

1.2

3.7

8.9

u/ml

1.24

108

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

904

5591

1.23

7.76

1.7

1.4

15.7

15.6

iu/ml

0.01

140

(3020682) Albumin/Creatinine [Ratio] in Urine

9425

67531

1.08

7.69

4.0

3.9

9.5

8.4

mg/mmol

1.17

5633

41693

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

1814

11939

1.16

7.66

3.6

3.5

73.1

53.5

u/ml

0.80

1750

11518

(1002224) Polysomnography panel

841

7760

0.81

7.63

1.0

1.1

—

(3019174) dRVVT (LA screen)

107

2.76

7.48

1.3

1.2

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

301

1611

1.42

7.42

1.5

—

(3034426) Prothrombin time (PT)

114

487

1.77

7.41

1.2

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

584

3457

1.28

7.37

1.6

—

(3039162) Centromere protein B Ab [Units/volume] in Serum

447

2553

1.33

7.35

1.3

1.2

55.8

58.8

u/ml

0.08

175

(3026470) Cobalt [Mass/volume] in Blood

259

1355

1.45

7.24

2.0

4.1

3.5

ug/l

0.42

233

1197

(3044009) aPTT.lupus sensitive (LA screen)

105

2.74

7.20

1.2

—

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

1107

7042

1.19

7.14

2.3

2.2

429.9

571.4

ug/l

1.03

1036

6586

(3043409) Potassium [Moles/volume] in Arterial blood

1018

6430

1.20

7.09

4.3

3.9

mmol/l

0.86

951

6049

(3004716) Salmonella sp identified in Stool by Organism specific culture

1407

9152

1.17

6.97

1.4

—

(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay

413

2353

1.33

6.94

3.5

3.9

41.3

51.7

u/ml

0.83

408

2326

(3026389) Candida sp identified in Specimen by Organism specific culture

515

3026

1.29

6.92

1.4

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

467

2712

1.31

6.86

1.4

1.5

—

(44806071)

177

2.26

6.84

1.1

—

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

451

2613

1.31

6.75

6.2

6.1

11.9

mg/l

0.00

410

2382

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

418

1.79

6.74

1.3

1.2

—

(3003181) Sodium [Moles/volume] in Urine

621

3757

1.25

6.59

1.3

65.1

62.2

mmol/l

1.04

503

2976

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

659

4015

1.24

6.58

3.0

2.9

—

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

1211

7827

1.18

6.52

1.1

7.5

u/ml

1.12

119

(3009508) Creatinine [Moles/volume] in Urine

9193

66138

1.07

6.45

3.2

3.1

6.7

7.3

mmol/l

40.23

7686

55047

(3001019) Free T4 and TSH panel - Serum or Plasma

1107

9800

0.85

6.44

1.7

—

(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum

158

767

1.56

6.38

1.7

2.0

61.3

54.8

ug/l

0.41

153

750

(43055442) Apixaban [Mass/volume] in Serum or Plasma

285

1.94

6.34

1.5

113.0

112.2

ug/l

0.02

236

(3025577) Chromium [Mass/volume] in Blood

248

1322

1.42

6.33

2.1

2.0

2.6

2.3

ug/l

0.54

214

1106

(3004809) Band form neutrophils/100 leukocytes in Blood

562

3380

1.26

6.30

3.5

3.2

1.4

1.5

0.53

451

2599

(43055246) Days in therapeutic INR range/Days INR result determined [Ratio]

106

467

1.72

6.27

7.2

5.2

70.2

70.1

0.01

366

(3028707) Methadone [Presence] in Urine by Screen method

146

1695

0.65

6.24

1.6

2.2

—

(4015189)

122

563

1.64

6.09

2.5

2.2

—

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

681

4208

1.23

6.00

1.3

1.2

40.3

47.3

u/ml

0.58

427

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

460

2718

1.28

5.99

2.4

2.0

28.0

26.1

mg/l

0.27

128

724

(3000012) Reticulocyte production index

226

1198

1.43

5.98

1.4

1.5

—

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1260

8231

1.16

5.96

2.3

2.2

7.5

7.4

g/l

0.44

885

6056

(3008295) Osmolality of Serum or Plasma

351

2001

1.33

5.95

1.4

277.0

277.5

mosm/kgh2o

0.15

274

1529

(3042631) Mycobacterium sp identified in Specimen

498

2976

1.27

5.92

2.6

—

(3023183) Ammonium ion [Moles/volume] in Plasma

632

3881

1.23

5.92

2.6

2.1

32.1

32.7

umol/l

0.31

524

3217

(3012215) Mononuclear cells/100 leukocytes in Synovial fluid

114

523

1.65

5.84

1.3

1.2

36.8

38.6

0.17

352

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1256

8223

1.16

5.78

2.3

2.2

—

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1254

8209

1.16

5.78

2.3

2.2

3.9

3.8

g/l

0.77

831

5799

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

226

1207

1.42

5.76

1.8

—

(3006442) Creatine [Moles/volume] in Serum or Plasma

251

1367

1.39

5.72

1.7

1.5

64.5

69.0

umol/l

0.99

107

(3052592) Norovirus Ag [Presence] in Stool

412

1.73

5.71

1.4

1.3

—

(3040151) Glucose [Moles/volume] in Capillary blood

406

2380

1.29

5.65

8.3

10.3

7.4

7.5

mmol/l

0.07

330

1949

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

817

5182

1.20

5.54

1.1

6.8

7.9

u/ml

0.24

587

(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay

174

892

1.48

5.52

1.9

1.7

97.3

101.9

0.90

157

834

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

1809

12182

1.13

5.51

6.5

6.7

25.2

24.8

mmol/l

3.69

1792

12057

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1177

7701

1.16

5.49

2.4

2.3

3.1

g/l

0.50

844

5938

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

1158

10080

0.86

5.47

1.6

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

507

3074

1.25

5.37

1.4

—

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

780

4942

1.20

5.37

2.8

2.7

1.7

1.6

mg/l

2.69

696

4479

(3009015) Lactate [Moles/volume] in Synovial fluid

207

2.01

5.36

1.3

5.9

6.3

mmol/l

0.19

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

200

1061

1.43

5.32

1.8

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

200

1062

1.43

5.30

1.8

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

200

1062

1.43

5.30

1.8

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

200

1062

1.43

5.30

1.8

—

(3012544) pH of Venous blood

2877

19931

1.10

5.20

3.9

3.7

7.4

0.38

106

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

3353

23406

1.09

5.13

3.8

3.9

26.2

25.3

ug/l

0.05

2700

18928

(40761539) Cells [Type] in Urine sediment by Light microscopy

109

513

1.61

5.11

1.3

1.1

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

308

1770

1.32

5.02

1.6

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

308

1770

1.32

5.02

1.6

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

308

1770

1.32

5.02

1.6

—

(3002032) Base excess in Venous blood by calculation

2766

19171

1.10

4.96

3.9

3.7

2.2

1.9

mmol/l

3.80

2293

15633

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

4162

29359

1.08

4.95

1.4

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

661

5948

0.84

4.77

1.6

1.7

—

(3019977) pH of Arterial blood

216

1186

1.38

4.77

2.6

2.5

7.4

0.04

420

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

374

2223

1.27

4.75

1.5

1.6

—

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

9238

66999

1.06

4.72

3.3

3.1

33.1

34.5

u/l

1.01

8739

63306

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

1401

9387

1.13

4.69

1.1

1.0

—

(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood

385

1.67

4.66

3.0

2.4

—

(3021447) Carbon dioxide [Partial pressure] in Venous blood

2761

19192

1.09

4.66

3.9

3.7

5.9

5.8

kpa

4.82

2669

18634

(3008757) Leukocyte morphology finding [Identifier] in Blood

379

2269

1.26

4.55

3.9

3.6

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

312

1823

1.30

4.55

2.1

2.0

2.4

u/field

0.58

150

706

(3014007) Fractional oxyhemoglobin in Arterial blood

1918

13114

1.11

4.53

7.9

8.7

93.7

93.9

0.33

1911

13065

(3020717) Zinc [Moles/volume] in Serum or Plasma

171

911

1.42

4.52

1.5

1.3

21.3

26.4

umol/l

1.54

164

854

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

154

2.06

4.45

1.1

1.0

—

(3051593) INR in Capillary blood by Coagulation assay

194

1060

1.38

4.44

11.2

10.5

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

440

2688

1.24

4.44

1.4

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

249

2473

0.76

4.42

1.6

1.5

—

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

234

2343

0.75

4.40

1.4

0.4

0.3

nmol/l

0.50

163

1651

(3034459) Mononuclear cells/100 leukocytes in Pleural fluid

234

1.84

4.39

1.4

62.3

76.7

2.28

199

(3051101) Glucose [Moles/volume] in Cord blood

444

0.44

4.36

5.1

5.8

—

(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma

286

1663

1.30

4.35

2.1

1.8

4.0

3.9

mg/l

0.15

272

1576

(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood

1914

13123

1.11

4.31

7.8

8.5

1.4

1.65

1903

13032

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

205

1137

1.36

4.30

1.5

—

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

152

806

1.43

4.16

2.7

2.3

—

(3006217) Methemoglobin/Hemoglobin.total in Arterial blood

1906

13093

1.11

4.15

7.9

8.6

0.7

0.67

1897

13006

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

894

5863

1.16

4.14

1.6

0.5

10.0

iu/ml

1.87

195

1275

(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma

110

548

1.52

4.12

1.5

0.4

ug/l

0.14

355

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

267

1.76

4.12

1.0

1.1

—

(3014111) Lactate [Moles/volume] in Serum or Plasma

2610

18208

1.09

4.09

6.1

6.6

1.3

mmol/l

0.01

2507

17517

(40758558) Short blood count panel - Blood

7340

53087

1.06

4.06

6.4

6.7

—

(3023487) Leukocytes [#/volume] in Peritoneal fluid

118

603

1.48

3.94

1.9

1.7

5192.7

2887.8

e6/l

0.22

392

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

838

5494

1.16

3.93

2.2

2.0

11.2

11.1

mg/l

0.10

777

5103

(3017354) Segmented neutrophils/100 leukocytes in Blood

352

2131

1.25

3.91

3.2

59.2

58.4

0.24

246

1357

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

1043

6949

1.14

3.88

2.4

0.8

1.0

g/l

0.56

869

5891

(3014576) Chloride [Moles/volume] in Serum or Plasma

3722

26398

1.07

3.84

6.4

6.8

104.2

104.4

mmol/l

1.59

3617

25822

(3011335) Digoxin [Mass/volume] in Serum or Plasma

174

1.91

3.84

2.5

2.3

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

201

1135

1.34

3.81

1.5

—

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

257

1.74

3.80

1.0

1.1

—

(3020961) Endomysium IgA Ab [Titer] in Serum

1303

8815

1.12

3.79

1.1

134.0

219.5

titre

1.18

214

(3013166) Neutrophils/100 leukocytes in Synovial fluid

121

627

1.46

3.78

1.4

1.3

58.4

54.9

0.48

106

526

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

560

3567

1.19

3.77

1.4

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

278

1645

1.28

3.76

1.2

—

(3034770) Mitochondria Ab [Titer] in Serum

809

5313

1.15

3.72

1.2

1205.4

900.1

titre

0.53

184

(3003694) ABO and Rh group [Type] in Blood

6599

52065

0.95

3.68

1.4

1.3

—

(3027273) Bicarbonate [Moles/volume] in Venous blood

1521

10407

1.11

3.62

3.4

3.3

25.4

25.3

mmol/l

0.76

1476

10105

(3048879) Bone marrow aspiration report

118

615

1.45

3.60

1.9

1.7

—

(3013293) Extractable nuclear Ab [Presence] in Serum

314

1.64

3.57

1.7

1.5

—

(3002523) Influenza virus A Ag [Presence] in Specimen

257

2465

0.79

3.56

1.1

—

(3010838) Calcium [Moles/time] in 24 hour Urine

192

1091

1.33

3.52

1.7

1.6

5.5

5.8

mmol/24h

0.07

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1140

7692

1.12

3.50

2.3

2.2

10.2

g/l

0.11

915

6371

(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer

453

1.52

3.49

2.7

2.5

6.6

7.7

mmol/l

2.95

272

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

446

0.51

3.48

2.0

2.1

—

(3043681) Transitional cells [#/area] in Urine by Computer assisted method

112

2.09

3.48

1.1

1.0

1.3

u/field

1.53

(3003101) Alpha 1 antitrypsin [Mass/mass] in Stool

2.48

3.44

1.6

1.1

200.1

190.6

ug/g

0.07

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

148

811

1.38

3.44

1.9

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

148

811

1.38

3.44

1.9

—

(3003740) Influenza virus B Ag [Presence] in Specimen

259

2467

0.79

3.40

1.1

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

1674

13827

0.91

3.38

1.3

—

(3021387) Prolactin [Units/volume] in Serum or Plasma

492

4393

0.84

3.38

1.7

329.8

314.7

mu/l

0.27

449

3998

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

149

821

1.37

3.36

1.9

—

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

221

1291

1.30

3.35

1.9

2.0

—

(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma

770

5085

1.15

3.33

1.4

199.4

146.3

pmol/l

1.09

755

4965

(43055458) Rivaroxaban [Mass/volume] in Serum or Plasma

178

1.83

3.32

1.2

94.3

110.5

ug/l

0.31

113

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

820

5441

1.14

3.31

1.3

—

(40762814) Titanium [Mass/volume] in Blood

370

1.55

3.25

2.3

3.5

3.8

ug/l

0.24

126

(3020876) Protein [Mass/time] in 24 hour Urine

292

1774

1.25

3.23

2.0

1.9

0.6

1.1

g/24h

—

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

949

0.68

3.22

2.2

1.5

5.7

5.4

ug/l

0.03

648

(3042010) Triglyceride [Moles/volume] in Pleural fluid

288

1.63

3.21

1.3

1.2

1.1

1.5

mmol/l

0.37

188

(3044242) Glucose [Moles/volume] in Arterial blood

174

990

1.33

3.21

2.1

1.9

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

316

1940

1.23

3.18

1.7

—

(3049717) Cytology report of Urine Cyto stain

1236

8429

1.11

3.18

2.5

2.7

—

(3013727) Leukocytes other/100 leukocytes in Blood

121

651

1.41

3.16

3.8

3.6

53.4

53.3

0.02

116

628

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

707

4667

1.15

3.10

1.4

1.5

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

639

0.61

3.10

1.1

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

1876

13075

1.09

3.08

1.2

142.5

143.3

iu/ml

0.03

743

5023

(3033923) Metanephrine [Moles/time] in 24 hour Urine

443

1.48

3.05

1.1

0.7

umol/24h

0.08

219

(3025443) Phadiatop IgE Ab [Units/volume] in Serum

160

907

1.33

3.04

1.1

1.4

5.8

u/ml

5.62

140

(3024263) Appearance of Synovial fluid

191

1112

1.30

3.01

1.5

1.7

—

(3027923) C peptide [Moles/volume] in Serum or Plasma

183

1060

1.31

3.00

1.3

1.4

1.1

1.2

nmol/l

0.41

137

833

(3019832) Treponema pallidum Ab [Presence] in Serum

1024

8603

0.90

2.94

1.4

1.5

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

446

2860

1.18

2.88

1.4

—

(3043722) Hyaline casts [#/area] in Urine sediment by Automated count

2.57

2.85

1.3

1.0

1.1

u/field

0.08

(3023419) Bacteria identified in Sputum by Culture

421

2690

1.18

2.85

2.4

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

220

1317

1.26

2.82

1.4

—

(3051611) Lipemic interference index of Serum or Plasma

357

2251

1.20

2.80

3.8

3.3

—

(21491866) Provasopressin.C-terminal [Moles/volume] in Serum or Plasma by Immunoassay

172

1.76

2.78

1.2

1.3

9.1

17.5

pmol/l

1.38

146

(21494890) Protein electrophoresis panel - 24 hour Urine

350

2205

1.20

2.78

2.0

2.1

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

220

1323

1.26

2.73

1.2

1.1

—

(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis

129

722

1.35

2.71

1.5

1.4

15.1

15.5

pmol/l

0.29

110

606

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

740

4950

1.13

2.71

1.1

1.2

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

906

0.70

2.70

1.3

—

(3026692) Albumin [Mass/volume] in Peritoneal fluid

394

1.48

2.68

1.4

1.2

14.8

14.5

g/l

0.08

302

(3004451) EKG impression Narrative

177

1039

1.29

2.67

1.3

1.2

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

429

2763

1.18

2.67

1.1

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

787

5297

1.13

2.62

1.3

1.4

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

213

1283

1.26

2.62

1.2

—

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

386

2469

1.18

2.61

1.3

1.2

7.4

7.5

mmol/l

0.23

279

1795

(3011412) CD3 cells [#/volume] in Blood

287

1787

1.22

2.60

2.2

2.3

1.0

1.1

e9/l

1.06

181

1070

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

211

1272

1.25

2.58

1.2

—

(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood

224

1362

1.24

2.55

2.0

1.9

15.9

14.9

0.39

580

(44806118)

336

2129

1.19

2.54

1.4

1.5

—

(3007566) Smooth muscle Ab [Titer] in Serum

789

5323

1.12

2.54

1.2

112.9

145.1

titre

0.62

443

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

329

2081

1.20

2.54

1.7

1.6

—

(3015401) Amylase [Enzymatic activity/volume] in Pleural fluid

253

1.58

2.54

1.4

1.2

47.1

74.4

u/l

0.48

184

(3037556) Urate [Mass/volume] in Serum or Plasma

110

608

1.37

2.53

1.4

—

(44790048)

336

2130

1.19

2.53

1.4

1.5

—

(44790049)

336

2130

1.19

2.53

1.4

1.5

—

(44790047)

336

2130

1.19

2.53

1.4

1.5

—

(3050129) First trimester maternal screen panel - Serum or Plasma

162

1565

0.78

2.51

1.6

1.4

—

(3037297) Penicillin G IgE Ab [Units/volume] in Serum

2.08

2.50

1.1

1.0

0.1

u/ml

—

(3000093) Morphology [Interpretation] in Blood Narrative

310

1955

1.20

2.48

1.1

—

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

123

1229

0.76

2.47

1.3

1.4

1.5

g/l

0.67

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

1569

10967

1.08

2.47

8.0

8.8

24.6

24.4

mmol/l

2.36

1433

10189

(3033799) Differential panel - Peritoneal fluid

515

1.39

2.46

1.9

1.6

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

197

1186

1.26

2.46

1.5

—

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

4954

35918

1.05

2.45

2.9

2.7

1.3

e6/l

0.02

2969

20644

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

241

1485

1.23

2.44

1.3

1.2

11.9

11.8

mmol/l

0.11

438

(3017569) Oxygen content in Arterial blood

167

987

1.28

2.43

2.3

2.1

—

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

1801

12667

1.08

2.43

1.3

41.1

53.3

au/ml

1.54

560

(1175426) CD3 cells/100 lymphocytes in Blood

227

1391

1.23

2.43

2.0

1.9

72.1

72.2

0.03

216

1322

(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline

175

1041

1.27

2.42

1.3

1.2

5.8

6.0

mmol/l

1.73

164

973

(3003434) Protein [Mass/volume] in Pleural fluid

448

2922

1.16

2.41

1.5

1.4

32.7

32.9

g/l

0.11

409

2621

(3025130) Human papilloma virus identified in Specimen

294

2653

0.84

2.40

1.5

1.7

—

(3027859) Formaldehyde IgE Ab [Units/volume] in Serum

4.41

2.38

1.0

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

178

1064

1.27

2.37

3.8

3.9

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

344

2201

1.18

2.36

1.1

—

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

234

1445

1.22

2.34

1.2

1.3

0.6

1.4

u/ml

1.32

111

678

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

388

2510

1.17

2.33

1.1

1.6

1.5

g/l

1.68

351

2253

(3042552) Rheumatoid factor [Units/volume] in Pleural fluid

182

1.66

2.33

1.1

17.8

14.7

iu/ml

0.11

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

551

4726

0.88

2.33

1.3

—

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

554

3680

1.14

2.32

4.6

5.3

530.6

1492.9

iu/ml

1.08

541

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

1973

13953

1.07

2.31

2.4

28.9

26.0

au/ml

0.36

735

(3018688) Ampicillin IgE Ab [Units/volume] in Serum

2.36

2.29

1.1

1.0

—

(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood

331

2118

1.18

2.28

1.1

1.3

2.0

iu/ml

0.96

(3045788) Cell count panel - Pleural fluid

308

1959

1.19

2.28

1.6

1.5

—

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

1344

9372

1.09

2.27

4.4

4.0

24.5

24.2

mmol/l

3.34

1185

8375

(3017414) Tyrophagus putrescentiae IgE Ab [Units/volume] in Serum

2.52

2.25

1.0

0.5

0.2

u/ml

—

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

537

1.37

2.25

1.8

1.6

4412.5

8492.4

e6/l

1.76

266

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

487

3215

1.15

2.25

1.3

44.6

32.7

u/l

0.74

427

2769

(3001686) Cold agglutinin [Titer] in Serum or Plasma

360

1.45

2.24

1.2

1.4

80.0

210.9

titre

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

549

4696

0.88

2.24

1.5

1.6

—

(3024354) Oxygen [Partial pressure] in Venous blood

2223

15808

1.07

2.22

3.2

3.1

4.5

kpa

0.14

2144

15284

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

215

1326

1.23

2.20

5.5

6.4

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

477

3150

1.15

2.20

1.2

—

(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose

463

1.39

2.19

1.6

1.4

9.0

8.4

mmol/l

0.70

270

(40762365) Oxygen content in Arterial blood by calculation

344

1.45

2.16

2.7

2.6

14.5

14.9

ml/dl

0.62

319

(3045716) Anion gap in Serum or Plasma

158

944

1.27

2.15

2.2

2.3

9.2

9.1

mmol/l

0.12

114

701

(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay

100

562

1.35

2.13

1.2

1.1

105.5

109.0

0.46

512

(3026029) Penicillin V IgE Ab [Units/volume] in Serum

1.91

2.13

1.1

1.0

0.4

0.1

u/ml

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

1029

7117

1.10

2.12

1.3

—

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

293

1873

1.18

2.08

4.2

4.9

77.6

106.5

u/ml

0.44

559

(3002256) Pathology report gross observation

3931

28463

1.05

2.08

1.3

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

124

722

1.30

2.08

1.2

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

2563

18351

1.06

2.07

1.5

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

798

6642

0.91

2.03

1.7

3.3

3.5

mg/l

0.30

594

4772

(3014051) Protein [Presence] in Urine by Test strip

703

4783

1.11

2.03

2.5

2.1

—

(3011048) Pyruvate [Moles/volume] in Blood

1.96

2.00

1.0

1.4

73.9

82.0

umol/l

0.44

(3002331) Protein [Mass/volume] in Peritoneal fluid

369

1.41

2.00

1.4

1.3

29.2

46.8

g/l

0.56

291

(4062490)

311

2006

1.17

2.00

1.5

1.4

—

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

157

0.43

1.98

1.3

1.1

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

320

2072

1.17

1.97

3.4

3.7

—

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

544

1.33

1.97

1.1

90.2

89.8

0.03

243

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

415

1.38

1.96

1.6

2.2

—

(3004119) Hemoglobin [Mass/volume] in Venous blood

1798

12757

1.07

1.96

3.2

3.3

127.7

128.1

g/l

0.31

1739

12464

(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma

2.12

1.95

1.1

—

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

223

1.53

1.91

2.2

2.1

—

(3002619) Bacteria identified in Specimen by Culture

411

1.38

1.91

1.6

1.2

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

487

0.67

1.90

1.3

1.2

—

(3011436) Histone Ab [Units/volume] in Serum

450

1.36

1.90

1.1

—

24.0

u/ml

—

(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood

1387

9765

1.08

1.90

2.8

1.2

0.18

1382

9714

(3009466) Valproate [Moles/volume] in Serum or Plasma

321

2809

0.86

1.88

4.6

4.8

357.5

365.1

umol/l

0.41

272

2412

(3000510) Lepidoglyphus destructor IgE Ab [Units/volume] in Serum

2.28

1.88

1.0

0.6

0.1

u/ml

—

(3023199) Leukocytes [#/volume] in Pleural fluid

396

2616

1.15

1.88

1.5

1.4

1552.0

2970.5

e6/l

3.44

290

1901

(3016038) Potassium [Moles/volume] in Urine

220

1387

1.20

1.86

1.2

1.1

34.1

34.2

mmol/l

0.02

192

1156

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

843

5819

1.10

1.86

1.2

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

318

2070

1.16

1.85

1.2

—

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

557

1.32

1.84

1.1

88.3

89.1

0.08

247

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

293

2575

0.86

1.83

1.1

3.3

3.5

u/ml

0.12

115

1171

(3020650) Glucose [Presence] in Urine

479

1.34

1.83

1.3

1.5

—

(3028192) IgG subclass 2 [Mass/volume] in Serum

309

2010

1.16

1.82

1.5

1.4

2.9

g/l

0.22

206

1423

(3024139) IgG subclass 3 [Mass/volume] in Serum

309

2010

1.16

1.82

1.5

1.4

0.4

g/l

0.93

208

1424

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

192

1198

1.21

1.82

2.4

2.5

0.2

e9/l

0.09

171

1052

(3027874) Urate [Moles/volume] in Urine

2.05

1.81

1.1

2.2

1.6

mmol/l

—

(3027135) IgG subclass 1 [Mass/volume] in Serum

309

2012

1.16

1.80

1.5

1.4

6.8

g/l

0.05

206

1425

(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy

114

1.72

1.79

1.1

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

314

1.42

1.79

1.5

1.6

—

(3000991) Gas panel - Venous blood

2389

17154

1.06

1.78

7.8

7.9

—

(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight

350

2302

1.15

1.78

1.3

—

34.1

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

508

3424

1.12

1.78

1.5

—

(3052851) Hemolysis interference index of Serum or Plasma

920

6391

1.09

1.78

3.6

3.2

—

(3022493) Free Hemoglobin [Mass/volume] in Plasma

133

800

1.26

1.78

3.1

4.2

2369.0

1545.1

mg/l

0.14

569

(3014765) Yersinia sp identified in Stool by Organism specific culture

849

5877

1.09

1.77

1.2

—

(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum

248

1589

1.18

1.77

1.2

1.1

22.6

35.4

u/ml

—

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

1354

9559

1.07

1.74

2.8

2.7

0.7

0.04

1303

9164

(3028308) Erythrocytes [#/volume] in Pleural fluid

360

2379

1.14

1.73

1.5

1.4

70603.5

57212.1

e6/l

0.32

212

1416

(3021162) Amylase [Enzymatic activity/volume] in Specimen

323

1.40

1.72

2.0

2.8

3149.3

1683.6

u/l

0.34

294

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

323

1.40

1.72

2.4

3.1

—

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

915

6368

1.09

1.71

2.1

2.2

37.1

37.7

g/l

2.71

757

5403

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

446

1.34

1.70

1.2

1.3

—

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

880

6115

1.09

1.70

2.3

0.0

g/l

0.14

792

5540

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

133

805

1.25

1.70

1.8

149.8

128.7

umol/l

0.26

432

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

198

1250

1.20

1.69

2.3

2.4

507.2

499.4

e6/l

0.08

170

1058

(42529406) Shigella sp [Presence] in Stool by Culture

848

5887

1.09

1.68

1.2

—

(44813793)

220

1405

1.18

1.65

1.1

—

(3034274) Bile acid [Moles/volume] in Serum --fasting

186

1170

1.20

1.65

1.5

1.7

8.8

9.6

umol/l

0.15

145

833

(3008401) Mugwort IgE Ab [Units/volume] in Serum

297

2583

0.87

1.65

1.1

1.4

0.9

u/ml

0.43

969

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

959

6700

1.08

1.64

1.5

—

(1175825) Sexually transmitted pathogens panel - Specimen by NAA with probe detection

2.21

1.63

1.2

—

(3000285) Sodium [Moles/volume] in Blood

257

1.44

1.63

1.0

1.2

—

(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma

295

1.41

1.63

1.3

1.2

1539.6

121.7

ng/l

0.50

205

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

541

3683

1.11

1.62

1.3

—

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

3283

23832

1.05

1.60

2.5

8.9

8.5

umol/l

0.44

2845

20536

(3043410) Blood group antigens tested for on Red Blood Cells

544

1.29

1.59

1.6

1.8

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

163

1018

1.21

1.58

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

505

1.30

1.57

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

505

1.30

1.57

1.1

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

505

1.30

1.57

1.1

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

505

1.30

1.57

1.1

—

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

334

2870

0.88

1.57

1.1

562.8

4473.9

iu/ml

0.48

554

(3003888) Timothy IgE Ab [Units/volume] in Serum

311

2684

0.87

1.56

1.1

3.3

3.2

u/ml

0.03

115

1191

(3010726) Horse dander IgE Ab [Units/volume] in Serum

275

2393

0.87

1.56

1.0

1.1

0.6

1.6

u/ml

2.89

527

(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma

108

1.68

1.54

1.2

1.0

—

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

140

0.49

1.53

1.1

1.6

—

(3006245) CD3-CD19+ cells/100 cells in Blood

107

641

1.26

1.53

2.0

10.3

10.1

0.06

582

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

230

1487

1.17

1.52

1.3

2.2

mmol/l

0.02

214

1372

(3008116) Ketones [Moles/volume] in Urine by Test strip

370

1.35

1.52

1.3

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

561

1.28

1.52

1.1

1.2

—

(3044007) Cell count panel - Peritoneal fluid

495

1.30

1.51

2.0

1.7

—

(3012565) Volume of 24 hour Urine

169

1066

1.20

1.49

2.0

2.2

1882.1

1937.6

0.33

147

931

(3043138) Epithelial cells.renal [#/area] in Urine by Computer assisted method

1.81

1.49

1.2

1.1

0.8

1.3

u/field

0.66

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

121

1.62

1.49

1.0

—

(3005082) Progesterone [Moles/volume] in Serum or Plasma

334

0.66

1.46

1.3

28.5

28.7

nmol/l

0.01

275

(3006270) Folate [Moles/volume] in Blood

286

1887

1.15

1.46

1.2

339.2

357.5

nmol/l

0.81

232

1553

(3003129) Base excess in Capillary blood by calculation

538

1.28

1.46

1.7

1.8

0.6

0.7

mmol/l

0.09

510

(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay

132

815

1.22

1.45

1.3

1.8

162.1

147.5

1.18

115

765

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

195

1.47

1.44

1.3

1.1

—

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

519

1.28

1.44

1.3

127.2

132.4

nmol/l

0.10

377

(3016244) Insulin [Units/volume] in Serum or Plasma

150

940

1.21

1.43

2.8

3.0

24.5

25.7

mu/l

0.12

145

881

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

1095

7740

1.07

1.42

3.1

3.3

3632.6

1086.5

u/ml

0.54

931

6584

(3033658) Prothrombin time (PT) actual/Normal

7141

52702

1.03

1.42

4.0

3.7

88.1

90.7

13.29

6922

51416

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

221

1.44

1.41

1.0

—

(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method

123

1.60

1.41

1.0

—

(3031659) Enterovirus NOS Ab [Titer] in Cerebral spinal fluid

1.89

1.41

1.1

—

(3006462) Nitrate [Presence] in Urine

163

1032

1.19

1.40

4.0

3.2

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

157

991

1.20

1.40

3.1

3.4

—

(40757373) Influenza virus identified in Isolate

409

1.31

1.39

1.3

1.6

—

(3007449) CD3+CD8+ (T8 suppressor) cells/100 cells in Blood

106

643

1.25

1.39

2.0

1.9

29.6

29.4

0.04

598

(3008898) HLA-B27 [Presence]

841

5896

1.08

1.38

1.1

—

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

235

1.42

1.37

2.2

2.1

—

(3023383) Lactate [Moles/volume] in Pleural fluid

108

658

1.24

1.37

1.3

3.3

3.5

mmol/l

0.34

606

(3009214) Lutropin [Units/volume] in Serum or Plasma

444

3714

0.90

1.36

1.3

14.5

14.2

u/l

0.17

367

3030

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

489

3349

1.10

1.36

1.8

1.6

—

(40762887) Creatinine [Moles/volume] in Blood

1.96

1.36

1.1

1.2

—

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

395

2676

1.12

1.35

1.2

1.3

277.2

283.7

pmol/l

0.13

291

2074

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

294

1.36

1.34

2.9

2.6

0.6

0.5

u/field

0.27

294

(3015665) Acarus siro IgE Ab [Units/volume] in Serum

2.01

1.34

1.0

0.8

0.1

u/ml

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

525

1.27

1.34

1.1

—

(3014702) Chromogranin A [Moles/volume] in Serum or Plasma

354

2385

1.12

1.33

3.2

3.3

5.3

8.2

nmol/l

0.63

341

2314

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

416

2830

1.11

1.32

2.3

2.5

1868.4

4946.8

u/ml

0.36

144

(3049242) von Willebrand panel - Platelet poor plasma

1.89

1.32

1.2

1.7

—

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

648

0.77

1.32

1.6

—

(3011985) Renin [Units/volume] in Plasma

424

2888

1.11

1.32

1.4

1.5

52.3

58.5

mu/l

0.34

363

2561

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

398

2703

1.11

1.31

1.1

—

(3023709) Somatotropin [Mass/volume] in Serum or Plasma

527

1.26

1.30

2.7

2.1

1.5

1.0

ug/l

0.50

506

(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood

1347

9619

1.06

1.30

4.0

3.9

47.1

47.5

0.21

1334

9509

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

106

649

1.23

1.30

2.6

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

106

649

1.23

1.30

2.6

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

389

3262

0.90

1.27

1.3

1.2

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

576

1.25

1.27

1.7

1.6

8.9

9.0

ug/l

0.12

576

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

176

1.46

1.26

2.4

2.3

—

(3036782) Glucose [Moles/volume] in Pleural fluid

298

1995

1.13

1.26

1.4

1.3

6.2

6.4

mmol/l

0.73

279

1843

(3033942) Copper [Moles/time] in 24 hour Urine

1.86

1.26

1.0

1.2

0.2

0.7

umol/24h

—

(3041918) Cholesterol [Moles/volume] in Pleural fluid

396

1.30

1.26

1.4

1.2

1.5

1.7

mmol/l

0.36

247

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

436

2984

1.11

1.25

1.1

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

286

1911

1.13

1.25

1.1

1.2

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

145

922

1.19

1.23

1.2

1.1

—

(3010503) CD19 cells [#/volume] in Blood

181

1173

1.17

1.23

2.3

2.5

0.2

0.4

e9/l

0.48

175

1138

(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid

238

1575

1.14

1.22

1.3

12.5

13.8

u/l

0.68

215

1461

(3003338) MCHC [Mass/volume]

22576

171870

0.98

1.22

21.9

18.6

330.7

331.7

g/l

55.03

22375

170457

(3017315) Amylase [Enzymatic activity/volume] in Urine

179

1161

1.17

1.20

1.3

1.2

249.7

338.9

u/l

0.87

167

1081

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

486

4015

0.91

1.20

1.6

0.9

0.8

nmol/l

1.50

409

3336

(3036005) Urine sediment comments by Light microscopy Narrative

2.39

1.19

1.0

1.1

—

(3023420) DNA double strand Ab [Units/volume] in Serum

310

2090

1.12

1.19

1.5

41.3

28.5

iu/ml

0.64

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

327

1.32

1.19

1.6

1.1

—

(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture

154

1.47

1.18

1.0

1.2

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

357

2991

0.90

1.17

1.1

2.2

1.2

u/ml

0.65

105

1075

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

171

1501

0.86

1.17

1.4

—

(3024928) Oxygen saturation in Venous blood

603

4206

1.08

1.17

3.0

3.1

—

(3000330) Specific gravity of Urine by Test strip

1528

10991

1.05

1.17

3.9

3.5

—

(3016273) Islet cell 512 Ab [Units/volume] in Serum

0.44

1.15

1.0

—

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

149

1.47

1.14

1.7

1.5

—

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

803

5670

1.07

1.14

2.3

0.0

g/l

2.15

719

5117

(3042934) Triiodothyronine (T3) Ab [Presence] in Serum

2.40

1.14

1.0

—

(3036603) Volume of Urine

163

1432

0.86

1.14

1.5

1.6

2023.6

1942.2

0.25

357

(4281824)

358

2442

1.11

1.13

1.2

1.1

—

(3024869) Neuronal Ab [Presence] in Serum

390

1.28

1.12

1.1

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

390

2673

1.10

1.12

1.2

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

425

2926

1.10

1.12

1.1

—

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

150

1.46

1.11

1.2

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

123

1102

0.84

1.10

1.1

—

(3032057) Clostridioides difficile [Presence] in Stool

472

1.25

1.10

2.1

1.8

—

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

198

1710

0.87

1.10

1.0

0.4

0.3

u/ml

0.09

353

(3035880) pH of Pleural fluid

180

1179

1.15

1.09

1.3

—

(21494814) CD8 cells/100 lymphocytes in Specimen

118

747

1.19

1.08

2.0

1.9

—

(3006576) Bicarbonate [Moles/volume] in Blood

116

736

1.19

1.05

5.4

6.6

25.3

25.1

mmol/l

0.24

106

663

(40768441) Liver Pathology biopsy report

209

1389

1.14

1.04

1.2

—

(3004775) Volume in Urine collected for unspecified duration

207

1774

0.88

1.04

2.1

2.2

703.9

669.1

0.59

141

1181

(3030136) 5-Hydroxyindoleacetate [Moles/volume] in Serum or Plasma

213

1418

1.14

1.04

3.2

3.4

125.0

135.5

nmol/l

0.20

208

1398

(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction

295

2003

1.11

1.04

1.4

1.3

380.5

480.3

u/l

0.77

280

1895

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

104

938

0.84

1.02

1.3

1.4

82.7

63.4

pmol/l

0.67

303

(3012441) Differential panel - Pleural fluid

328

2243

1.11

1.02

1.6

1.4

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

281

1906

1.11

1.01

1.5

1.6

—

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

345

2866

0.91

1.00

1.3

38.8

36.8

u/l

0.44

281

2304

(3027974) Hepatitis B virus e Ag [Presence] in Serum

101

0.52

1.00

1.1

1.5

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

2808

20549

1.04

1.00

1.5

—

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

561

1.21

0.99

1.1

1.2

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

146

1276

0.86

0.99

1.2

—

(3041806) Other cells [#/volume] in Blood by Manual count

143

0.58

0.99

1.8

1.5

—

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

129

1.46

0.99

2.1

2.0

—

(3028717) Thiamine [Mass/volume] in Blood

219

1.35

0.98

1.3

1.1

—

(3025315) Body weight

161

1.41

0.97

7.1

4.3

—

(40758292) HTLV I+II Ab panel - Serum

265

1.31

0.97

1.4

—

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

625

1.20

0.97

1.8

1.9

—

(3007302) Hemoglobin [Mass/volume] in Mixed venous blood

1.68

0.96

16.9

13.7

—

(4211845)

172

1137

1.14

0.95

3.9

3.1

—

(3012984) Norclozapine [Mass/volume] in Serum or Plasma

110

0.55

0.94

6.3

7.3

—

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

293

1.29

0.94

12.5

10.2

6.2

5.2

mmol/l

0.56

293

(3015076) Soybean IgE Ab [Units/volume] in Serum

830

0.84

0.93

1.0

0.2

1.0

u/ml

—

101

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

186

0.65

0.92

2.1

2.0

—

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

144

1.42

0.92

1.2

1.1

—

(3008860) Bordetella pertussis IgM Ab [Presence] in Serum

2.16

0.91

1.8

1.2

—

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

785

5591

1.06

0.91

2.3

0.0

g/l

0.00

714

5102

(3002621) Streptococcal DNAse B [Units/volume] in Serum

151

1.40

0.90

1.1

1.0

—

(3014591) Smooth Alder IgE Ab [Units/volume] in Serum

1.95

0.90

1.0

—

(3040370) OLANZapine [Moles/volume] in Serum or Plasma

570

0.81

0.89

2.2

2.4

155.2

151.5

nmol/l

0.10

503

(3041008) Bicarbonate [Moles/volume] standard in Arterial cord blood

101

1.50

0.89

1.5

1.4

23.9

23.7

mmol/l

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

3047

23671

0.97

0.88

1.6

—

(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay

1.53

0.88

1.0

1.1

—

(3020951) Lymphocytes/100 leukocytes in Cerebral spinal fluid

290

1.28

0.87

1.8

1.3

61.2

48.2

1.09

137

(3004280) Aldosterone [Moles/volume] in Serum or Plasma --supine

1.57

0.87

1.0

188.6

131.4

pmol/l

—

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

433

3027

1.08

0.87

1.2

1.3

0.3

0.2

nmol/l

0.15

205

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

1.60

0.87

1.3

1.2

—

(3000492) Spirometry study

2536

18581

1.03

0.87

1.5

—

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

291

1.27

0.86

1.7

1.6

—

(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma

620

1.18

0.85

1.2

115.3

112.1

0.54

541

(1175556) inFLIXimab Ab [Units/volume] in Serum by Immunoassay

441

1.22

0.85

2.4

2.3

112.4

147.5

au/ml

—

(42870325) Hepcidin 25 amino acid peptide [Moles/volume] in Serum or Plasma

265

1.28

0.84

1.3

5.5

298675.1

nmol/l

1.92

225

(3027401) Testosterone Free/Testosterone.total in Serum or Plasma

1.73

0.84

1.0

1.3

0.02

(3037577) Monocytes/100 leukocytes in Cerebral spinal fluid

134

1.41

0.84

2.3

1.4

9.1

13.3

1.31

(3023511) Choriogonadotropin [Units/volume] in Urine

177

1504

0.89

0.83

1.3

—

(3045142) Bone marrow Pathology biopsy report

321

2222

1.09

0.82

1.3

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

423

2963

1.08

0.82

1.3

—

(3022475) Manganese [Moles/volume] in Blood

135

0.62

0.82

1.1

1.2

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

713

5086

1.06

0.82

1.7

1.8

4.3

13.9

iu/l

1.18

270

1833

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

637

4529

1.06

0.81

1.3

—

(40768806) Pleura Pathology biopsy report

329

2282

1.09

0.81

1.6

1.5

—

(3007463) Buprenorphine [Presence] in Urine

1.89

0.81

9.2

6.8

—

(3035509) Tobramycin [Mass/volume] in Serum or Plasma

220

1.31

0.81

3.5

2.9

1.7

1.2

mg/l

0.43

161

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

637

4530

1.06

0.81

1.3

—

(3009208) Meadow Fescue IgE Ab [Units/volume] in Serum

0.00

0.80

0.0

1.1

—

10.4

—

(3040794) Aluminum [Moles/volume] in Urine

0.00

0.80

0.0

1.2

—

(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid

141

934

1.14

0.80

1.3

1.2

56.3

59.1

0.15

107

(3046861) Legionella sp Ag [Presence] in Urine

110

1.44

0.80

1.0

1.1

—

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

181

1219

1.12

0.80

1.1

20.7

26.4

u/l

1.17

128

940

(43534046) Estradiol (E2) [Moles/volume] in Serum or Plasma by High sensitivity method

223

0.71

0.79

1.2

0.2

0.3

nmol/l

1.39

142

(3038864) risperiDONE [Moles/volume] in Serum or Plasma

0.50

0.79

1.0

1.5

33.3

23.8

nmol/l

—

(3013945) Hepatitis B virus e Ab [Presence] in Serum

0.56

0.79

1.0

1.5

—

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

175

1.34

0.79

5.8

—

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

156

1043

1.13

0.78

2.4

2.8

39.5

39.0

0.10

350

(3018133) Calcium [Moles/volume] in Urine

282

1.26

0.78

1.5

1.6

2.4

2.7

mmol/l

0.62

246

(3023430) Cat dander IgE Ab [Units/volume] in Serum

238

1980

0.91

0.77

1.0

2.5

3.3

u/ml

0.59

722

(44786800) Granulocytes/100 leukocytes in Body fluid

289

1.26

0.77

1.4

1.3

30.8

23.1

0.70

231

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

308

0.76

0.77

1.2

1.1

—

(3015183) Erythrocyte sedimentation rate

133

882

1.14

0.76

1.2

—

(3012403) Metanephrines [Moles/time] in 24 hour Urine

1.70

0.75

1.2

1.1

—

23.7

—

(3024980) IgG subclass 4 [Mass/volume] in Serum

446

3144

1.07

0.75

1.6

1.5

0.7

0.8

g/l

0.19

313

2385

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

170

1.33

0.75

1.0

1.2

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

850

0.86

0.74

1.1

—

(3001729) Color of Synovial fluid

177

1.32

0.74

1.6

1.5

—

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

211

0.72

0.74

1.1

—

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

254

0.74

0.73

1.2

1.4

—

(3009542) Hematocrit [Volume Fraction] of Blood

24295

184429

0.98

0.73

17.7

15.4

38.9

39.3

7.82

15517

128546

(3018851) Theophylline [Moles/volume] in Serum or Plasma

198

1.30

0.72

1.9

1.6

37.7

48.3

umol/l

1.99

198

(3014133) Dog dander IgE Ab [Units/volume] in Serum

256

2112

0.92

0.72

1.0

1.1

1.9

3.2

u/ml

1.13

750

(3016724) Homocysteine [Moles/volume] in Serum or Plasma

191

1302

1.11

0.71

1.3

1.4

13.8

12.8

umol/l

0.99

178

1221

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

495

0.82

0.70

1.2

1.1

—

(3014599) Egg white IgE Ab [Units/volume] in Serum

111

958

0.87

0.70

1.0

0.4

1.5

u/ml

1.21

212

(40761847) Hazelnut recombinant (rCor a) 8 IgE Ab [Units/volume] in Serum

147

0.67

0.70

1.0

0.1

0.2

u/ml

—

(43055190) Macrophages [#/area] in Urine sediment by Microscopy high power field

101

1.42

0.69

1.1

1.4

0.8

1.2

u/field

2.01

(40768793) Breast Pathology biopsy report

735

5282

1.05

0.68

1.3

—

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

220

1.27

0.68

1.0

1.1

1.9

1.7

umol/24h

0.54

220

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

180

1505

0.90

0.68

1.0

329.5

348.7

ng/l

0.29

118

1074

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

486

3453

1.06

0.68

1.3

1.4

—

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

443

3567

0.94

0.67

1.6

1.7

44.7

44.3

nmol/l

0.14

430

3429

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

428

3030

1.07

0.67

1.2

1.3

0.7

1.8

nmol/l

1.23

404

2914

(21494434) Karyotype in Bone marrow

253

1755

1.09

0.67

1.1

1.2

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

391

2761

1.07

0.66

1.2

1.3

—

(3016184) Myelin associated glycoprotein Ab [Units/volume] in Serum

127

0.65

0.66

1.2

1.3

—

22868.8

—

(3004446) Plasmodium sp identified in Blood by Light microscopy

171

0.71

0.65

2.6

2.4

—

(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection

638

1.15

0.65

1.5

1.7

1266.0

39979.1

u/ml

1.40

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

178

1218

1.10

0.63

1.2

1.1

83.5

86.8

u/l

0.28

129

977

(3036048) Francisella tularensis Ab [Titer] in Serum

408

1.19

0.63

1.2

126.7

916.0

titre

—

(3038205) Alternaria alternata IgE Ab [Units/volume] in Serum

1.51

0.63

1.0

0.2

u/ml

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

408

3284

0.94

0.63

1.2

—

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

284

1.22

0.63

2.0

1.8

18.1

17.5

umol/l

0.14

284

(3003531) Amoxicillin IgE Ab [Units/volume] in Serum

1.72

0.63

1.0

—

(3015147) Influenza virus A IgG Ab [Units/volume] in Serum

1.72

0.63

1.0

—

(1761868) Lipid panel - Serum or Plasma

9338

71329

0.98

0.62

3.1

2.9

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

413

0.82

0.62

1.2

1.1

—

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

4483

33287

1.02

0.61

3.2

2.9

3.0

e6/l

0.12

2536

18153

(3020893) t(14;18)(q32;q21.3)(IGH,BCL2) fusion transcript [Presence] in Blood or Tissue by Molecular genetics method

0.00

0.60

0.0

1.0

—

(4198724)

485

0.84

0.60

1.5

1.9

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

116

779

1.13

0.59

1.4

—

(3035320) C reactive protein [Mass/volume] in Body fluid

215

1492

1.09

0.59

3.0

2.4

—

(3024932) HLA-DR beta [Type]

538

1.15

0.59

1.1

—

(3009471) Fatty acids.nonesterified [Moles/volume] in Serum or Plasma

1.74

0.58

4.8

6.2

0.3

0.2

mmol/l

—

(3028433) Virus identified in Specimen by Culture

652

1.14

0.58

1.2

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

540

0.85

0.58

1.2

1.1

—

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

218

1516

1.09

0.57

1.7

1.6

—

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

127

1069

0.90

0.57

2.1

319.8

76.4

ug/min

0.56

240

(40768795) Lymph node Pathology biopsy report

307

2165

1.07

0.57

1.2

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

251

0.78

0.57

1.2

1.1

—

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

179

1479

0.91

0.56

1.5

1.6

4.9

6.1

u/l

0.73

710

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

2473

19111

0.98

0.56

2.3

2.4

44.4

42.3

u/l

0.09

2099

16254

(3047189) Immunofixation for 24 hour Urine

143

976

1.11

0.56

1.5

1.8

—

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

772

0.88

0.56

2.9

3.0

28.5

28.4

umol/l

0.03

580

(3023410) Appearance of Cerebral spinal fluid

233

1902

0.92

0.56

1.4

1.5

—

(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

121

0.69

0.54

1.1

—

(3042299) inFLIXimab [Mass/volume] in Serum or Plasma

479

1.15

0.54

3.0

2.9

6.5

7.7

mg/l

1.08

377

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

109

735

1.12

0.54

2.4

2.6

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

560

0.86

0.53

1.2

1.4

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

559

0.86

0.52

1.1

—

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

102

0.67

0.52

1.3

1.1

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

220

1539

1.08

0.52

1.2

—

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

214

0.78

0.52

1.0

1.1

—

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

184

1510

0.92

0.52

1.0

756.4

725.0

ng/l

0.39

112

1042

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

100

673

1.12

0.51

1.2

0.3

g/l

0.50

540

(3020618) Glucose [Moles/volume] in Synovial fluid

1.41

0.51

1.1

1.0

6.4

5.3

mmol/l

—

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

205

0.77

0.51

1.0

1.1

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

533

0.86

0.51

1.2

1.1

—

(40768446) Kidney Pathology biopsy report

100

674

1.12

0.51

1.4

1.7

—

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

108

1.33

0.50

3.7

5.0

—

(3042847) Granulocytes/100 leukocytes in Cerebral spinal fluid

155

1.27

0.50

1.3

1.2

21.1

24.4

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

130

1082

0.91

0.50

1.0

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

167

1373

0.92

0.50

2.2

1.8

—

(44806420)

659

0.88

0.49

2.4

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

119

813

1.11

0.48

1.4

1.2

—

(3002385) Erythrocyte distribution width [Ratio]

22487

169195

1.01

0.48

20.3

17.3

13.9

13.8

14.69

22005

165449

(40760435) Tropomyosin IgE Ab [Units/volume] in Serum

163

1.25

0.48

1.0

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

228

1605

1.07

0.48

1.2

—

titre

—

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

133

915

1.10

0.47

1.5

1.6

4.5

6.5

nmol/l

0.30

103

776

(3022640) Eosinophils/100 leukocytes in Cerebral spinal fluid

116

1.30

0.47

2.1

1.3

0.5

1.9

1.57

(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum

1.40

0.47

1.0

—

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

131

1084

0.91

0.46

1.1

—

(3008536) Aspergillus sp Ab [Presence] in Serum

401

1.15

0.46

2.2

2.0

—

(3003327) Ova and parasites identified in Stool by Light microscopy

875

6390

1.04

0.46

1.6

1.7

—

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

171

1193

1.08

0.46

1.1

4.8

5.9

nmol/l

0.20

237

(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method

176

0.77

0.46

1.2

1.1

—

(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma

376

2695

1.05

0.45

1.8

19.5

25.2

ug/l

2.38

367

2634

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

268

1.18

0.45

1.4

1.6

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

535

0.88

0.45

1.2

1.1

—

(3045781) Inhibin B [Mass/volume] in Serum or Plasma

402

1.15

0.45

4.5

2.9

72.4

109.4

ng/l

0.71

128

(46236287) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Pleural fluid by Immunoassay

1.35

0.44

1.0

1.2

7710.1

2626.2

ng/l

—

(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma

475

3429

1.05

0.44

1.3

1.4

17.1

20.2

u/ml

—

(3032743) Legionella sp IgG Ab [Presence] in Serum

131

1.27

0.44

1.0

1.1

—

(43533860) Galactose-alpha-1,3-galactose (Alpha-Gal) IgE Ab [Units/volume] in Serum

225

0.81

0.44

1.1

0.0

0.6

u/ml

1.73

142

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

186

1512

0.93

0.44

1.0

44.4

42.9

ng/l

0.20

123

1055

(3035637) Corticotropin [Mass/volume] in Plasma

340

2434

1.06

0.44

1.4

1.5

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

533

0.88

0.43

1.2

1.1

—

(3018562) Neutrophils/100 leukocytes in Cerebral spinal fluid

152

1.24

0.43

2.3

1.4

39.8

39.3

0.02

103

(40761872) Peanut recombinant (rAra h) 2 IgE Ab [Units/volume] in Serum

199

0.80

0.42

1.0

0.0

0.6

u/ml

—

137

(3029075) Extractable nuclear Ab panel - Serum

554

1.12

0.42

1.0

1.1

—

(3041184) Isoniazid [Presence] in Urine

1.57

0.42

2.4

2.6

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

476

1.13

0.42

1.1

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

117

967

0.91

0.42

1.2

1.3

—

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

247

1755

1.06

0.42

1.3

1.6

1.4

nmol/l

1.52

220

1584

(3039114) Acanthocytes/1000 erythrocytes in Blood by Light microscopy

1.51

0.41

1.2

—

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

239

0.82

0.41

1.2

1.1

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

288

0.84

0.41

1.3

1.2

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

288

0.84

0.41

1.3

1.2

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

288

0.84

0.41

1.3

1.2

—

(3024471) HLA-A [Type]

556

1.11

0.41

1.0

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

676

5290

0.96

0.40

2.2

2.3

110.8

102.5

ug/min

0.15

355

3056

(3007542) Rye IgE Ab [Units/volume] in Serum

1.34

0.40

1.0

1.1

0.0

0.1

u/ml

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

449

1.13

0.40

1.1

—

(21494567) Legionella sp IgM Ab [Presence] in Serum

133

1.25

0.40

1.0

1.1

—

(3022689) Creatine [Moles/volume] in Urine

664

0.90

0.40

1.6

1.4

—

(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma

414

1.13

0.39

1.6

1.8

2.9

2.7

ug/l

0.09

250

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

622

1.11

0.39

1.3

51.5

240.8

ug/l

2.77

350

(3036071) Salmonella sp Ab [Titer] in Serum

560

0.89

0.39

1.0

1.1

—

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

493

1.12

0.39

8.7

8.6

—

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

348

2504

1.05

0.39

1.2

69.3

60.3

u/l

0.28

230

1667

(3016750) Collection duration of Urine

156

1268

0.93

0.39

1.9

2.1

501.4

501.3

min

0.00

113

928

(21494815) CD4 cells/100 lymphocytes in Specimen

215

1526

1.06

0.39

2.0

38.0

41.1

0.43

203

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

1028

7556

1.03

0.39

1.6

—

(3026250) Tacrolimus [Mass/volume] in Blood

102

703

1.10

0.38

34.7

32.5

6.9

7.2

ug/l

0.97

618

(3038071) Oxygen [Partial pressure] in Mixed venous blood

423

1.13

0.38

8.7

8.5

—

(4133840)

502

1.11

0.37

1.2

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

139

973

1.08

0.37

1.3

1.5

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

139

973

1.08

0.37

1.3

1.5

—

(3038515) Glucose [Moles/volume] in Venous blood

596

4664

0.96

0.37

3.5

3.3

7.4

7.6

mmol/l

1.06

578

4581

(3017115) Methotrexate [Moles/volume] in Serum or Plasma

225

1.18

0.37

7.9

7.3

0.4

umol/l

0.01

205

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

589

0.90

0.37

1.1

—

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

184

1302

1.07

0.37

1.1

275.1

283.1

mg/l

0.14

157

1140

(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay

367

1.13

0.36

1.1

92.0

86.1

0.44

105

(1617658) Protocol used for examination of sentinel lymph nodes

236

1886

0.94

0.36

1.0

—

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

219

0.83

0.36

1.1

—

(37021550) Renin [Units/volume] in Plasma --upright

446

1.12

0.36

1.1

1.3

39.4

71.7

mu/l

2.06

334

(3051651) Icteric interference index of Serum or Plasma

176

1245

1.07

0.36

4.4

3.8

—

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

163

1.21

0.36

1.2

1.1

—

(3040491) Angiotensin converting enzyme [Enzymatic activity/volume] in Pleural fluid

219

1.17

0.35

1.1

17.5

19.5

u/l

0.39

151

(4146454)

336

2424

1.05

0.35

2.7

—

(3000060) B lymphocytes [#/volume] in Blood

454

1.12

0.35

2.0

1.9

335.7

539.2

e6/l

0.31

250

(40758355) Pancreatic polypeptide [Moles/volume] in Serum or Plasma

291

0.86

0.35

3.1

2.6

55.8

67.0

pmol/l

0.62

256

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

169

1197

1.07

0.34

1.1

6.2

9.3

iu/ml

1.51

290

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

165

1168

1.07

0.34

1.1

1.0

—

(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid

240

1911

0.95

0.34

1.1

76.3

77.9

au/ml

—

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

492

1.11

0.33

1.0

—

(3039744) RNA polymerase III Ab [Units/volume] in Serum

184

0.82

0.33

1.0

9.5

4.1

u/ml

—

(3017509) Phencyclidine [Presence] in Urine

126

0.78

0.33

1.2

1.3

—

(3032868) Hemoglobin electrophoresis panel in Blood

126

0.78

0.33

1.3

1.6

—

(3017461) Flecainide [Moles/volume] in Serum or Plasma

123

1.23

0.33

1.3

1.7

1.0

0.7

umol/l

0.64

(40757494) Bilirubin.total [Moles/volume] in Blood

163

1155

1.07

0.33

1.9

2.1

17.0

26.7

umol/l

0.89

104

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

150

1060

1.07

0.33

1.1

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

280

2017

1.05

0.32

1.1

—

(3033086) Enterovirus NOS Ab [Titer] in Serum

1.34

0.32

1.0

—

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

382

3004

0.96

0.32

1.3

1.2

288.4

281.8

u/ml

0.19

233

1916

(3030862) Granulocytes [#/volume] in Cerebral spinal fluid

617

1.09

0.32

1.4

1.2

27.3

23.7

0.17

106

(3018461) Alpha 1 globulin [Mass/time] in 24 hour Urine by Electrophoresis

280

0.86

0.32

4.3

5.0

39.4

46.0

ug/min

0.35

224

(3026051) Polymorphonuclear cells/100 leukocytes in Pleural fluid

523

1.10

0.31

1.4

1.3

27.4

21.7

0.82

440

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

167

1187

1.06

0.31

1.1

—

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

211

1511

1.06

0.31

1.2

—

(3025059) Transferrin.carbohydrate deficient [Mass/volume] in Serum or Plasma

131

1.21

0.31

1.0

1.2

35.0

43.9

mg/l

—

(3040893) Potassium [Moles/volume] in Capillary blood

0.71

0.31

3.1

1.9

4.6

4.3

mmol/l

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

218

1563

1.05

0.31

2.4

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

215

1541

1.05

0.31

1.1

—

(3006567) Chloride [Moles/time] in 24 hour Urine

1.32

0.31

1.0

1.1

—

(3032492) JC virus DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection

1.32

0.31

1.0

1.1

—

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

589

1.09

0.31

2.9

3.0

—

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

659

4839

1.03

0.30

1.3

611.5

553.0

mg/l

0.40

629

4603

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

132

1065

0.94

0.30

1.4

1.7

—

(3032352) Blasts [#/volume] in Cerebral spinal fluid

188

1.17

0.29

2.0

1.8

—

(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture

107

0.78

0.29

1.8

3.4

—

(40761995) Spermatozoa Progressive [#/volume] in Semen

0.75

0.29

3.1

3.0

—

(4212803)

197

0.84

0.29

1.0

1.1

—

(4094501)

759

5881

0.97

0.28

1.1

—

(40763480) Human metapneumovirus Ag [Presence] in Specimen

1.26

0.28

1.4

—

(3033670) Parathyrin related protein [Moles/volume] in Serum or Plasma

375

1.11

0.28

1.2

1.1

2.9

8.7

pmol/l

—

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

194

1392

1.05

0.28

1.0

1.1

305.3

508.6

mg/l

0.47

171

1245

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

163

1164

1.06

0.28

1.1

1.0

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

404

3159

0.97

0.28

2.1

1.9

5824.0

3505.5

u/l

0.65

154

1171

(3051659) 25-hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

147

1.18

0.28

1.2

1.1

15.0

14.7

nmol/l

—

(3009871) Measles virus Ab [Titer] in Serum

666

1.08

0.27

1.7

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

129

1037

0.94

0.27

1.1

1.2

—

(40767665) Peanut recombinant (rAra h) 9 IgE Ab [Units/volume] in Serum

114

0.80

0.27

1.0

0.1

0.8

u/ml

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

113

912

0.94

0.27

1.2

1.3

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

600

4411

1.03

0.27

1.2

—

(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay

1.21

0.27

1.0

—

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

327

2564

0.96

0.26

1.8

186.7

191.6

pmol/l

0.43

309

2382

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

305

1.11

0.26

1.2

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

178

1278

1.05

0.26

1.1

—

(3015822) Parvovirus B19 DNA [Presence] in Serum by NAA with probe detection

1.26

0.26

1.1

—

(3036035) von Willebrand factor (vWf) Ag actual/normal in Platelet poor plasma by Immunoassay

603

1.08

0.25

1.3

1.8

191.8

169.6

0.96

568

(3000919) Neutrophils/100 leukocytes in Pleural fluid

596

1.08

0.25

1.3

1.4

22.6

20.9

0.22

541

(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay

121

0.81

0.25

1.2

1.1

—

(40760409) HLA-A [Type] by High resolution

1.28

0.25

1.0

—

(40760410) HLA-B [Type] by High resolution

1.28

0.25

1.0

—

(46236302) HLA-C [Type] by High resolution typing

1.28

0.25

1.0

—

(40763590) HLA-DQ beta [Type]

1.28

0.25

1.0

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

106

854

0.94

0.25

1.2

—

(3014891) Appearance of Pleural fluid

329

0.90

0.25

1.8

1.6

—

(3036525) Urea [Moles/time] in 24 hour Urine

121

1.19

0.24

3.2

—

(36203821) Streptococcus pneumoniae Danish serotype 1 IgG Ab [Mass/volume] in Serum

121

1.19

0.24

1.6

0.5

2.0

mg/l

2.22

(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification

127

906

1.06

0.24

3.5

5.0

36.6

1018.1

u/ml

—

141

(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma

548

4033

1.03

0.24

3.5

41.6

38.5

u/ml

0.15

527

3891

(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma

216

1565

1.04

0.23

1.5

1.4

13.7

12.7

u/l

1.18

205

1513

(3004268) Protein electrophoresis panel - Cerebral spinal fluid

1.30

0.23

1.0

1.1

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

757

0.94

0.23

1.0

1.1

1775.6

1486.1

miu/ml

1.52

757

(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma

181

1307

1.05

0.23

1.9

16.2

16.5

nmol/l

0.24

169

1227

(3040661) Urea [Moles/volume] in Peritoneal dialysis fluid

0.73

0.22

4.6

5.6

16.4

17.3

mmol/l

—

(36204005) Streptococcus pneumoniae Danish serotype 19F IgG Ab [Mass/volume] in Serum

115

1.18

0.22

1.6

2.6

mg/l

0.72

(3005260) Streptococcus pneumoniae Danish serotype 9V IgG Ab [Mass/volume] in Serum

115

1.18

0.22

1.6

0.3

1.2

mg/l

1.37

(36204286) Streptococcus pneumoniae Danish serotype 5 IgG Ab [Mass/volume] in Serum

115

1.18

0.22

1.6

0.2

1.8

mg/l

3.55

(36204187) Streptococcus pneumoniae Danish serotype 4 IgG Ab [Mass/volume] in Serum

115

1.18

0.22

1.6

1.7

1.1

mg/l

0.19

(36204094) Streptococcus pneumoniae Danish serotype 23F IgG Ab [Mass/volume] in Serum

115

1.18

0.22

1.6

4.7

3.0

mg/l

0.26

(3005665) Streptococcus pneumoniae Danish serotype 6B IgG Ab [Mass/volume] in Serum

115

1.18

0.22

1.6

0.7

2.2

mg/l

1.51

(3016284) Epstein Barr virus nuclear Ab [Units/volume] in Serum

1.22

0.22

1.4

1.1

—

(3001186) Copper [Moles/volume] in Serum or Plasma

440

1.08

0.22

1.3

1.2

17.9

17.4

umol/l

0.37

393

(3045759) Histamine [Moles/volume] in Serum or Plasma

0.00

0.22

0.0

1.8

—

(3020393) Adenovirus Ag [Presence] in Stool

194

1.13

0.21

1.1

1.0

—

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

387

2841

1.03

0.21

1.1

14.3

11.4

au/ml

—

143

(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay

0.78

0.21

1.1

1.0

—

(4027681)

141

1014

1.05

0.21

1.2

1.3

—

(3027696) Helicobacter pylori Ab [Titer] in Serum

1.18

0.21

1.0

1.1

1032.0

2018.8

titre

—

(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen

0.76

0.21

6.3

6.0

—

(3008896) Cortisol [Moles/volume] in Urine

0.00

0.21

0.0

1.2

—

(3049233) Organic acids panel - Urine

0.00

0.21

0.0

1.0

—

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

187

1357

1.04

0.20

1.2

1.1

37.0

44.0

mg/l

1.87

155

1127

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

224

1.11

0.20

1.2

1.1

—

(3045066) Thymidine kinase [Enzymatic activity/volume] in Serum

538

1.07

0.19

1.9

22.3

41.8

u/l

1.66

489

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

577

4266

1.02

0.19

1.3

1.2

3.7

3.8

mmol/l

1.38

542

4010

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

112

803

1.05

0.19

1.1

341.6

326.4

ng/l

0.02

177

(3001893) Eosinophils/100 leukocytes in Pleural fluid

664

1.06

0.19

1.3

1.4

2.8

2.4

0.15

564

(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma

334

1.09

0.19

1.7

1.2

—

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

132

952

1.05

0.19

1.0

1.1

1.2

1.1

u/l

0.56

462

(3024891) Influenza virus A+B Ag [Presence] in Specimen

633

4878

0.98

0.19

1.1

1.2

—

(3013862) HLA-DP [Type]

1.22

0.18

1.0

—

(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma

104

746

1.05

0.18

1.5

28.8

30.5

umol/l

1.18

712

(3034092) Cytoplasmic Ig cells/100 cells in Blood

240

1.10

0.18

8.3

8.9

—

(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method

0.82

0.18

10.6

8.1

—

(3000034) Microalbumin [Mass/volume] in Urine

274

2133

0.97

0.18

3.3

2.9

26.2

45.8

mg/l

1.65

191

1498

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

298

0.91

0.18

1.3

1.1

—

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

329

0.92

0.17

1.4

—

(3008037) Lactate [Moles/volume] in Venous blood

638

4910

0.98

0.17

3.4

3.2

1.5

1.6

mmol/l

1.50

621

4810

(3010375) cycloSPORINE [Mass/volume] in Blood

105

755

1.05

0.17

24.1

28.3

110.9

114.7

ug/l

0.22

641

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

270

1.09

0.17

1.1

1.3

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

149

1081

1.04

0.17

1.3

1.2

—

(3013762) Body weight Measured

0.76

0.17

1.0

1.1

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

453

0.93

0.17

1.3

1.2

—

(3019396) Amylase.pancreatic [Enzymatic activity/volume] in Urine

0.71

0.17

1.0

204.8

201.6

u/l

—

(3038385) Creatinine [Moles/volume] in Peritoneal fluid

0.71

0.17

2.0

1.7

147.4

210.0

umol/l

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

100

719

1.05

0.17

1.1

—

(3035933) Granulocytes/100 leukocytes in Blood

432

1.07

0.16

1.6

1.8

—

(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum

115

0.85

0.16

1.1

—

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

213

1.10

0.16

1.1

1.2

—

(3027300) Silver Birch IgE Ab [Units/volume] in Serum

440

1.06

0.16

1.0

1.1

3.5

7.9

u/ml

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

136

1069

0.96

0.16

1.1

—

(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay

367

1.07

0.15

1.1

80.5

73.7

0.49

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

275

2133

0.97

0.15

1.1

—

(42528717) Cashew nut recombinant (rAna o) 3 IgE Ab [Units/volume] in Serum

114

0.86

0.15

1.0

0.0

2.5

u/ml

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

776

5949

0.99

0.15

2.0

1.8

—

(4035726)

2601

19501

1.01

0.15

1.4

—

(3029396) Erythrocyte agglutination [Presence] in Blood

185

1.10

0.15

2.4

—

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

156

1.11

0.15

1.1

10.9

10.0

u/l

0.14

156

(3037441) Creatinine [Moles/volume] in Peritoneal dialysis fluid

0.81

0.15

4.6

6.1

421.7

384.9

umol/l

—

(40763476) Honey bee phospholipase A2 recombinant (rApi m) 1 IgE Ab [Units/volume] in Serum

0.78

0.14

1.0

—

(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

1.19

0.14

1.0

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

480

0.94

0.14

1.1

—

(3027570) Oxalate [Moles/time] in 24 hour Urine

106

1.14

0.14

1.3

1.4

286.2

336.1

umol/24h

0.45

106

(3012494) Peanut IgE Ab [Units/volume] in Serum

441

0.94

0.14

1.0

0.6

0.7

u/ml

0.03

211

(3016018) Differential panel - Cerebral spinal fluid

269

2082

0.98

0.14

1.3

1.4

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

384

1.06

0.14

1.1

1.2

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

114

895

0.96

0.13

1.1

1.0

—

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

171

1332

0.97

0.13

2.4

2.5

669.4

654.4

e6/l

0.09

564

(3020191) Ethanol [Moles/volume] in Serum or Plasma

184

1431

0.97

0.13

1.4

1.3

promille

0.06

149

1076

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

207

0.91

0.13

1.2

1.1

—

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

246

0.92

0.13

1.0

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

217

1683

0.97

0.13

1.1

—

(3011325) HIV 1+2 Ab [Presence] in Serum

0.83

0.13

1.1

1.0

—

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

341

1.06

0.13

1.1

—

(3020491) Glucose [Moles/volume] in Blood

204

1501

1.03

0.12

1.5

1.9

7.0

mmol/l

0.08

135

1028

(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid

107

1.13

0.12

1.0

—

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

179

1390

0.97

0.12

1.3

1.2

27.7

24.2

u/l

0.39

149

1187

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

505

1.05

0.12

1.8

1.1

—

(3020123) Porphyrins [Interpretation] in Serum or Plasma

115

1.12

0.11

1.1

—

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

115

1.12

0.11

1.0

—

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

127

0.89

0.11

1.0

1.1

—

(3042733) HLA Ab [Presence] in Serum

537

0.96

0.11

4.9

5.3

—

(3042517) Benzodiazepines panel - Urine

108

1.12

0.11

1.6

2.0

—

(3011841) English Walnut IgE Ab [Units/volume] in Serum

111

0.88

0.11

1.0

0.0

0.6

u/ml

—

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

228

0.93

0.11

1.1

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

137

1007

1.03

0.10

1.7

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

360

2763

0.98

0.10

2.6

2.4

—

(3012989) Citrate [Moles/time] in 24 hour Urine

1.11

0.10

2.0

1.5

1.2

2.1

mmol/24h

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

724

1.03

0.10

1.2

1.4

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

734

0.97

0.09

2.0

1.9

—

(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma

1.08

0.09

1.6

2.2

—

(3034099) Cytomegalovirus Ab [Titer] in Cerebral spinal fluid

1.08

0.09

1.0

1.1

—

(46235168) Fasting glucose [Moles/volume] in Blood

211

0.93

0.09

1.3

2.5

7.5

7.2

mmol/l

0.14

100

(3019420) Tryptase [Mass/volume] in Serum or Plasma

136

1001

1.03

0.09

1.5

1.6

9.5

8.6

ug/l

0.21

122

912

(3005011) Chlamydia sp Ab [Titer] in Serum

257

0.94

0.09

1.8

1.7

—

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

184

1420

0.98

0.09

1.3

1.2

91.4

87.8

u/l

0.21

158

1240

(40759836) Histone Ab [Presence] in Serum by Immunoblot

207

1533

1.02

0.09

1.2

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

465

1.04

0.09

1.2

1.1

—

(3028029) Mesothelial cells/100 leukocytes in Pleural fluid

324

1.05

0.08

1.3

1.4

8.9

11.9

0.36

166

(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection

1.14

0.08

1.2

1.4

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

207

1535

1.02

0.08

1.2

—

(3040562) Leukocytes [#/volume] in Peritoneal dialysis fluid by Manual count

0.77

0.08

4.6

9.5

—

(3036955) Alkaline phosphatase.liver/Alkaline phosphatase.total in Serum or Plasma

1.10

0.08

1.9

2.1

—

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

200

1539

0.98

0.08

1.3

1.2

162.3

162.2

titre

0.00

258

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

207

1536

1.02

0.08

1.2

—

(3014114) Aureobasidium pullulans IgG Ab [Mass/volume] in Serum

1.04

0.08

1.0

—

(3010657) Triiodothyronine (T3) Free [Mass/volume] in Serum or Plasma by Dialysis

1.04

0.08

1.6

1.4

—

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood

340

0.96

0.08

5.9

7.6

—

(3005532) Lymphocytes/100 leukocytes in Pleural fluid

107

788

1.03

0.07

1.3

1.4

64.6

62.9

0.18

653

(3020356) Listeria sp identified in Specimen by Organism specific culture

1.06

0.07

1.0

1.1

—

(3009677) Dengue virus Ab [Presence] in Serum

0.85

0.07

1.3

1.2

—

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

293

0.95

0.07

1.2

1.1

—

(3009461) 5-Hydroxyindoleacetate [Moles/time] in 24 hour Urine

1.05

0.07

1.2

—

(40765089) Chromosome analysis panel - Blood by G-banded

185

0.94

0.07

1.0

—

(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma

728

0.98

0.06

1.4

1.3

2.8

3.4

umol/l

1.18

664

(3009224) EGFR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

0.88

0.06

1.0

—

(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

103

796

0.98

0.06

2.3

48.0

55.9

umol/l

2.13

635

(3046294) Neutrophil cytoplasmic Ab.classic [Titer] in Serum

200

1534

0.98

0.06

1.3

1.2

253.3

171.8

titre

—

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

414

0.97

0.06

1.7

1.6

—

(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

207

0.95

0.06

1.1

1.0

—

(3004437) Lymphocytes/100 leukocytes in Peritoneal fluid

149

1.06

0.06

2.2

1.7

66.3

60.4

0.31

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

210

1565

1.01

0.05

1.8

1.7

—

(3050794) Legionella sp Ab [Presence] in Serum

164

1.06

0.05

1.1

—

(43055514) Macroprolactin [Presence] in Serum or Plasma

291

0.96

0.05

1.6

1.5

—

(44786774) Adalimumab [Mass/volume] in Serum or Plasma

535

0.97

0.05

1.7

1.8

8.8

9.3

mg/l

0.35

428

(40761873) Peanut recombinant (rAra h) 1 IgE Ab [Units/volume] in Serum

122

0.93

0.05

1.0

0.0

0.2

u/ml

—

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

428

3207

1.01

0.05

1.2

—

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

456

1.03

0.05

1.1

—

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

252

0.96

0.05

4.0

5.2

—

(40765096) Chromosome analysis panel by Banding

572

0.98

0.05

1.1

—

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

162

1207

1.01

0.05

1.6

1.4

5.9

5.8

u/l

0.07

142

992

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

524

1.02

0.04

1.2

278.8

314.8

pmol/l

0.35

381

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

236

0.96

0.04

1.1

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

165

1231

1.01

0.04

1.0

1.1

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

605

4545

1.01

0.04

1.3

237.8

214.5

miu/ml

0.78

256

2009

(3014148) Varicella zoster virus Ab [Titer] in Serum

262

1962

1.01

0.04

1.1

—

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

568

4268

1.01

0.04

1.4

29.2

34.5

e6/l

0.17

459

3308

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

207

1549

1.01

0.03

1.2

—

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

174

0.96

0.03

1.1

1.0

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

207

1550

1.01

0.03

1.2

—

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

143

0.95

0.03

1.0

1.1

—

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

219

1.03

0.03

1.2

1.1

—

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

408

3099

0.99

0.03

1.3

1.4

127.6

115.9

u/ml

0.48

108

718

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

207

1551

1.01

0.03

1.2

—

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

568

4273

1.00

0.03

1.5

1.4

1958.0

2136.7

e6/l

0.08

484

3487

(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method

135

0.95

0.02

4.6

—

(3008691) Amylase [Enzymatic activity/volume] in Peritoneal fluid

107

1.06

0.02

1.3

1.4

123.8

1011.5

u/l

0.71

(3021879) Hepatitis B virus core Ab [Presence] in Serum

1573

11859

1.00

0.02

1.3

1.4

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

2806

21229

1.00

0.02

1.5

1.6

—

(3018001) Oat IgE Ab [Units/volume] in Serum

112

0.94

0.02

1.0

0.1

0.2

u/ml

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

393

0.98

0.02

1.2

1.1

—

(3044290) Cell count panel - Cerebral spinal fluid

526

3988

1.00

0.02

1.3

1.4

—

(40761871) Peanut recombinant (rAra h) 3 IgE Ab [Units/volume] in Serum

119

0.95

0.02

1.0

0.0

u/ml

—

(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis

138

1.04

0.01

1.2

—

(3019768) Coxiella burnetii Ab [Presence] in Serum

108

1.05

0.01

1.0

1.2

—

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

270

0.98

0.01

1.4

1.9

—

(3020874) Milk IgE Ab [Units/volume] in Serum

129

980

0.99

0.00

1.0

u/ml

0.02

274

(3026726) Creatinine [Moles/volume] in Specimen

169

1.03

0.00

2.2

2.5

239.8

385.6

umol/l

0.57

161

(40771922) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood

151

1.00

0.00

1.5

1.3

1.0

ml/s/173m2

—

(40758358) Immune stain study

109

0.97

0.00

1.0

—

(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay

0.98

0.00

1.1

—

(3003577) Lead [Moles/volume] in Blood

110

0.96

0.00

1.8

1.3

0.1

umol/l

—

(21493619) Chromosome 12 trisomy and chromosome region 11q22.3 and 13q14 and 17p13.1 deletion in Blood or Tissue by FISH

1.02

0.00

1.1

1.2

—

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

102

1.04

0.00

1.1

1.3

—

(3030313) Adrenal Ab [Titer] in Serum

133

1.02

0.00

1.0

1.1

—

(46234826) Other cells/100 leukocytes in Peritoneal fluid by Manual count

117

0.97

0.00

2.0

1.7

6.5

16.4

—

(3003985) Beta hydroxybutyrate [Moles/volume] in Serum or Plasma

173

1.00

0.00

2.6

2.3

0.7

0.9

mmol/l

0.41

114

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

336

0.99

0.00

1.3

1.2

—

(3019779) Phenytoin [Moles/volume] in Serum or Plasma

262

1.01

0.00

3.7

3.1

38.6

40.3

umol/l

0.19

223

(40766799) MGMT gene methylation score in Tissue by Molecular genetics method

139

0.98

0.00

1.0

—

(1761482) Bacteria [#/volume] in Urine by Culture

777

5869

1.00

0.00

4.4

4.2

—

(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen

0.99

0.00

1.5

1.4

—

(36304052) Adalimumab Ab [Units/volume] in Serum or Plasma

443

1.01

0.00

1.4

1.6

95.9

136.3

au/ml

0.40

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

480

1.01

0.00

1.3

1.2

—

(3004905) Lipase [Enzymatic activity/volume] in Serum or Plasma

378

1.00

0.00

5.5

5.0

37.1

55.2

u/l

1.44

159

(3030703) Everolimus [Mass/volume] in Blood

0.00

0.0

24.7

—

5.4

—

(3010937) Rubella virus Ab [Presence] in Serum

0.90

0.00

1.0

1.1

—

(3045519) Venlafaxine [Moles/volume] in Serum or Plasma

1.01

0.00

1.3

1.4

350.4

477.7

nmol/l

—

(3001556) Androgen free Index in Serum or Plasma

0.88

0.00

1.1

1.2

—

(3009220) Epithelial cells.squamous [#/volume] in Urine sediment

0.00

0.0

1.1

—

2.2

—

(3017937) Magnesium [Moles/time] in 24 hour Urine

0.91

0.00

1.4

1.2

—

(3045191) Normetanephrine [Moles/volume] in Urine

0.00

0.0

1.2

—

(40757578) FLT3 gene targeted mutation analysis in Bone marrow by Molecular genetics method

0.90

0.00

1.0

1.1

—

(3039542) Porphyrins [Moles/time] in 24 hour Urine

0.00

0.0

1.2

—

(3005117) Influenza virus A Ab [Titer] in Serum

0.00

0.0

1.0

—

(3050099) BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection

0.99

0.00

3.8

3.5

—

(42529039) t(15;17)(q24.1;q21.1)(PML,RARA) fusion transcript/control transcript [# Ratio] in Bone marrow by Molecular genetics method

0.00

0.0

4.2

—

(3027114) Cholesterol [Mass/volume] in Serum or Plasma

0.00

0.0

1.0

—

(3033463) Neutrophils [#/volume] in Cerebral spinal fluid

0.00

0.0

1.0

—

(3022670) pH of Venous cord blood

0.00

0.0

1.2

—

(3043649) Fibrin monomer [Presence] in Platelet poor plasma by Hemagglutination

1.02

0.00

1.0

1.1

—

(3047185) IgG [Mass/volume] in Urine

0.94

0.00

1.0

1.1

—

44.1

—

(3004959) Base excess in Arterial cord blood by calculation

0.00

0.0

1.2

—

(3004560) Lymphocytes [#/volume] in Cerebral spinal fluid

0.00

0.0

1.0

—

(3006598) pH of Arterial cord blood

0.00

0.0

1.2

—

(3032641) Amino acids panel - Urine

0.00

0.0

1.4

—

(3014339) Estrone (E1) [Moles/volume] in Serum or Plasma

0.98

0.00

1.0

1.1

275.0

261.0

pmol/l

—

(3019298) Eosinophils/100 leukocytes in Peritoneal fluid

0.92

0.00

1.0

1.2

0.0

0.6

—

(3006392) Corynebacterium diphtheriae [Presence] in Specimen by Organism specific culture

0.00

0.0

1.0

—

(3017501) Neutrophils [#/volume] in Blood by Manual count

0.00

0.0

2.0

—

Mortality – FinRegistry

↥

Association

Association between endpoint I9_VARICVE and mortality.

Females

Parameter	HR [95% CI]	p-value
I9_VARICVE	1.201 [1.11, 1.3]	< 0.001
Birth year	0.995 [0.99, 1.0]	0.154

During the follow-up period (1.1.1998 — 31.12.2019), 13569 out of 81126 females with I9_VARICVE died.

Males

Parameter	HR [95% CI]	p-value
I9_VARICVE	1.353 [1.25, 1.46]	< 0.001
Birth year	0.987 [0.98, 1.0]	0.003

During the follow-up period (1.1.1998 — 31.12.2019), 9441 out of 36537 males with I9_VARICVE died.

Mortality risk

Mortality risk for people of age

years, who have I9_VARICVE.

N-year risk	Females	Males
1	0.094%	0.249%
5	0.673%	1.642%
10	1.582%	3.913%
15	3.14%	7.079%
20	5.497%	11.948%

Relationships between endpoints

↥

Index endpoint: I9_VARICVE – Varicose veins

GWS hits: 212

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Varicose veins

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints